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Abstract. 
Pharmaceuticals and personal care products (PPCPs) have recently emerged as a 
significant new class of organic micro-contaminants. Of recent years a number of 
reports detailing the presence of PPCPs in a variety of environmental matrices and 
compartments have been published in the peer-reviewed literature. However, in 
Ireland very little research has been conducted to determine the level of 
environmental contamination due to the presence of drug residues. 
The primary focus of this research is to develop suitably sensitive analytical 
methods for the determination of residual PPCP contamination based upon solid 
phase extraction (SPE) and liquid chromatography mass spectrometry (LC-MS). 
Monolithic silica based stationary phases were used for the development of high 
performance liquid phase separations of common pharmaceuticals, the antifouling 
and anti-dandruff agent zinc pyrithione and a range of illicit drugs and abused 
pharmaceuticals. As a pre-requisite to all the developed methods, a SPE sample 
enrichment procedure was also developed focusing upon either off-line formats 
using modern hydrophilic lipophilic balanced polymeric phases or the use of 
column switching, whereby short reversed-phase monolithic micro-columns were 
applied as suitable traps for on-line preconcentration. Method performance data for 
all the developed methods were also determined and analytical detection limits 
were found to lie in the n g ~ - '  range. The developed methods were applied for the 
determination of the selected analytes in environmental aquatic samples. 
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concerning pharmaceuticals in the environment, (see footnote on 
previous page for further information). 
Possible sources and entry pathways of human and veterinary 
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The time of flight mass analyser. 
Optimised MeOH gradient separation of 19 pharmaceuticals on 20 
cm reversed-phase silica monolithic column (pH 3.0 formic acid). 
Peak identification: 1 Paracetamol; 2 Trimethoprim; 3 Caffeine; 4 
Salicylic acid; 5 o-Toluic acid; 6 Clotrimazole; 7 2-Naphthoic acid, 
(internal standard); 8 Ketoprofen; 9 Clofibric acid; 10 Naproxen; 11 
Warfarin; 12 Bezafibrate; 13 Flurbiprofen; 14 Diclofenac; 15 
Ibuprofen; 16 Meclofenamic acid; 17 Mefenamic acid; 18 & 19 
Gemfibrozil and Triclosan. 
3.2 Resolution response surface for pH and buffer strength optimisation. 
Standard mixture as in Figure 3.1. 
3.3 Optimised MeOH gradient separation of 19 pharmaceuticals on 20 
cm reversed-phase silica monolithic column (pH 4.5, 1 mM formic 
acid). Peak identification: 1 Paracetamol; 2 Salicylic acid; 3 
Trimethoprim; 4 Caffeine; 5 o-Toluic acid; 6 Clofibric acid; 7 2- 
Naphthoic acid, (internal standard); 8 Ketoprofen; 9 Bezafibrate; 10 
Naproxen; 11 Warfarin; 12 Flurbiprofen; 13 Diclofenac; 14 Ibuprofen; 
15 Meclofenamic acid; 16 Mefenamic acid; 17 Clotrimazole; 18 
Gemfibrozil; 19 Triclosan. 
3.4 As Figure 3.3 with applied linear flow gradient from 1 mlminml at t=O 
to 3 mlmin-' at 75 minutes. Peak identification: 1 MetFormin; 2 
Paracetamol; 3 Salicylic acid; 4 Trimethoprim; 5 Caffeine; 6 o-Toluic 
acid; 7 Propranolol; 8 Clofibric acid; 9 2-Naphthoic acid, (internal 
standard); 10 Ketoprofen; I I Bezafi brate; 12 Naproxen; 13 Warfarin; 
14 Flurbiprofen; 15 Diclofenac; 16 Indomethacin; 17 Ibuprofen; 18 
Meclofenamic acid; 19 Mefenamic acid; 20 Clotrimazole; 21 
Gemfibrozil; 22 Triclosan. 
3.5 Investigation into the effect of increasing the operational separation 
temperature on the overall resolution product, (R). Separation 
conditions were as per those previously described in Table 3.2. 
3.6 Plot of relative % recovery versus SPE elution volume (mL) using 
Strata-X SPE cartridges and elution with 50 % v/v ethyl acetate in 
acetone. Key: black trace; ibuprofen, green trace; clofibric acid, pink 
trace; ketoprofen, orange trace; diclofenac, blue trace; mefenamic 
acid, red trace; salicylic acid. 
3.7 Chromatogram of the extracted 1 pg~ ' l  spiked Malahide Estuary 
sample. Conditions as in Figure 3.4. Peak identification: 1 MetFormin, 
2 Paracetamol, 3 Salicylic acid, 4 Trimethoprim, 5 Caffeine, 6 o-Toluic 
acid, 7 Propranolol, 8 Clofibric acid, 9 2-Naphthoic acid, (internal 
standard, 10 Ketoprofen, 11 Bezafibrate, 12 Naproxen, 13 Warfarin, 
14 Flurbiprofen, 15 Diclofenac, 16 Indomethacin*, 17 Ibuprofen, 18 
Meclofenamic acid, 19 Mefenamic acid, 20 Clotrimazole*, 21 
Gemfibrozil*, 22 Triclosan, 23 Ivermectin*, (*Actual spiking level: 2 
P P ~ ) .  
3.8 Partial contour plot of spiked Malahide estuary sample, 
distinguishable UV spectra can be obtained even for ultra trace 
residues with sample preconcentration using SPE. 
4.1 On-line SPE experimental set-up. 
4.2 Standard separation of chosen pharmaceuticals. Peak identification: 
1; MetFormin, 2; Atenolol, 3; Salbutamol, 4; Acetaminophen, 5; 
Amoxicillin, 6; Salicylic acid, 7; Trimethoprim, 8; Sulfamethazine, 9; 
Sulfamethoxazole, 10; Caffeine, 11 ; Ciprofloxacin, 12; Furosemide, 
13; Propranolol, 14; Clofibric acid, 15; Carbamazepine, 16; 
Ketoprofen, 17; Bezafibrate, 18; Nimesulide, 19; Naproxen, 20; 
Fluoxetine, 21; Warfarin, 22; Flurbiprofen, 23; Diclofenac, 24; 
Indomethacin, 25; Ibuprofen, 26; Meclofenamic acid, 27; Mefenamic 
acid, 28; Clotrimazole, 29; Gemfibrozil, 30; Triclosan, 31; Ivermectin. 
The blue trace is offset by 2.5 minutes in time and 5 mAU, the red 
trace is offset by 5 minutes in time and 10 mAU for the purposes of 
clarity, separation conditions as per Table 3.1. 
4.3 Extraction column backpressure generated at various flow rates of 
Milli-Q water. 
4.4 Matrix removal using MeCN washes; (A) depicts the determination of 
the % MeCN required for the removal of the sample matrix. (B) 
depicts the removal of the preconcentrated matrix under the chosen 
isocratic solvent wash conditions (1 0% MeCN). 
4.5 On-line SPE wash development, depicting the effect of the matrix 
removal wash procedure upon the retention of the analytes on the 
xiii 
short monolithic extraction column, a MeCN gradient (dashed line), 
was used to completely remove the retained components from the 
trap column. The black trace depicts the matrix profile, the blue trace 
depicts the elution profile of the retained analytes, (200 n g ~ ~ ' )  and the 
red trace depicts a 'blank extraction' of reagent water. 
4.6 Extraction to extraction carryover. The black trace depicts the elution 
of the 'unwashed' sample matrix from the extraction and analytical 
columns. The red trace depicts the resulting UV trace and shows that 
there is no residual matrix contamination on the analytical column. 
The blue trace is the resulting UV trace of the reconditioned 
monolithic trap. 
4.7 Overlay chromatogram of 200 ngLbl analyte spikes in river, (red trace) 
and potable water, (blue trace). Peak Identification: I; Ketoprofen, 2; 
Bezafibrate, 3; Nimesulide, 4; Naproxen, 5; Fluoxetine, 6; Warfarin, 7 ;  
Flurbiprofen, 8; Diclofenac, 9; Indomethacin, 10; Ibuprofen, 11; 
Meclofenamic acid, 12; Mefenamic acid, 13; Clotrimazole, 14; 
Gemfibrozil, 15; Triclosan, 16; Ivermectin. Separation conditions as 
per Table 3.1. 
4.8 TIC and EIC traces of river water spiked with 200ngL-I using (A) 
positive and (B) negative electrospray polarity. m/z Values: 
Ketoprofen (255.0); Bezafibrate (362.1); Naproxen, (231.0); 
Fluoxetine (31 0.0); Ibuprofen (251 1 )  Clotrimazole (277.0); 
Gemfibrozil (121.1); Mefenamic acid (240.0); Meclofenamic acid 
(294.0); lndomethacin (312.0); Diclofenac (250.0); Flurbiprofen 
(199.0); Nimesulide and Walfarin both (307.0). 
5.1 The structures of the pyrithione ligand tautomeric pair; (A) 2- 
mercaptopyridine-N-oxide and (B) N-hydroxypyridine-2-thione, (C) the 
structure of zinc pyrithione; (ZnPT) and (D) the structure copper 
pyrithione; (CuPT). 
5.2 Overlaid pyridine phenol test chromatograms to examine the silanol 
activity of perspective analytical columns. Test conditions: mobile 
phase 50% MeCN in water with UV detection at 254 nm, column 
temperature 40°c, concentrations; 0.5 pLrnL-' pyridine and 4 mgmL-' 
phenol. Peak Identification: I Phenol, 2, Pyridine. 
5.3 The effect of stationary phase metal contamination upon ZnPT, the 
bottom trace depicts a 20 m g ~ - '  ZnPT injection prior to washing the 
stationary phase with dipicolinic acid, the upper trace depicts an 
injection of the same 20 m g ~ - '  standard ZnPT solution after washing 
the stationary phase with dipicolinic acid. The MeOH gradient used is 
depicted by the black line, TR ZnPT = 16.60 minutes. 
5.4 A 5 mgL-' injection of ZnPT on the Chromolith Performance RP-18e 
monolithic column using the multi step gradient, TR ZnPT = 9.2 
minutes. 
5.5 5 mgL" ZnPT standard injections using LC-APCI-MS on the 
Chromolith Performance RP18e monolithic column. The blue trace 
was recorded using a mobile phase of methanol and 10 mM 
ammonium acetate I acetic acid buffer pH 4.7, the red trace was 
recorded using 10 mM ammonium acetate pH 6.5. The calculated 
USP asymmetry value for the red trace was 0.95. 
5.6 APCI-MS spectrum of ZnPT showing the [M+H]' pseudomolecular ion 
at rnlz 31 7.0 and a decomposition product ion at mlz 221 . I .  lnset A 
shows the expanded isotopic pattern of the pseudomolecular ion and 
lnset B depicts the theoretical isotopic patter as calculated by the 
Sheffield Chemputer re-plotted using Microsoft ~ x c e l ~ ~ .  
5.7 Proposed structure of the ion at rnlz 221.2 and the MSlMS daughter 
ion at rnlz 11 1.2. 
5.8 APCI-MS spectrum of CuPT showing the [M+H]+ pseudomolecular 
ion at rnlz 316.0. lnset (A) shows the expanded isotopic pattern of the 
pseudomolecular ion and lnset (B) depicts the theoretical isotopic 
patter as calculated by the Shefield Chemputer re-plotted using 
Microsoft ~ x c e l ~ ~ .  
5.9 Optimisation of the APCl ionisation parameters, (A) corona voltage 
optimisation and (B) APCl temperature optimisation, inserted y-error 
bars are the standard deviation of the three replicate measurements. 
Overlaid EIC rnlz 31 7.0 traces showing the degradation of ZnPT upon 
its passage through the Merck sample pump at a flow rate of 6 
mlmin-'. 
Optimisation of the C18 extraction parameters, (A) the sample pH and 
(B) the salt concentration. In each instance an increase in the % 
recovery is observed with increasing pH and [NaCI]. 
1 pgL-I ZnPT spike in laboratory tap water depicting the matrix 
interference even after the use of a solvent wash procedure. 
Overlay of EIC mlz 316 trace depicting the extraction of 1 p g ~ - l  ZnPT 
using the Si-SAX-C18 tandem column. 
EIC mlz 316 chromatogram depicting the extraction of 1 pgl-' ZnPT 
from river water. 
Overlaid EIC mlz 316 traces depicting minimal sample to sample 
carryover on the analytical and extraction columns. 
The effect of different copper salts upon the transchelation of ZnPT to 
CuPT: extracted EIC rnlz 316 traces depicting a 1 pgL-' ZnPT extract 
to which a 20 fold excess of CU" had been added, samples prepared 
in river water. 
The determination of ZnPT as CuPT in anti-dandruff shampoo 
samples diluted in river water as a waste matrix. The blue trace 
represents Dove Anti-Dandruff shampoo which contains 0.37% wlw 
ZnPT, the concentration corresponding to the blue trace is -76 ngL-'. 
The red trace represents Head and Shoulders Classic Clean 
shampoo which contains 0.80% wlw ZnPT, the concentration 
corresponding to the red trace is -80 ngl-'. 
Overlaid EIC rnlz 316 traces for the analysis of the BCSS-1 extracted 
and preconcentrated sediment phase and the BCSS-1 water phase. 
Degradation of CuPT in filtered river water upon exposure to natural 
sunlight under laboratory conditions. 
(A) Plot of plate height (H) versus mobile phase linear velocity using 
diazepam as the test analyte, (B) Plot of plate number (N) versus 
mobile phase linear velocity and (C) Plot of plate number (N) versus 
the generated backpressure on the 1.8 pm column (+), the 10 cm 
monolithic column (m) and the 20 cm monolithic column (A). 
6.2 Kinetic comparison of the examined stationary phases; (A) a plot of to 
versus the pressure drop limited plate number (N), and (B) a plot of 
the to based separation impedance Eo versus the ratio of pressure 
drop limited plate number (N/Nopt). Symbols: 1.8 pm column (+), the 
10 cm monolithic column (m) and the 20 cm monolithic column (A). 
6.3 Minimum resolution response surface for the optimisation of the pH 
and buffer concentration of the aqueous mobile phase. Experiments 
were performed using a 1 mgL-' standard mixture of analytes. 
6.4 Separation of a 1mgL-' standard solution of all analytes using a 
multistep gradient of MeOH and 5 mM ammonium acetate, pH 4.5 
on the 200.0 mm x 3 mm i.d. monolithic column at a flow rate of 
0.35 m~min- '  using ESI-MSIMS detection. The traces have been 
offset for the purpose of clarity. Peak identification, 1 morphine, 2 
amphetamine, 3 MDMA, 4 benzoylecgonine, 5 ketamine, 6 heroin, 
7 cocaine, 8 cocaethylene, 9 LSD, 10 EDDP, 11 papaverine, 12 
methadone, 13 fluoxetine, 14 temazepam, 15 diazepam and 16 A'- 
THC. 
6.5 Resulting chromatograms from banknote analysis depicting; (A) the 
presence of -24 ng of cocaine (blue trace) on a €5 note overlaid upon 
the EIC mlz 304 trace for the un-circulated €5 note (red trace) and (B) 
the presence of -20 ng cocaine and -4 ng of benzoylecgonine on a 
€20 banknote, (blue and red traces respectively). 
6.6 Graphical representation of cocaine contamination on the analysed 
banknotes. The highest levels were detected on one €5 note and one 
€20 note as labelled in the above figure. It can also be seen that the 
levels of contamination are higher on the €20 and €50 notes than on 
the €5 and €1 0 notes. 
7.1 The structure of (A) the Phenomenex strata-x'" hydrophilic lipophilic 
balanced polymeric sorbent, (B) the additional strong cation 
xvii 
exchange functionality of the strata-xcTM sorbent and (C) the weak 
cation exchange functionality of the strata-XCW~ sorbent. 
7.2 Plot of % relative recovery versus SPE elution volume using Strata- 
XC SPE cartridges and elution with 5% vlv NH40H in 1:1 acetone 
ethyl acetate. Key: black trace; methadone, blue trace; cocaine, red 
trace; temazepam. 
7.3 Extracted ion chromatograms for a 200 ngL-' mixed analyte spike 
solution prepared in river water collected from the River Boyne. Peak 
identification: 1 Morphine mlz 286 - m/z 268, TR 4.1 mins; 2 MDMA 
rnlz 194 - mlz 163, TR 8.6 mins; 3 Benzoylecgonine rnlz 290 - rnlz 
168, TR 9.7 mins; 4 Ketamine mlz 238 - mlz 220, TR 10.0 mins; 5 
Cocaine mlz 304 - rnlz 182, TR 10.2 mins; 6 Cocaethylene mlz 31 8 - 
rnlz 196, TR 11.5 mins; 7 LSD rnlz 324 - rnlz 223, TR 11.8 mins; 8 
EDDP mlz 278 - rnlz 249, TR 12.5 mins; 9 Papaverine (Internal 
Standard) rnlz 340 - rnlz 202, TR 13.9 mins; 10 Methadone mlz 31 0 - 
rnlz 265, TR 16.8 mins; 11 Temazepam rnlz 301 - mlz 283, TR 17.9 
mins; 12 Fluoxetine rnlz 301 - m/z 148, TR 18.3 mins; 13 Diazepam 
mlz 285 - rnlz 257, TR 20.0 mins. 
7.4 (A) The presence of ngL-' quantities of benzoylecgonine and cocaine 
in the influent and effluent of the Ringsend Wastewater Treatment 
Works, key: benzoylecgonine influent; red trace, benzoylecgonine 
effluent; pink trace, cocaine influent; blue trace, cocaine effluent; 
black trace, and (6) the presence of n g ~ - '  quantities of EDDP in the 
treated effluent of the Navan Wastewater Treatment Centre. 
Tables: 
Table 
Caption 
Number 
3.1 Chemical structures of the pharmaceuticals and metabolites selected 
for study. 
3.2 Liquid chromatographic method parameters. 
Dual gradient HPLC method performance data. 
Sorbent selection performance data (calculated % recoveries). 
Extraction repeatability and overall method precision calculated using 
1 pg~ - l  spikes in river water, (*actual spiking level was 2 vg~-') .  
Overall method sensitivity data calculated in two different sample 
matrices, (1 L extraction volume), values quoted are in vgL-'. 
The chemical structures of the additionally included pharmaceuticals. 
pK, and Log P data for the selected pharmaceutical analytes. 
The effect of sample loading flow rate upon analyte recovery. 
Analyte recovery as a function of sample pH. 
Overall method sensitivity using on-line SPE. 
Overall method precision and analyte recovery from two different 
sample matrices, (n = 10). 
Tuned ESI-MS method parameters, (optimisation was performed 
using a nebuliser pressure of 55 psi, dry gas flow of 8 Lmin-' and a 
drying temperature of 300°C). 
Optimised ion focusing APCI-MS parameters for ZnPT, (the 
optimisation was performed using a nebuliser pressure of 50.0 psi, a 
dry gas flow of 10.0 Lmin-I, a drying temperature of 325OC, a corona 
voltage of +3200 V and an APCl temperature of 500°C). 
Online SPE LC-APCI-MS method performance data. 
TOC and metal content of the two certified sediment samples. 
Calculated concentrations of CuPT in the aqueous and sediment 
phases after a 2 hour mixing period. 
The chemical structures of the illicit drugs and abused 
pharmaceuticals chosen for study. 
Optimised ion focusing parameters for ESI-MSIMS detection, (the 
optimisation was performed using a nebuliser pressure of 10.0 psi, a 
dry gas flow of 3.0 Lmin" and a drying temperature of 300°C. 
Spectra were collected over the range 50 - 600 mlz). 
Selected product ion transitions for MSIMS monitoring. 
6.4 Method performance data. 
6.5 Banknote analysis. 
7.1 Wastewater treatment plants sampled for the presence of illicit drugs. 
7.2 pK, and Log P, (as theoretically calculated XLogP) data for the 
selected illicit drugs and pharmaceutical analytes. 
7.3 Initial sorbent selection investigations; calculated analyte recovery for 
a 2 p g ~ - l  mixed spike using the sorbents and conditions mentioned in 
the text, (values quoted are mean recovery f standard deviation, n = 
3). 
7.4 Calculated analyte recovery for the optimisation of the elution 
solvent. 
7.5 Recovery data for extraction pH optimisation. 
7.6 Method performance data for the developed SPE LC-MSIMS 
procedure. 
7.7 Concentrations (ng~- ' )  of illicit drugs detected in collected wastewater 
and surface water samples. 
7.8 Cocaine loads within the sampled wastewater treatment plants. 
7.9 Estimated community consumption of cocaine within the catchments 
served by the sampled wastewater treatment plants. 
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APCl 
BOD 
CE 
CuPT 
DC 
DDD 
DOC 
DOM 
EDDP 
EIC 
EMEA 
EPA 
ERA 
ESI 
EtOAc 
EU 
FA 
FePT 
GAC 
GC 
GC-MS(1MS) 
GREAT-ER 
HPLC 
HPTLC 
IC 
ICP 
IMB 
Atmospheric Pressure Chemical lonisation 
Biochemical Oxygen Demand 
Capillary Electrophoresis 
Copper (11) Pyrithione 
Direct Current Potential 
Defined Daily Dose 
Dissolved Organic Carbon 
Dissolved Organic Matter 
2-Ethyldine-I ,5-dimethyl-3,3-diphenyl pyrrolidine 
Extracted Ion Chromatogram 
European Medicines Evaluation Agency 
Environmental Protection Agency, (Irish) 
Environmental Risk Assesment 
Electrospray lonisation 
Ethyl Acetate 
European Union 
Formic Acid 
Iron (Ill) Pyrithione 
Granular Activated Carbon 
Gas Chromatography 
Gas Chromatography Mass Spectrometry, (tandem-MS) 
Geography Referenced Regional Exposure Assessment Tool 
for European Rivers 
High Performance Liquid Chromatography or LC 
High Performance Thin Layer Chromatography 
Ion Chromatography 
Inductively Coupled Plasma 
Irish Medicines Board 
IMO 
IPA 
IR 
KD 
Koc 
Kow 
LC 
LC-MS(1MS) 
LLE 
LOD 
LOEC 
LOQ 
LSD 
MDMA 
MEC 
MeCN 
MeOH 
MES 
MIPS 
MnPT 
MS 
MSDS 
MtBE 
NADPH 
NMR 
NOEC 
NOM 
PAHs 
PAPS 
PEC 
PNEC 
International Marine Organisation 
lsopropyl Alcohol 
Infra-red Spectroscopy 
Liquid-Solid Distribution Coefficient 
Organic Carbon Partition Coefficient 
Octanol Water Partition Coefficient 
Liquid Chromatography or HPLC 
Liquid Chromatography Mass Spectrometry, (tandem-MS) 
Liquid-Liquid Extraction 
Limit of Detection 
Lowest Observed Effect Concentration 
Limit of Quantitation 
Lysergic Acid Diethylamide 
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I .O Pharmaceuticals and Personal Care Products - 
An emerging class of environmental pollutants. 
1 . 1  Introduction: 
Until relatively recently pharmaceuticals and personal care products (PPCPs), 
enjoyed anonymity as an undiscovered class of environmental micro 
contaminants. In 1985 Richardson and Bowron hypothesised that PPCPs may 
indeed enter the aquatic environment as a result of either industrial or human 
waste disposal to wastewater treatment plants (WWTPs) where they may 
totally biodegrade, partially biodegrade or persist. Therefore, as a consequence 
treated effluents that are discharged into receiving waters may contain residues 
of pharmaceutical compounds [I ] .  The concept that PPCPs may be present in 
the environment was a new one. However, the presence of PPCPs in the 
environment received little attention until the late 1990s and the advent of 
sophisticated analytical instrumentation and methodologies capable of 
detecting the ultra trace quantities of PPCPs likely to be present. Up to then 
research focused on classes of pollutants that could be readily analysed with 
confidence using traditional 'gold standard' gas chromatographic mass 
spectrometric (GC-MS) methods such as polynuclear aromatic hydrocarbons 
(PAHs), chlorinated organics and pesticides to name but a few [2]. The fact that 
PPCPs reflect an emerging class of organic micro pollutants is clearly 
demonstrated by Fig. 1 .I, which depicts the number of peer-reviewed articles 
concerning PPCPs in the environment published within the last decade'. 
Pollution arising from PPCP presence presents an immense and 
troubling problem. In Ireland alone there are -3,000 compounds licensed by the 
Irish Medicines Board (IMB), for market and use as human and veterinary 
medicines [3] and consequently each of these compounds along with their 
range of metabolites may possibly enter the environment. This number of 
-3,000 only accounts for compounds that require a license for sale in this 
' Fig. 1 .I was constructed by searching for term 'Pharmaceutical* AND Environment' within the IS1 Web of 
Science 'Science Citation Index'. Returned results were screened for suitability. The search was last 
performed on 2oth December 2006; the database was last updated 16 '~  ~ecember  2006. 
country, i.e. pharmaceuticals and medicines but overlooks those chemicals 
present in personal care products such as fragrances, hair products, soaps and 
detergents etc. all of which can be freely purchased 'off the shelf' or 'over the 
counter' in most shops and supermarkets. 
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Figure 1.1: Peer-reviewed articles published within the period of 1995 to 2006 concerning 
pharmaceuticals in the environment, (see footnote on previous page for further information). 
Ideally all anthropogenic chemicals that enter the environment should 
harmlessly biodegrade; however, pharmaceuticals by design are highly stable 
and potent biomolecules and to date very little is known about the possible 
impact they may have in the environment due to the lack of toxicological 
information. Another worrying concept connected with PPCP pollution is that 
unlike industrial chemicals or pesticides that are emitted from point sources 
during times of acute usage, PPCPs may be introduced into to the environment 
continually by humans wherever they may be. Therefore even areas that were 
once thought to be pristine, e.g. tourist attractions such as areas of natural 
beauty, due to lack of industry or agriculture may in fact be polluted with 
detectable amounts of PPCPs [4]. 
The alarming presence of PPCPs in the environment has resulted in the 
addition of two pharmaceuticals and one personal care product to the 'Oslo 
Paris Convention for the Protection of the Marine Environment of the North 
East Atlantic - OSPAR' priority chemical list [5]. The said pharmaceutical 
substances are clotrimazole (antifungal agent) and diosgenin, (steroid 
hormone); the personal care product is musk xylene, (synthetic musk present in 
perfumes and fragrances). These substances were chosen due to their 
persistence, ability to bioaccumulate and also their toxicity and rank as highly 
as other pollutants such as heavy metals, organo halogens and biocides. 
This section aims to present the reader with a concise review of current 
knowledge concerning the occurrence, fate and effects of pharmaceutically 
active compounds in the environment. Future prospects concerning the 
removal and avoidance of PPCP pollution will also be presented. 
1.2 Sources of Pharmaceuticals in the Environment: 
The detection of a multitude of pharmaceutical compounds in the environment 
posed the question of how such speciality compounds, specifically designed for 
use in human and veterinary medical practice could end up in ground and 
surface waters. When compared to other aquatic pollutants such as pesticide 
residues, the entry of pharmaceuticals into the environment depends on a 
number of integral factors [6]. These factors include the overall pharmaceutical 
consumption rate, the pharmacological fate of the drug within the body, the 
behaviour of the drug during the wastewater treatment process and the ability 
of the receiving water to provide adequate dilution [6,7,8]. Information 
concerning each factor is important when attempting to predict which 
pharmaceuticals may be present in the environment. Although it is 
acknowledged that the treatment of wastewater provides the biggest 
contribution to the environmental pharmaceutical load other sources including 
landfill leachate and aquacultural processes may also play their part. Wastes 
and effluents from pharmaceutical production are not, however, expected to be 
significant emitters due to 'Good Manufacturing Practice' regulations that 
require the manufacturing process to quantitatively account for all the 
intermediates and products during a particular synthesis [9]. Possible sources 
of entry of pharmaceutical compounds are visible in Fig. 1.2. 
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Figure 1.2: Possible sources and entry pathways of human and veterinary pharmaceuticals 
into the environment, adapted from, [6]. 
1.3 The Role of Druq Metabolism: 
Pharmacokinetics is the branch of pharmacology that describes the processes 
affecting the absorption, distribution, metabolism and elimination of 
pharmaceutically active compounds in the body [lo]. From the perspective of 
PPCPs as environmental pollutants the most important pharmacokinetic 
process is drug metabolism as it provides information as to whether: 
A drug will be metabolised within the body or be excreted in an unchanged 
form. 
If metabolism does occur, the proportions that will be excreted as parent 
molecule and metabolites. 
The types of metabolites that might be expected, i.e. which metabolic 
pathway dominates. 
An important aspect of drug design is that of drug delivery, i.e. ensuring 
that the compound arrives at the desired site in the desired form to evoke its 
pharmacological effect. In order to cross cell membranes, pharmaceuticals 
must possess sufficient lipophilicity and consequently the primary function of 
drug metabolism is to transform these lipophilic compounds into more polar 
metabolites that are suitable for elimination and excretion primarily through the 
kidneys via the urine [ I  I ] .  
Metabolism is an enzymatic process and involves transformation of the 
compound via Phase I and Phase II reactions. Phase I processes involve the 
functionalisation of the parent molecule in preparation for Phase II processes to 
occur and normally consists of the addition or activation of a reactive functional 
group on the parent molecule. Typical Phase I processes include oxidation, 
reduction, hydrolysis, hydration or dealkylation [ I  21. These reactions are 
predominantly governed by cytochrome P450 microsomal oxidase enzymes 
located in the endoplasmic reticulum of cells and require the presence of 
cofactors such as nicotinamide adenine dinucleotide phosphate (NADPH). 
Phase II processes involve the conjugation of an extremely polar moiety to the 
Phase I product leading to a hydrophilic drug conjugate that is readily removed 
by Glomerular filtration in the kidney. Typical conjugates include sugars or 
glucuronides, sulphate, amino acids, glutathione or acetyl groups [12]. A 
diverse group of enzymes regulate Phase II reactions individual to the 
conjugate, e.g. sulphotransferases, glucuronyltransferases etc. each requiring 
its own individual cofactor such as 3'phosphoadenosine-5'-phosphosulphate 
(PAPS), or uridine diphosphate (UDP), respectively [12]. An example of Phase I 
& II processes is depicted in Fig. 1.3 [I I ] .  
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Figure 1.3: The metabolism of the non steroidal anti-inflammatory drug diclofenac by Phase I & 
I I  reactions, adapted from [I I]. 
As demonstrated by Fig. 1.3 most pharmaceuticals are metabolised into 
a certain array of metabolites. However, the process becomes considerably 
more complicated as the enzymes involved in the metabolic reactions may be 
induced or inhibited by other chemicals to which a person may be exposed to 
either intentionally, accidentally or unknowingly through daily life [13]. Induction 
will increase elimination rates whilst conversely inhibition will reduce the rate of 
elimination and promote retention of the parent compound within the body. 
Therefore, prediction of the most prominent form likely to be encountered in the 
environment is made increasingly difficult. 
While the primary function of metabolism is to remove pharmaceutical 
compounds from the body, conversion by Phase I & II reactions may yield two 
ultimate outcomes. The first and more favourable of these is that the drug in 
question is rendered pharmacologically inactive and therefore, should it enter 
the environment it should be no major cause of concern. The second more 
worrying scenario is that metabolism converts the pharmaceutical compound 
into a more potent or toxic form, (through either pro-drug activation or parent 
compound conversion). Examples of more potent metabolites include the 
conversion of codeine and heroin into morphine whilst common drugs used in 
high quantities such as paracetamol are know to have highly toxic metabolites 
such as N-acetyl-p-benzo quinone imine [ I  I ] .  
1.4 The Treatment of Wastewater: 
In the course of everyday life human activity consumes large quantities of 
water. The discharge from households and industry into drains and sewers is 
referred to as wastewater. Wastewater is on average >99.9% spent water with 
the other 0.1% comprising of dissolved and suspended solids [14]. The actual 
composition of wastewater is highly variable, however, likely components 
include micro organisms including pathogens, organic material, inorganic 
nutrients such as nitrogen and phosphorous compounds and metals [15]. Each 
of these components may exhibit their own unwanted effects if wastewater 
were discharged directly into ground and surface waters. Therefore, in an 
attempt to reduce the threat of pollution wastewater usually receives some form 
of treatment before final discharge into the environment. In Ireland the 
treatment of wastewater is governed by the Environmental Protection Agency 
Act of 1992 and more so by the 'Urban Wastewater Treatment Regulations 
1994' passed to enact into Irish law EU directive 911271EEC [16]. Under Section 
85 of the 1992 Act, discharges to sewers must be monitored and are licensed 
under the Integrated Pollution Control system to protect the receiving treatment 
plant and the general aquatic environment in the long run [16]. A schematic of 
wastewater treatment processes is depicted in Fig. 1.4. 
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Figure 1.4: An overview of wastewater treatment, adapted from [14]. 
Wastewater treatment is a stepwise process of physical, biological and 
chemical means designed to remove the aforementioned wastewater 
components and protect the effluent receiving water body. Physical processes 
are usually involved in the preliminary and primary treatment stages. 
Preliminary treatment involves the filtration of influents to remove debris and 
large particles. The screened influent then passes into holding basins where 
the wastewater is held for sufficient periods of time to allow solids to settle to 
the bottom of the basin while organic matter such as oils, fats and greases float 
to the top. Solids may settle out in a variety of ways depending on their physical 
properties, i.e. size and density, formation of associated masses of particles or 
compression; whereby settling particles drag other dissolved solids downwards 
[16]. Both layers can then be physically removed before the next process 
occurs. 
Biological treatment of wastewater occurs during the secondary stage, a 
process that is generally referred to as activated sludge treatment. Activated 
sludge consists of a complicated ecosystem of micro organisms ranging from 
heterotrophic and facultative bacterial species of Achromobacter, Arthrobacter, 
Citromonas, Flavobacterium, Nitrobacter, Nitrosomonas and Pseudomonas to 
higher protozoa such as Amoeba, Opercularia and Trachelophyllum and also 
rotifers and nematodes [ I  71. Activated sludge treatment involves the mixing of a 
concentrated microbial population with wastewater under aerobic conditions, in 
order to provide both oxygen and a carbon source necessary for microbial 
respiration. Such conditions encourage high rates of microbial growth and 
consequently increased rates of microbial respiration leading to a reduction in 
the quantity of organic matter present within the wastewater [17]. Bacteria 
account for the highest proportion of microbes within the sludge and as 
bacterial cells grow they may produce a slime layer surrounding the cell wall. 
The slime layer imparts an absorptive surface onto the bacterial cell allowing for 
the formation of flocculated agglomerations of microbes, commonly referred to 
as 'flocs' [18]. The forming floc surface also absorbs colloidal and suspended 
matter; ionic substances may also be absorbed due to interaction with 
oppositely charged biomolecules within the bacterial cell wall [17]. Activated 
sludge treatment is a dynamic process as bacteria within a floc assimilate and 
utilise the adsorbed material, therefore producing free sites on the surface of 
the floc capable of adsorbing more and more of the wastewater matrix. 
However, a crucial factor is the treatment time, (or the hydraulic retention time) 
spent within the aeration tank in order to allow sufficient microbial activity; if the 
treatment time is not long enough, little organic material will be removed. The 
ecological make up of activated sludge is another important factor in 
maintaining a viable process. Protozoa species ,aid with treatment process by 
feeding off the bacterial populations thereby preventing the bacteria from 
reaching excessive lag phase numbers. Protozoal feeding also helps with the 
removal of suspended matter [17]. The final process involved with sludge 
treatment is clarification, i.e. liquid solid separation; the flocculated biomass is 
allowed to settle out of solution yielding a clarified effluent [16]. The effluent 
may then by subjected to tertiary treatment or be discharged into a receiving 
water body. The remaining sludge is either reintroduced, into the aeration tank 
as bacterial innoculum or is itself inactivated and disposed [16]. 
Tertiary treatment of wastewater may be physical or chemical in nature. 
The objective of tertiary treatment processes is to remove non biodegradable 
organic materials, metals and nutrients present even after the primary and 
secondary processes. Chemical methods are used for the removal of 
eutrophication nutrients, i.e. nitrates and phosphates. Phosphates can be 
precipitated out of solution by the addition of calcium or iron [18], while nitrates 
can be converted to volatile ammonia at high pH which is easily purged from 
solution by aeration. Nitrates may also be reduced at low pH to nitrogen gas or 
nitrous oxides [ I  81. Disinfection to inactivate any residual microbes, particularly 
pathogens may also be required and practices such as chlorination may also 
aid with the removal of some pharmaceuticals [19,20,21,22]. Non- 
biodegradable organics may be subjected to advanced oxidation using ozone, 
whilst metallic elements maybe precipitated out of solution by reaction with an 
appropriate chelating agent [23]. Physical methods such as UV radiation may 
also be used for non biodegradable organic removal. 
An important parameter for determining the performance of the 
treatment process is a measurement of the dissolved oxygen concentration of 
the wastewater influent and effluents. The most common measurement 
performed is that of biochemical oxygen demand (BOD) which measures the 
quantity of oxygen required by microbes for organic matter consumption [16]. 
Each treatment stage is designed to reduce the BOD of the wastewater with the 
highest proportion as expected being removed by the activated sludge process. 
The more efficient the treatment process, the lower the expected BOD of the 
effluent. 
1.5 The Behaviour o f  Pharmaceuticals in WWTPs: 
Richardson and Bowron proposed three possi,ble outcomes for pharmaceutical 
compounds during the treatment of wastewater [I]; mainly full degradation or 
partial degradation or persistence and discharge into the receiving environment 
with the treated effluents. The two most probable means for- the removal of 
pharmaceuticals in wastewater treatment plants include microbial degradation 
either to produce compounds of lower molecular weight or ideally complete 
metabolism into C02 and H20, or the sorption of pharmaceuticals to particles 
and solid matter that can be removed by filtration or settling [4]. 
In 1996, Rogers reviewed the behaviour of many classes of organic 
contaminants including some pharmaceuticals in sewage sludge [24]. At the 
time, information concerning the behaviour of pharmaceuticals was mostly 
speculative due to lack of suitably sensitive analytical methods, however, it was 
suggested that the presence of pharmaceutical compounds need not be a 
cause of concern and it was acknowledged that many compounds, mostly 
antibiotics, were readily biodegradable [24]. The occurrence and behaviour of 
pharmaceuticals in wastewater treatment plants was further investigated by 
Ternes in 1998 [25], who reported the presence of a multitude of drug residues 
from many pharmacological classes in the influent, effluent and receiving water 
of a municipal treatment plant near Frankfurt in Germany. By determining the 
difference between the concentrations detected in the plant effluent and influent 
the overall removal efficiency of the treatment process was estimated. It was 
reported that on average r 60% of the detected drug residues were removed 
however, some compounds showed particularly low removal, e.g. the 
antiepileptic drug carbamazepine and clofibric acid, a metabolite of many lipid 
lowering agents and these compounds were ubiquitously present in the aquatic 
environment as a result [25]. Ternes also examined the presence and 
behaviour of highly polar and ionic compounds used as x-ray contrast media in 
the treatment plant and discovered that such chemicals were not removed 
during treatment and passed freely through the plant contaminating the 
receiving waters [26]. Other studies conducted have reported similar findings 
both in the United ~ ingdom [27] and Spain [28]. Carballa et a/. focused upon 
sampling at each stage of the treatment process in an attempt to ascertain 
which treatment step provided the highest rate of removal, [28]. It was found 
that the degree of hydrophobicity of the analyte was important as more non 
polar compounds were observed to adsorb onto the primary and secondary 
sludge with more polar analytes remaining in the water phase and therefore, 
passing unhindered through the treatment plant [28]. Interestingly levels of 
some compounds, e.g. 17P-estradiol, were observed to increase after 
secondary treatment suggesting the cleavage of Phase II metabolites during 
biological processes. Information regarding the behaviour and removal of 
pharmaceutical compounds in wastewater treatment plants is of great 
importance when attempting to estimate the loading of such compounds into 
the environment. For example, Fischer and Borland estimate that between 15 
to 30 tonnes of active pharmaceutical ingredients are released into the 
environment surrounding Sydney, Australia on a yearly basis [29] due to the 
insufficient treatment of wastes. With appropriate treatment these quantities 
could be significantly reduced. 
The microbial processes leading to the removal of pharmaceuticals 
during wastewater treatment have not been fully investigated. Studies 
conducted have shown that the microbiological usage of pharmaceutical 
compounds as carbon or nitrogen sources for metabolism occurs only in the 
absence of a primary substrate [30]. However, an equal probability exists that 
microbes may show no preference and metabolise pharmaceuticals even in the 
presence of a primary substrate depending on the affinity and resistance of the 
microbes enzymes to such pharmaceuticals. The removal rate of some 
pharmaceutical compounds in WWTPs is observed to increase with increased 
residence time [27], possible explanations for such an observation include the 
increased diversity of the microbial community with increasing sludge age or 
the ability of microbes to respond to limiting organic carbon availability [31]. 
Sorption to filterable solids during wastewater treatment has received 
more attention as it is generally a more understandable process than microbial 
degradation. Pharmaceuticals present in the aqueous phase of a WWTP may 
adsorb onto particulate and suspended material by hydrophobic interaction 
between nonpolar moieties of the molecule and lipid rich cell membranes of 
microbes or other agglomerations of fatty material on the sludge. Electrostatic 
interactions between oppositely charged groups on the pharmaceutical and the 
surface of microbes or particles may also be involved [31,32]. The distribution 
of pharmaceuticals between the aqueous phase and the solid phase is an 
equilibrium process, represented by solid water distribution coefficient; KD, 
whereby; 
(Eq. 1.1) 
Csorbed and C,,,,o,, are the concentrations of pharmaceutical in the solid and 
water phases respectively [32]. KD values allow for the prediction of whether a 
substance will show appreciable adsorption or will preferentially remain in the 
aqueous phase. KD values for several pharmaceuticals have been 
experimentally investigated but found to be quite low thereby suggesting that 
the drugs chosen would be expected to exhibit negligible adsorption and 
therefore, microbial degradation plays a major part in the removal of 
pharmaceuticals in actual treatment plants [33,34]. Another study performed by 
Urase and Kikuta attempted to estimate both the sorption and degradation of 
pharmaceuticals during activated sludge treatment [35]. They observed that the 
pH of the sludge played an important role in determining whether drugs would 
adsorb onto the sludge, however, microbial life would be eliminated under 
acidic conditions and therefore, the use of acidic conditions is not feasible. A 
theoretical model for the prediction of probable concentrations and subsequent 
removal rates was described by Khan and Ongerth [36] for the 'Top 50' 
prescribed pharmaceuticals in Australia. Parameters included within the model 
included data on pharmaceutical quantities used, metabolic and excretory data, 
chemical and physical properties for each compound and operating data for the 
types of treatment plants involved. The model predicted that removal rates 
ranging from 14% for the antibiotic roxithromycin to 99% for the 
antihypertensive irbesartan. 
Two other items which were observed to affect the behaviour of 
pharmaceuticals during the treatment process were rainfall and the 
infrastructure of the plant [25,37]. Ternes reported that the removal of several 
pharmaceuticals, predominantly analgesics, was significantly reduced during 
periods of increased rainfall [25]. It was also observed that the rate of removal 
took several days to recover to its previous level. It was suggested that the 
reasons for decreased pharmaceutical removal may include a reduction in 
microbial activity or a change in the sorption and flocculation due to increased 
fluid flow though the plant. Wolf et a/. investigated the effect of sewer 
infrastructure in the German city of Rastatt and its role in the release of 
pharmaceutical compounds to the environment [37]. High concentrations of 
iodinated x-ray contrast media were detected in groundwater in the vicinity of 
sewer pipes illustrating that significant leakage of untreated sewage was 
occurring underneath the city and also that measurable quantities of 
pharmaceutical compounds were being introduced to groundwater as a result. 
lodinated x-ray contrast media were therefore suggested as an anthropogenic 
maker species for monitoring the presence of untreated wastewater in 
environmental waters. 
1.6 Pharmaceutical Disposal and Landfill Leachate: 
According to Slack et a/. approximately 60-7O0/0 of all municipal waste produced 
in the developed world is disposed of in landfill sites [38] and up to 5% of such 
wastes may contain hazardous materials originating solely from household use. 
However, as there is no legal definition of what constitutes hazardous 
household wastes and therefore, no enforced segregation procedures; it is 
difficult to accurately predict the quantities of hazardous substances being 
placed in landfill sites [38]. Slack et a/. conducted a survey in the United 
Kingdom in order to gauge the amounts of hazardous materials held in 
households and the disposal routes for such products including expired or 
unused pharmaceuticals [38]. It was discovered in the case of pharmaceuticals, 
the public did not understand that pharmaceuticals constituted a hazard or how 
to safely dispose of such waste. Only 19% of expired or unused 
pharmaceuticals were returned to pharmacies for proper disposal with -50% 
being dumped in the bin and ultimately landfill and another -20% being flushed 
down the toilet [38]. 
Emissions from landfill sites are normally gases, airborne particles or 
more importantly leachate in the case of pharmaceutical pollution. Leachate is 
expected to be complex and heterogeneous in composition depending on the 
types of wastes disposed in the landfill, contain both inorganic and organic 
constituents which pose a multitude of risks [39]. An important parameter in 
leachate analysis is the quantity of dissolved organic carbon (DOC), as it 
provides a surface for adsorption and also affects the mobility of metallic 
elements [39]. 
The first report of pharmaceutical compounds in landfill leachate was in 
1995 when Holm et a/. detected large amounts of sulphonamides, barbiturates 
and phenazone type analgesics in leachate plumes and groundwater in the 
vicinity of a landfill in Sweden that received both municipal waste and waste 
from pharmaceutical production over the course of its lifetime [40]. It was also 
observed that concentrations of the detected pharmaceuticals decreased with 
increasing distance from the landfill site. Phenazone type analgesics were also 
detected by Ahel and Jelicic in soils and groundwater below a Croatian landfill 
site [41]. It was estimated that the landfill site could contain up to 800 kg of 
phenazone and that such a level was adequate to maintain high levels of 
phenazone compounds in the groundwater surrounding the landfill for more 
than 100 years [41]. 
The design and upkeep of landfill sites is important in preventing the 
introduction of pharmaceuticals into the environment through leachate. A study 
of the organo-geochemical composition of seepage and leakage waters from a 
landfill site was undertaken by Schwarzbauer et a/. using GC-MS [42]. More 
than 180 individual organic compounds were identified, mostly acids or 
molecules with polar groups. Pharmaceuticals detected in both seepage and 
leakage water included ibuprofen, propylphenazone, clofibric acid and various 
sulfonamides [42]. Of these compounds propylphenazone was quantified to 
levels of 110-140 pg~ - ' .  The study concluded that the organic character of 
seepage water contained a mixture of natural and plant derived materials but 
also significant quantities of xenobiotic compounds suitable as tracer molecules 
for environmental contamination originating from landfill sites. A further study 
was performed by the same group to test this hypothesis [43]. It was observed 
that the selected marker species were indeed highly suitable for contamination 
tracing with propylphenazone and the insect repellent N,N-diethyl toluamide 
being detected in all samples taken surrounding the landfill site. It was also 
found that the concentration of the selected marker species decreased with 
increasing spatial distribution from the site. Sampling was performed at monthly 
intervals over the space of a year in order to assess time dependence on the 
concentration of the selected marker species. Only slight decreases were 
observed with detected levels remaining rather stable suggesting that landfills 
act as a constant source of pharmaceuticals into the environment. 
1.7 Environmental Processes and Fate of PPCPs: 
Once pharmaceutical compounds enter the environment the question exists as 
to their fate, i.e. are they transported along the watercourse and diluted to such 
levels whereby their presence becomes negligible, do they adsorb onto solids 
and accumulate over time leading to increased concentrations, or are they 
degraded or transformed into various other chemicals in the presence of 
sunlight. Few studies have been undertaken in an attempt to answer such 
questions but primary findings will be discussed in the following sections. 
1.7.7 Environmental Transport: 
Pharmaceuticals are predominantly introduced into the aquatic environment 
with treated wastewater at levels in the ngL-' to the low pgL-I range; the dilution 
of such residues, (and therefore, the dilution of the risk that they pose) depends 
upon the volume of the receiving water body and its ability to adequately 
disperse such chemicals. Ashton et al. investigated the introduction of drug 
residues into surface water from treatment plants in the United Kingdom [44]. 
Samples of surface water were collected upstream and downstream of the 
plant along with the discharged effluent. In four instances, pharmaceuticals 
were detected prior to the treatment plant, the highest detection was the 
analgesic ibuprofen at a level of 181 n g ~ ' .  It was suggested that the detection 
of drug residues before the plant indicates that these chemicals were 
transported over a long range and therefore, have adequate stability to survive 
in the aquatic environment [44]. A statistical analysis of the concentrations of 
pharmaceuticals detected in the discharged effluent and receiving surface 
water was also performed and it was found that a positive correlation existed 
between the two, i.e. the levels of pharmaceuticals detected in surface water is 
a 'diluted' reflection of the quantities present in effluent which in turn is a 
reflection of overall usage of those particular pharmaceuticals [44]. 
Other studies conducted have also illustrated that pharmaceuticals can 
undergo long range transport in the aquatic environment. Thomas and Hilton 
detected fourteen pharmaceuticals in British estuaries of the Thames, the Tyne, 
the Mersey, the Tees and Belfast Lough [45] and suggest that the detection of 
pharmaceutical analytes in estuaries is a result of contaminated surface water 
infiltration. Two separate studies were conducted to determine pharmaceutical 
residues in the North Sea [46,47]. The North Sea is a particularly sensitive 
water mass which accepts rivers from the United Kingdom, Norway, Sweden, 
Denmark, Germany, Holland, Belgium and France. Clofibric acid was detected 
in both studies; it was observed that a concentration gradient existed from the 
mouth of certain rivers, in particular the Elbe, to the open sea and that levels 
detected were relatively stable over a considerable period of time and 
comparable with other "classic" pollutants such as Lindane [46,47]. 
A detailed study of the river Elbe in Germany was conducted by Wiegel 
et a/. [48]. It was found that the river was heavily polluted with pharmaceutical 
residues due to the large number of WWTPs discharging into the river. 
Transport of pharmaceutical residues can be observed with increasing 
concentrations being detected with distance from the rivers source to its exit; 
-700 km [48]. Levels of clofibric acid were detected in the rivers plume into its 
North Sea estuary and the authors conceded that the river is a significant 
source of clofibric acid in to the monitored marine environment. 
The stability of pharmaceuticals in the environment is significant 
however, it is also acknowledged that due to a 'steady state' of introduction, 
levels entering the environment are sufficient to replace those being removed 
[49]. Pharmaceutical residues therefore, lend themselves as appropriate 
marker species for tracking the transport and dilution of wastewater in the 
environment [50]. 
I .  7.2 Photochemical Attenuation: 
Knowledge concerning the fate of pharmaceutical compounds in the natural 
environment is essential when attempting to quantify the risk that they pose. 
Pharmaceuticals may be subject to both biotic processes, e.g. biological 
transformation and abiotic processes e.g. hydrolysis, photolysis or sorption in 
aquatic systems. Of the above processes, studies have shown that photolysis 
of pharmaceutical compounds in aquatic systems is significantly more 
important than other biotic and abiotic processes [51]. Two distinct pathways 
exist by which photolytic reactions may occur; direct photolysis, wherein a 
molecule upon the absorption of light becomes unstable and decomposes or 
indirect photolysis, wherein molecules interact with the reactive intermediate of 
another species produced by its absorption of light [52,53]. Research on the 
photochemical fate of pharmaceutical chemicals is limited, with only a handful 
of papers on the subject published to date. Of those only two have attempted to 
evaluate the fate of a variety of compounds while the majority have focused on 
a single analyte or chemically similar analytes. 
The fate of the bactericide Triclosan was investigated in two separate 
studies. Lindstrom et a/. examined the behaviour of Triclosan and methyl 
Triclosan in Swiss wastewater effluents and surface water [54]. They observed 
that Triclosan showed no appreciable sorption to sediments due to its presence 
in the phenolate anionic form at the pH of the lake water. The primary method 
of Triclosan removal from the lake was due to direct photolysis of the anionic 
form of Triclosan due to a spectral shift upon dissociation that allowed for 
significant overlap with the spectrum of natural light. It was also noticed that the 
levels of Triclosan present in the lake varied seasonally with sunlight intensity, 
with increased quantities present in the winter. In summer a stratification of the 
lake occurred leading to significant degradation of Triclosan in the surface layer 
[54]. Mezcua et a/. focused upon the formation of 2,7- and 2,8-dibenzodichloro- 
p-dioxin as products of the photodegradation of Triclosan [55]. Again it was 
observed that only the dissociated form of Triclosan displayed significant 
photoactivity. . .. 
Buser et a/. reported the rapid photodegradation of the non steroidal 
inflammatory diclofenac in Swiss lakes [51] and found that photolysis 
accounted for the removal of up to 90% of the pharmaceutical. Again, as was 
the case with Triclosan, sorption to suspended solids and sediments was 
discounted as an important attenuation process. Direct photolysis was found to 
be an extremely fast process with >95% removal in just 4 hours of exposure. 
Seasonal variations of light intensity were also examined and observed to 
follow the same patterns as Triclosan with higher concentrations being detected 
and predicted during the winter months. Schmitt-Jansen et a/. also examined 
the photodegradation of diclofenac and noted the formation of six 
photoproducts, four more polar than the parent molecule and two less polar 
than diclofenac, within a period of 53 hours of irradiation using LC-UV [56]. The 
observed photoproduct peaks were the observed to decrease in intensity after 
such time and were completely absent after 144 hours of irradiation with natural 
sunlight. The chemical identification of the observed photoproducts was not 
undertaken. Similar research was also undertaken by Packer et a/. [57], Lam et 
a/. [58] and Zhang et a/. [59]. 
The presence of antibiotic compounds in the environment has caused 
concern due to the possible development of microbial antibiotic resistance. 
Turiel et a/. investigated the photochemical fate of two commonly used and 
potent quinolone and fluoroquinolone antibiotics; oxolinic acid and ciprofloxacin 
respectively [60]. It was noted that ciprofloxacin degraded much faster than 
oxolinic acid upon irradiation. The matrix in which the experiment was 
performed also played an import role as humic material was observed to 
decrease the rate of photodegradation [60]. Results suggested that quinolone 
antibiotics, due to their much slower rates of degradation may pose more of a 
risk to the development of microbial resistance than fluoroquinolones. However, 
attempts to identify the photoproducts of ciprofloxacin revealed that those 
compounds still contained the active centre of the molecule. Therefore it was 
suggested that in attempting to perform environmental risk assessments both 
the parent molecule and degradation products should be considered. lsidori et 
a/. recommended the same approach as they investigated the ecotoxicity of 
both the anti-inflammatory naproxen and its photoproducts and the diuretic 
furosemide and its photoproduct and observed that the photoproducts were 
more toxic than the parent pharmaceuticals [61,62]. 
A detailed investigation into the direct and indirect photolysis of the 
selective serotonin reuptake inhibitor, fluoxetine, in surface waters was 
performed by Lam et al. [53]. The direct first order photolytic half life of 
fluoxetine was experimentally determined to be 7 days but the reaction was 
observed to proceed faster at alkaline pH. Degradation pathways were 
elucidated by mass spectrometric studies and three decomposition products 
were identified. Indirect photolysis was observed to proceed considerably faster 
than direct photolysis with an experimentally determined half life of 55.2 hours 
in reagent water and even lower values recorded in surface water [53]. The 
authors acknowledge that indirect photochemical reactions through hydroxyl 
radical mediated pathways could play an important role in the removal of 
fluoxetine from surface waters [53]. 
The role of innate photosensitisers such as nitrate and humic material on 
the photodegradation of a range of pharmaceuticals was investigated by 
Andreozzi et al. [52]. Humic material may act as a reactive intermediate due to 
its ability to produce hydroxyl radicals; however, it can also decrease the effect 
of radiation on other molecules by acting as a protective filter [52]. As was 
observed in other studies, seasonal variations affected. the rates of 
photodegradation. The presence of nitrate caused an increase in the rate of 
photodegradation of pharmaceutical compounds due to the production of 
reactive hydroxyl radicals during the photolysis of nitrate. The noted effects of 
humic acid were twofold, humic materials appeared to act as photosensitisers 
and increase the photodegradation of the antibiotic ofloxacin, the sulphonamide 
sulfamethoxazole, the P-blocker propranolol and clofibric acid, while the 
opposite 'filtering' effect was observed to reduce the photodegradation of 
carbamazepine and diclofenac [52]. However, although humic materials add a 
degree of complexity to the photochemical process, it is still the most significant 
abiotic process affecting pharmaceuticals in the natural environment. 
1.7.3 Sorption and Mobility in Solid Matrices: 
Pharmaceuticals may adsorb onto solids during the treatment of wastewater 
and therefore, be removed with the sludge. While this process attenuates the 
levels of pharmaceuticals being discharged along with the treated effluent, a 
problem exists with the disposal of sludge, which as a result is likely to contain 
quite significant quantities of pharmaceuticals, e.g. a German study found 
levels of Triclosan at -50 n g ~ - '  in WWTP effluent and -1200 ngg-' in the 
corresponding sludge [63]. Therefore, the probability exists that 
pharmaceuticals may leach out under suitable conditions. A similar problem 
exists with veterinary medicines that may be introduced into the environment 
through the spreading of treated animal wastes on lands as fertiliser thereby 
contaminating soils, groundwater and surface water through overland flow 
164,651. 
The sorption of drug residues in the environment leads to increased 
localised concentrations of those particular analytes. One particular analyte 
known to accumulate is the antibacterial agent Triclosan. As discussed 
previously (section 1.7.2) , it has been demonstrated that at high pH Triclosan 
is readily photo degraded, but the associated form of the molecule is relatively 
stable, so much so that it has been shown to bioaccumulate in fish exposed to 
treated wastewater effluent and even in human milk [66]. However, conflicting 
reports were published by the manufacturers of Triclosan who claim that the 
molecule is not persistent [67]. The sorption of veterinary pharmaceuticals to 
soils was reviewed by Tolls [68] who reported that traditional approaches to 
describe sorption such as KD, Kw and kc that cater solely for sorption through 
hydrophobic interaction do not properly portray the sorption behaviour of drugs 
in soils. These parameters fail to account for hydrogen bonding, ion exchange 
and chelation, which are more important sorption and retention mechanisms for 
pharmaceuticals likely to be charged at soil pH, [68]. Christian et a/. determined 
antibiotics in German soil, [69] and observed.that one particular sulphonamide; 
sulfadimidine, was stable for long periods of time after application. 
The potential for pharmaceuticals bound to soils to leach and 
contaminate groundwater has become the focus for many studies. Oppel et a/. 
investigated the leaching behaviour of six drugs from two different soil columns 
of different pH and organic content [70]. The study reported that 
carbamazepine, diazepam, ibuprofen and ivermectin were retained on both soil 
columns, while clofibric acid and iopromide were determined solely in the 
leachate. Using radio-labelled standards it was possible to determine the depth 
penetration of the pharmaceuticals in the column. In the low pH high organic 
content soil the radioactivity was recorded only up to a depth of 5 cm whilst in 
the high pH low organic content soil penetration of up to 20 cm was noted [70]. 
It was concluded that the retained drugs pose little threat to groundwater as a 
result of soil leachate and vice versa. The pH of the soil and the organic content 
were also important factors affecting the mobility of the monitored 
pharmaceuticals [71,72]. Kay et a/. published two studies concerning the 
mobility of three veterinary antibiotics in soil treated with slurry [73,74]. Both 
studies detailed that oxytetracycline and the macrolide tylosin do not leach from 
soil with the application of slurry but the sulphonamide; sulfachloropyridazine 
was highly motile, with quantitative recovery of the applied quantity used during 
the study. The high mobility of the sulfonamide was attributed to macropores in 
the soil structure that allowed for unhindered transport to drainage systems and 
ultimately surface water [73]. The application of slurry was observed to cause 
an increase in soil pH but tillage of the soil prior to application was found to 
remove the risk for all the studied compounds [74]. Similar findings to the above 
studies were reported by Drillia et a/. [75]. Again it was observed that the soil 
type and channels within the soil were important, however, simulated rainfall 
events were performed and it was observed that the flow and volume of rain 
affected the adsorption and the mobility of the drug through the soil. The higher 
the volume and flow, the less drug adsorbed, suggesting that high 
concentrations of pharmaceuticals may be released to surface and ground 
water during intense rainfall, although the increased volume will aid with dilution 
[751. 
The processes affecting the concentrations and fate of pharmaceuticals in the 
environment are highly complex. Pharmaceuticals have adequate stability and 
can be transported over considerable distance through the water course. Soils 
may adsorb some pharmaceutical residues, however, such an effect was 
observed to concentrate levels in the uppermost topsoil layer [76]. Rainfall can 
affect sorption and lead to increased introduction of drug residues into 
groundwater. Photolysis is an important process in the removal of 
pharmaceuticals from the natural environment but is itself a complicated 
process as many transformation products may still contain active groups and 
express pharmacodynamic effects. 
1.8 Assessinq the Ecotoxicoloqv and Risk ~ o s e d  b~ PPCPs: 
The presence of pharmaceutical residues in the environment has caused 
concern as these chemicals are specifically designed to exhibit a pronounced 
biological effect on the organism for which they were developed. The possibility 
also exists that drug residues may also affect different species that express the 
same receptors or more worryingly cause unknown chronic toxicological effects 
in other unrelated organisms that may go unnoticed until it becomes too late. In 
Europe an environmental risk assessment (ERA) is required to be performed 
prior to a licence being granted to a particular pharmaceutical in an attempt to 
predict whether or not the drug poses a significant toxicological risk to the 
environment. The assessment is a legal obligation and enforced under EU 
Directive 93139lEEC. A centralised agency, the European Medicines Evaluation 
Agency (EMEA), was also established under Regulation 2309193lEEC with 
responsibility for the licence and registration of medical products for use within 
the EU [77]. Reviews of the above legal framework have been undertaken with 
the updated Directives 2001182lEC and 2001183lEC now enforced. These 
directives cover the licensing of veterinary and human medicines respectively 
and undertaking appropriate environmental risk assessments are primary 
functions of both documents [78]. 
The EMEA risk assessment procedure is a tiered process as depicted in 
Fig. 1.5 below. 
Tier 7 
through PEC calculation. 
Tier 2 
PEC < 0.01 pgL-' Calculation of PNEC from 
acute toxicity data. 
1 Tier 3 
Refine data or further toxicity 
consideration required. 
1 
1 ERA ~ e p o r t  complete. I 
4 1 
Figure 1.5: Schematic of ERA, adapted from [79]. 
Product labeling. Possible precautionary or 
I safety measures needed. 
The first tier of the ERA process involves the calculation of a crude 
predicted environmental concentration (PEC) for the pharmaceutical in question 
or its metabolites. PECs are usually calculated using Equations 1.2, (initial 
directive) or 1.3, (updated directive) below, which account for approximate 
quantities of the drug used, its removal rate and dilution in receiving water. 
Ax(100-R) PEC = 
3 6 5 x P x V x D x l 0 0  
Where: 
A is the amount used per year, (kg.year'). 
R is the removal rate. 
P is the population considered. 
V is the volume of wastewater produced per capita per day, (m3). 
D is the dilution factor in the receiving body. 
OR: 
DDD x F,,, 
PEC = 
V x D x 1 0 0  
Where: 
DDD is the defined daily dose in mg per person per day. 
Fpen is referred to as the penetration factor, i.e. the faction of the population 
being treated with the particular drug. 
If the calculated PEC value is less that the 0.01 p g ~ - l  imit no further 
(Eq. 1.3), [80]. 
action is required and the investigation is complete. If, however, the calculated 
PEC is above the limit, the investigation proceeds to Tier 2 and the predicted 
no effect concentration (PNEC) is estimated by examining acute toxicity data 
performed on algae, Daphnia or fish and dividing the reported worst case 
endpoints, (i.e. EC50 or LC50) by an assessment factor to impart a margin of 
safety [81]. If the PECIPNEC ratio is less than one, i.e. the level of 
pharmaceutical that may exhibit a toxicological response is less than the 
predicted amount likely to be present, then the ERA is considered complete. If 
the ratio is greater than one, the third tier of the assessment should be 
performed which may involve carrying out chronic toxicity studies such as fish 
life cycle studies or the recommendation that the product is only administered 
and used in a controlled environment [77]. It is also noted the PEC limits are 
not set in stone and maybe changed accordingly to account for low dose high 
potency situations and vice versa. Also potential benefits out weigh 
environmental concerns as even if the compound is found to pose a significant 
risk it will still be granted a licence if it is proved to be a highly effective 
medicine [77]. 
A number of studies have been undertaken to evaluate the risk posed by 
established pharmaceutical compounds to the environment. By evaluating 
PECs, analytes likely to pose an environmental risk can be identified. 
Castiglioni et a/. undertook such an approach and using the results from 
developed analytical methods, compared the measured environmental 
concentration (MEC) with the calculated PECs [82]. It was observed that a 
refined PEC, corrected for metabolism and environmental half life provided a 
good estimation of the MEC, although PECs were generally higher than MEC. It 
was also observed that using the Equations 1.2 and 1.3 above to calculate 
crude PEC values leads to an over estimation. A similar investigation was 
performed by Ferrari et a/. and again it was noted that the PEC was a useful 
approximation of the MEC [79]. However, in all cases the PEC and MEC were 
above the Tier 1 so a Tier 2 assessment was performed. The results of the Tier 
2 assessment suggested that calculating the PNEC based upon acute toxicity 
bioassays may lead to confusing results and to avoid such situations PNEC 
values based upon chronic toxicity data may be more suitable. The reason 
being that the levels of pharmaceuticals in question are considerably lower than 
the minimum concentrations needed to exhibit a response in an acute toxicity 
bioassay [79]. Another ERA report by Christenen [83] found that three potent 
pharmaceuticals; 17-a-ethinylestradiol, phenoxymethylpenicillin and 
cyclophosphamide posed no threat to aquatic organisms or humans at the 
PEC. Similar research was also undertaken by Hernando et a/. [84], 
Lissemnore et a/. [85] and Pomati et a/. [86]. 
Jones et a/. assessed the 'Top 25' pharmaceuticals in the United 
Kingdom using the EMEA ERA approach in the aquatic compartment and 
attempted an assessment for sludge 1871. Using a lower Tier 1 limit of 1 n g ~ - '  it
was necessary to perform a Tier 2 assessment for all pharmaceuticals on the 
list. Again it was noted that Tier 2 results can be ambiguous due to the use of 
acute rather than chronic toxicity data to calculate the PNEC but the 
PECIPNEC ratio was less than unity for all but four compounds. Even in these 
situations it was acknowledged that calculations were performed using 'worst 
case scenarios' and likely environmental concentrations would be significantly 
lower, thereby minimising the risk [87]. In the case of sludge, as no toxicity data 
was available, no risk assessment was performed, however, modelled results 
suggest that sorption and accumulation in sludge are not likely to be major 
processes [87]. Similar results were reported by Stuer-Lauridsen et a/. who also 
noted the lack of toxicity data for sludge [88]. The calculation of PEC values for 
sludge were noted to be considerably more difficult as it requires masses of 
pharmaceutical consumed and masses of sludge produced. Large variations in 
the sludge PEC were observed depending on whether or not the value of KD 
was corrected to include all forms present, (i.e. the inclusion of pK, and pH into 
the expression). The results were found to vary by several orders of magnitude 
but it was noted that PEC values calculated using uncorrected KD may simulate 
a 'worst case scenario' [88]. 
Often the ERA procedure is performed only for a single compound and 
the possibility that the cumulative or even synergistic effects by functionally 
similar compounds are ignored. Such possible effects were investigated by 
Cleuvers [89,90] using a 'concentration addition' estimation. It was concluded 
that acute effects due to pharmaceuticals are rather unlikely due to 
heterogeneous toxicity in the mixture of drugs tested and also that the 
likelihood for increased mixture toxicity is reduced if any of the compounds 
present is below its no observed effect concentration (NOEC). As this is the 
most likely scenario due to the ultra trace concentrations of pharmaceuticals 
suspected to be present, acute mixture toxicity is not expected but further 
research to evaluate chronic mixture toxicity is recommended [89]. Golet et a/. 
estimated the exposure and risk of various fluoroquinolone antibiotics in 
Switzerland [91], using the combined concentration of fluoroquinolones 
detected to estimate the toxicity of a similar acting group of chemicals. The 
calculated risk quotients, (MECIPNEC) was less than unity in both river water 
and WWTP effluent and therefore, it was reported that there was only a low risk 
of fluoroquinolones exhibiting adverse effects [91]. 
A prioritisation of veterinary medicines -in the United Kingdom was 
performed by Boxall et a/. using a developed ERA approach specific for animal 
treatments [92]. The assessment focused upon quantity used, format of usage, 
metabolic data and existing toxicity data where available. Based upon the 
prioritisation, eleven compounds received the top score and it was 
recommended that further studies be performed to asses their environmental 
impact [92]. PEC values for veterinary medicines in soil were estimated by 
Blackwell et a/. [93] and it was found that the PEC was a conservative estimate 
of the MEC and although it does not account for persistence or accumulation a 
sufficient margin of safety was included and therefore acute toxicity was not 
expected. Koschorreck et a/. reported ERAS for three veterinary medicines [94]. 
In all cases Tier I & 2 exposures were required and for two compounds; a 
helmentic and a mastitis treatment, the active ingredients were found to pose a 
serious environmental threat after the Tier 2 assessment and warning levels 
were required to be fitted to the products. In the other case the Tier 2 exposure 
reported that the antibiotic posed no ecotoxicological threat [94]. 
Conceptual and computerised models have also been employed to 
asses the risk posed by pharmaceuticals. Conceptual ideas have attempted to 
link the pharmacodynamics with ecotoxicological risk posed [95,96]. It is 
proposed that such an assessment may be useful as unlike many other 
chemicals, a wealth of data exists for pharmaceuticals ranging from the activity 
for which the drug was designed, to mammalian data from clinical trials. No 
results exist to date using such conceptual approaches. Computerised models 
using quantitative structural activity relationships (QSARs), have also been 
reported [97,98,99]. QSARs allow for the generation of various types of data for 
a molecule based upon its structure and composition by comparison with 
similar molecules for which such information already exists [99]. The 
applicability of QSAR modelling was investigated by Sanderson et a/. who 
ranked 2986 different pharmaceuticals relative to the risk they pose to algae, 
daphnids and fish [99]. It was found that the QSAR model was fast and 
provided reasonable PEC approximations but the results obtained could be 
improved by using a combination of models [99]. The Geography Referenced 
Regional Exposure Assessment Tool for European Rivers (GREAT-ER) model, 
was applied by Schowanek and Webb to simulate European rivers to 
pharmaceutical exposure [98]. It was found that the model again provided 
reasonable PEC estimations, however, the authors acknowledged that a 
refinement to include information from monitoring programs would improve the 
data in order to avoid deviations in the returned results [98]. 
Results from actual toxicity studies have also been reported in the 
literature. Laville et a/. examined the effects of nine human pharmaceuticals on 
the enzyme activity of fish hepatocytes [loo]. The pharmaceuticals were 
classified and it was found that clofibrate, fenofibrate and fluoxetine were the 
most cytotoxic of the drugs studied and the majority of the pharmaceuticals 
exhibited enzyme inhibition. However, the concentrations required were >I000 
times than those that are environmentally relevant [loo]. Similar toxicological 
tests using cell cultures were also undertaken by Caminada et a/. and Gagne et 
a/. [101,102]. In the first instance, Caminada et al. reported effects at the mgL-' 
concentration level for twenty one common pharmaceuticals and therefore, 
concluded that no risk was posed at environmentally relevant levels. Gagne et 
a/. employed environmentally relevant concentrations by using treated 
wastewater as the matrix under investigation in their study and noted that the 
compounds investigated had the ability to exhibit an accelerating effect upon 
the rate of NADPH oxidation in the fish liver cells. A study into the estrogenic 
activity of thirty seven common pharmaceuticals was also performed using 
yeast cultures by Fent et a/. [103]. Six of the investigated pharmaceuticals, i.e. 
cimetidine, fenofibrate, furosemide, paracetamol, phenazone and tamoxifen 
were observed to exhibit weak estrogenic activity at the high y g ~ - '  
concentration level. 
Mimeault et a/. exposed goldfish to the lipid regulator gemfibrozil at an 
environmentally relevant concentration of 1.5 pg~ ' l  and observed 
bioaccumulation in the plasma of goldfish and also reduced the levels of 
circulating testosterone, thereby causing a disruption to the endocrine system 
of the test subjects [104,105]. A similar study reported feminisation of the 
'fathead minnow' exposed to oestrogen in a life cycle test [106]. Emblidge and 
DeLorenzo investigated the risk posed by clofibric acid to three estuarine 
species; algae, crustaceans and fish, but concluded that clofibric acid poses no 
risk to the investigated species at relevant environmental levels [107]. Nalecz- 
Jawecki and Persoone examined the effect of twenty eight pharmaceuticals 
upon crustaceans and reported that seventeen were neither toxic nor slightly 
toxic at a concentration level of 200 m g ~ - '  [ I  081. 
Perhaps the most worrying effect was reported by Schwartz et a/. and 
Ohlsen et a/. who detail the presence of antibiotic resistant bacteria in biofilms 
on the distribution systems of wastewater, surface water and drinking water 
[log]. Bacteria carrying resistant genes were found in drinking water, this is 
unusual as the resistance genes detected are normally associated with 
enterobacteria detected in wastewater and WWTPs. Both studies suggest that 
the transfer of drug resistant genes and plasmids via bacterial conjugation is 
extremely likely and therefore, the threat of further emergence of antibiotic and 
drug resistant microbes is increased due to the exposure to pharmaceuticals in 
the environment [ I  09,110]. 
1.9 PPCPs and Drinkinq Water: 
The presence of pharmaceutically active compounds in surface and 
groundwater poses a troubling concern as such systems are often used as 
supply for the production of potable water. Although the previous section 
focused upon the ecotoxicological risk caused by pharmaceutical residues to 
exposed marine organisms, the presence of drugs in drinking water would 
provide direct entry into human body for any residues present. To-date there 
have been very few published reports . confirming the presence of 
pharmaceuticals in drinking water, the reason for such a small number may be 
two fold: firstly the concentrations present may be too low and therefore, 
beyond the detection limits of most current analytical methods or secondly 
pharmaceutical residues may be efficiently removed during drinking water 
treatment [ I  I I ] .  
The presence of phenazone drugs and their metabolites in German 
drinking water was reported by Reddersen et a/. [ I  121 and Zuhlke et a/. [ I  131. 
Levels detected in both studies were in the p g ~ - I  range using GC-MS for the 
analysis of samples of Berlin's potable water. Clofibric acid, the macrolide 
antibiotic tylosin and the benzodiazepine diazepam were detected in Italian 
drinking water, albeit in the low n g ~ - '  range [114]. The levels detected in 
finished potable water were higher than those measured in the river from which 
the source supply was taken and such an unusual fact was unexplained by the 
authors. Stackelberg et a/. investigated the presence of organic compounds 
attributed in origin to wastewater infiltration in a drinking water treatment plant 
in the USA [115]. Pharmaceuticals were among the compounds detected, 
carbamazepine was present in the largest quantity at 0.258 v g ~ - '  along with 
caffeine and trace quantities of a metabolite of nicotine [115]. Analyses for 
pharmaceuticals were performed at the various stages of drinking water 
production in plants in Louisiana, USA and Ontario, Canada 11161. In both 
plants the analgesic naproxen was determined at -60 ngL-' in raw supply but 
was absent from all finished samples suggesting that the drug was efficiently 
removed during the final disinfection process, (ozonation and chlorination). 
Although the levels of drugs present in drinking water are extremely low 
the risk posed to humans through continual exposure needs to be assessed. 
Webb et a/. estimated the lifetime exposure of the average person who drinks 
two litres of drinking water per day every day over the course of a seventy year 
lifespan for sixty pharmaceutical compounds [117,118]. Assuming the worst 
case scenario, the lifetime ingestion of pharmaceutically contaminated drinking 
water was less than the daily recommended dose for the vast majority of 
compounds investigated [118]. Similar findings were recently reported by 
Schwab et a/. who employed an analogous model [ I  191. In the case where the 
lifetime exposure was greater than a recommended daily dose, (e.g. for 
ethinylestradiol and the x-ray contrast medium iopromide) the calculation could 
be refined and corrected to include metabolic and WWTP removal data. The 
question of the presence of antineoplastic and cytotoxic pharmaceuticals was 
also raised, as although these chemicals are used in the treatment of cancer, 
many are inherent carcinogens themselves and therefore, a significant risk is 
posed by any level, even the most minute exposure [118]. The general 
conclusion from both studies was that the risk is indeed low. However, further 
investigations need to be undertaken to asses the risk posed to more 
vulnerable groups of society such as infants, the elderly, dialysis patients etc. 
[ I  1 I ] .  Despite the low risk public perception will be an important factor, to quote 
from Ref. [120], "As a friend of mine said, even if there's no toxicological 
problem, it makes you a little uncomfortable to know that you are drinking 
something that's been through someone else's kidneys". 
1 . I  0 Technoloqies for the Removal of PPCPs: 
In the previous section the second proposed reason for the low levels of 
pharmaceutical compounds detected in drinking water was attributed to the so 
called 'polishing' treatments used during production. Disinfection of treated 
water is essential to prevent the outbreak of disease and is normally performed 
using strong oxidants such as chlorine, ozone, UV, peroxide etc. The 
applicability of such established techniques for the removal of anthropogenic 
chemicals, including pharmaceuticals, has attracted considerable attention of 
late. 
The first report of the oxidative treatment of pharmaceuticals in water 
was in 2000 by Zwiener and Frimmel [I211 who investigated the ability of 
ozone, and ozone along with hydrogen peroxide, to degrade three 
environmentally relevant pharmaceuticals. Results showed that the anti- 
inflammatory diclofenac was readily degraded at an exposed dose of 1 mgL". 
Using a combination of ozone and hydrogen peroxide diclofenac was again 
removed and ibuprofen and clofibric acid that were previously persistent could 
be reduced to approximately 50% of their initial concentration [121]. The study 
also examined the role of DOM present in natural waters. Such natural 
materials may also react with hydroxyl radicals formed during ozonelH202 
treatment in a scavenging manner, thereby reducing the efficiency of the 
oxidation process. In order to avoid such effects it was found that the quantity 
of ozone needed should equal the quantity of DOM present. Under such 
conditions the oxidative procedure was efficient in removing the drug residues 
present [121]. Ternes et a/. examined the removal of pharmaceutical residues 
using four different processes common to drinking water treatment [122]. Both 
slow sand filtration under both aerobic and anoxic conditions and flocculation 
using ferric chloride were inefficient in removing pharmaceutical residues. 
Granular activated carbon (GAC), was efficient at removing three of the four 
investigated analytes, however, as expected the most polar; clofibric acid 
showed little affinity for the carbon sorbent. Ozonation was also found to be 
efficient but also highly selective. It was observed that specific doses were 
required to remove each investigated pharmaceutical [I221 and in agreement 
with Zwiener and Frimmel, clofibric acid was stable even at high doses 
indicating that it may persist and be present in drinking water samples. Another 
paper investigating ozone applicability published by Ternes et a/., concerning 
the removal of pharmaceuticals and x-ray conti-ast media from wastewater, also 
confirmed that ozonation is a suitable tool for the removal of drug residues 
[123]. It was, however, noted that the ionic contrast agent diatrizoate was 
extremely persistent with a maximum removal of only 15% under extremely 
high ozone doses [123]. Ozonation was also examined as a feasible option for 
the removal of estrogenic activity during drinking water treatment [124]. By 
applying doses normally used during treatment, -1 mgL-' or higher, the three 
estrogenic compounds investigated and their estrogenic activity was almost 
completely removed. It was estimated that the half life of the most potent 
oestrogen, 17-a-ethinylestradiol at pH 8 was in the order of 1 ms [124]. 
A potential problem with the oxidative treatment of pharmaceutical 
compounds is the formation of unknown oxidation by-products. The oxidation of 
diclofenac using ozone and UV/H202 was investigated by Vogna et a/. [125]. 
Diclofenac degradation was found to be quite fast and efficient using both 
oxidation systems. Treatment with both oxidants was found to add hydroxyl 
groups to the molecule followed by cleavage of the carbon nitrogen bond to 
yield dihydrophenyl acetic acid, dichlorohydroquinone and dichloroaniline 
amongst others. By-products were identified by GC-MS, preparative thin layer 
chromatography (TLC) and 'H and I3c nuclear magnetic resonance 
spectroscopy (NMR). The identified oxidation by-products were further 
degraded into organic acids upon further ozone exposure [125]. Therefore, it 
may be concluded that oxidative treatment may have sufficient ability to 
completely remove pharmacological activity, however, diclofenac is a rather 
simple molecule and further research will indeed be necessary to evaluate the 
risk posed by the oxidation by-products formed during the degradation of more 
complex and potent chemicals. 
The oxidation of clofibric acid using ozone and UV/H202 was performed 
by Andreozzi et a/. [126]. The mineralisation of the compound under applied 
oxidant dose was monitored by the formation of chloride ions. As with previous 
studies it was observed that ozone degradation of clofibric acid was a faster 
process than UV/H202 but both oxidation systems were efficient. The degree of 
mineralisation was better under ozone with all chlorine quantitatively recovered 
as chloride indicating that no chlorinated oxidation by-products were formed 
[ I  261. 
The kinetics of the oxidation processes are important in attempting to 
evaluate the doses oxidant and contact times needed. Andreozzi et a/. 
evaluated the kinetics of clofibric acid oxidation using the two aforementioned 
oxidants [126]. It was observed that the kinetics of ozonation depended greatly 
upon the pH at which the experiments were performed, i.e. at higher pH the 
clofibric anion is the dominant species in solution and this moiety was much 
more reactive with ozone than the associated parent acid [126]. The pH of the 
experimental solution during the UV/H202 oxidation system was found not to 
play a major role. These findings can be explained by the fact that ozone is 
selective to certain functional groups while hydroxyl radicals are unselective 
and reacts with many sites on molecules [124]. The kinetics of the oxidation 
using UV/H202 were determined for two pharmaceutical intermediates by 
Lopez et a/. [127], it was found that second order rate constants were quite 
large, (1 08-1 0'' M-~S-') suggesting that the oxidation is quite efficient. The 
doses of oxidant required for complete substrate removal were significantly 
higher than those commonly used during disinfection treatments and therefore, 
maybe uneconomically feasible for large scale implementation 11271. The 
importance of pH on the kinetics and efficiency of the degradation were also 
noted by Balcioglu and Otker [I281 and Huber et a/., [I291 using ozone/H202 or 
ozone for the removal of antibiotics and mixed environmentally relevant 
pharmaceuticals respectively. It was found that antibiotics were efficiently 
removed at neutral pH, whilst at acidic pH the oxidation power of hydroxyl 
radicals was suppressed and at alkaline pH ozone depletion by cross reaction 
with hydroxide was observed [128]. As pH obviously affects the speciation of 
pharmaceuticals in aqueous solution Huber et a/. reported that sample pH 
values in the range of 5-10 allowed for the most efficient degradation of the 
analytes investigated [129]. The proposed reason is that in this pH range many 
pharmaceuticals can be considered as strong nucleophiles and therefore, are 
more prone to attack by electrophilic ozone [129]. Second order rate constants 
calculated for most of the test pharmaceuticals were in average two to three 
times higher than for other investigated organic pollutants such as MtBE or 
trichloroethylene, as a consequence it is expected that the oxidative 
degradation of pharmaceuticals is expected to be extremely efficient [129]. In a 
separate investigation Huber et a/. performed a pilot study to determine the 
applicability of ozonation for the oxidation of pharmaceutical contaminants in 
wastewater [130]. The effect of suspended material, that may scavenge ozone 
and hydroxyl radicals, was investigated but it was found that suspended matter 
did not affect the oxidation of the pharmaceutical analytes but as previously 
mentioned the ozone dose required was proportional to the quantity of DOM 
[130]. In practical terms it was observed that the ozone doses required were 
similar to those needed for microbe inactivation and therefore, ozonation or 
advanced oxidation procedures may indeed be a feasible option for the removal 
of pharmaceutical residues from both treated wastewater and drinking water. 
Biological methods have also been investigated as more ecofriendly 
means for pharmaceutical removal. Using biofilms and biofilm reactors it was 
investigated whether environmentally relevant pharmaceuticals such as clofibric 
acid, ibuprofen and diclofenac could be degraded [131,132]. Biofilms consist of 
eukaryotic and prokaryotic microbes agglomerated through extracellular 
secretions and may be static or dynamic. Ibuprofen was readily biodegradable, 
however, as the concentration of ibuprofen decreased, its two metabolites, 
hydroxyl-ibuprofen and carboxy-ibuprofen, were observed to increase in 
solution [132]. The experiment was performed using both isomers of ibuprofen 
and it was noted that microbial biodegradation of the inactive R-isomer readily 
occurred whilst worryingly the pharmacologically active S-isomer was observed 
to be resistant to degradation. Clofibric acid was also unsuccessfully removed 
by the biofilm [132]. Zwiener and Frimmel also reported that clofibric acid and 
diclofenac were also resistant to biodegradation under aerobic conditions but a 
slight removal improvement was reported when the films were operated under 
anoxic conditions. The formation of hydroxyl-ibuprofen as a function of 
ibuprofen removal was also noted [131]. The applicability of biofilms therefore, 
appears to be limited when compared to the excellent removal efficiency of 
chemical oxidants. 
1.1 1 Prevention is  better than Cure: 
As pharmaceuticals are continually being introduced into the environment along 
with treated wastewater effluents the problem appears to be persistent. Finding 
a solution will not be an easy task as the benefit to medicine outweighs 
environmental presence and risk. The advent of environmentally friendly 
pharmaceuticals is not going to happen in: the short term considering the 
amount of time and money required for drug development. A concept 
introduced in Sweden may provide some promise. Pharmaceuticals were 
ranked based upon the threat they pose to the environment allowing doctors to 
prescribe, or patients to choose, more environmentally friendly treatments from 
existing medicines [133]. The use of the 'precautionary principle', which can be 
interpreted as the lack of scientific facts concerning a potential hazard not 
justifying inaction to prevent such a hazard [133], is inappropriate of 
pharmaceuticals for the above reasons. 
As the majority of pharmaceuticals and their metabolites are excreted 
from the body through the urine, urine separation and subsequent treatment 
may be a viable for minimising the quantities of pharmaceuticals released to the 
environment [134]. Urine separation offers a number of potential benefits, 
primarily the removal of 80% of the nitrogen and 45% of the phosphate loading 
into wastewater treatment plants [ I  351. Larsen et a/. note that in the absence of 
urine a carbon nitrogen balance is achievable in WWTPs and under such 
conditions the microbial population feeding on organic matter could 
successfully remove all nitrogen content [134]. Urine separation does not 
require massive capital investment to be performed, simply the change over 
from standard to so called 'NoMix' toilets which store the urine in a tank for later 
remote controlled discharge [134]. Rauch et a/. developed a model for urine 
production in the average household that would help with planning the 
frequency of collection and subsequent treatment [136]. A report of urine 
separation in practice was also recently published [137]. A urine separation 
system was included when a student dormitory was being constructed. The 
system did not function as well as planned for nutrient removal, however, it was 
found that user attitudes and ignorance were to blame. Also the cost of 
implementing the system lay with the management company when compared 
with municipal sewer systems, whereby the expense is completely on the local 
authority. The author acknowledged that administrative change may be 
required to make the system more attractive. Urine separation is still hoped to 
be a prospect in minimising environmental contamination with pharmaceutical 
compounds, especially if used in conjunction with the aforementioned chemical 
oxidants [ I  331. 
An alternative use for spent activated sludge was proposed by Otero et 
at. [I381 who used sludge for the removal of two dyes and phenol from water. 
The sludge underwent pyrolysis and acid activation and it was found that such 
treatment imparted high porosity and a large surface area to the new sorbent. 
Studies with the three chosen compounds revealed that they could be 
efficiently removed from water although the interaction mechanism was not 
evaluated. It was suggested that the material may be used for the successful 
removal of other organic micro pollutants. 
It appears that finding an acceptable solution for the prevention of 
pharmaceutical compounds contaminating the aqueous environment is by no 
means an easy task and therefore, an area that requires significant research. 
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2.0 A Review o f  the Analytical Approaches used for 
the Determination of Pharmaceutical Residues in 
Environmental Samples. 
2.1 Introduction: 
Recent advances in analytical technology have allowed chemists to detect 
compounds at concentrations that were previously unattainable. The advent of 
commercially available interfaces for the coupling of LC with MS and reports of 
pharmaceutical compounds as environmental contaminants can be seen as two 
interrelated events. The traditional 'gold standard' GC-MS approach is not 
inherently suitable for the determination of pharmaceutical residues and 
consequently a derivatisation procedure must be incorporated into the procedure. 
Such an approach is not favourable as it increases the levels of variability of the 
method and also as derivatisation procedures are not specific the likelihood of 
multiple peaks for a single analyte with many functional groups increases, 
thereby making quantitation extremely complicated. The methods developed for 
the determination of pharmaceutically active compounds in the environment to 
date have focused upon the use of a three step procedure; i.e. sample 
preconcentration to increase method sensitivity, the use of liquid chromatography 
as an analytical separation method and finally specific detection using mass 
spectrometry. This section aims to review the theory and application of the 
analytical approaches used by researchers for the determination of trace 
residues of environmentally relevant pharmaceuticals to the present day. 
2.2 Sample Preparation: 
2.2.1 Considerations for sample preparation: 
It is unfortunately all too often the case that in environmental samples the 
analytes of interest are present at concentrations below or near to the limits of 
detection of the technique used to perform the analytical measurement. This is 
especially true in the case of pharmaceutical residues, whereby levels detected 
to date have been in the low I Jg~ - '  to the n g ~ - '  range [I]. In order to ensure that 
there is confidence in the analytical measurement and that the generated results 
reflect the composition of the original sample, it is therefore, required that the 
sample preparation process leads to an enrichment of the analyte to a level more 
amenable for detection by the analytical technique being employed. 
Consequently, the resultant analyte signal is significantly higher than the baseline 
noise. Therefore, the first consideration for the inclusion of a sample preparation 
technique into the analytical method is to yield lower overall method detection 
limits, i.e. increased analytical sensitivity [2]. 
The second consideration for the inclusion of a sample preparation 
procedure into the analytical method may include the need to 'clean up' the 
sample by removing the matrix prior to analysis [2]. Environmental samples 
contain a high proportion of DOM as a result of natural processes that may 
interfere with the analytical determination, e.g. DOM may spoil chromatography 
columns or absorb at the same wavelengths used in spectrophotometric methods 
etc. Therefore, it is often necessary to completely isolate the analyte of interest 
from the matrix which may then be discarded in order to increase the selectivity 
of the method [3]. 
The last consideration for the inclusion of a sample preparation procedure 
may involve the exchange of the analyte from the natural matrix, e.g. water, into 
a solvent more compatible with the analytical technique to be used [2]. It is a 
necessity for techniques such as infrared spectroscopy (IR) or nuclear magnetic 
resonance spectroscopy (NMR) and GC that the analyte must be present in a 
specific environment prior to analysis, usually an organic solvent, (or deuterated 
solvent in the case of NMR) as the sensitivity of such techniques is negatively 
affected by the presence of water [2]. 
Although a sample preparation procedure may be necessary for any or all 
of the above reasons, the following conditions must also be fulfilled in order to 
ensure that it is an efficient and viable process. It is desired that the sample 
preparation procedure is convenient and easy to perform and relatively 
inexpensive, that sample loss as a result of the procedure is at an absolute 
minimum, that there is sufficient analyte selectivity and that the procedure does 
not lead to the creation of conditions that may adversely affect the analytical 
measurement, i.e. extremely acidic extracts may ruin chromatography columns 
P I .  
2.2.2 The move towards solid phase extraction: 
In the past, the primary method of extracting and preconcentrating aqueous 
samples was solvent extraction, referred to as liquid-liquid extraction; (LLE). LLE 
involves the distribution of analytes between two immiscible liquids, usually water 
and an organic solvent such as ether or hexane and is normally performed by 
agitating the solvents to ensure mixing and mass transport and then allowing the 
two immiscible phases to coalesce and separate [5]. Although LLE is relatively 
simple to perform and manipulate, it does suffer from a number of drawbacks 
which include the large consumption of organic solvents, the high costs caused 
by spent solvent disposal, problems with inefficient phase separation and 
emulsion formation that may lead to ruination of the sample. Another significant 
problem with LLE is the small preconcentration factors achievable. The ability of 
LLE to enrich sample components is governed by the ratio of the two liquid 
phases and therefore, it is impossible or impractical to extract large volumes of 
sample often needed for suitable analyte enrichment with small volumes of 
organic solvent [5]. As a consequence of the above factors the reported use of 
LLE for environmental analysis has declined, however, LLE based techniques 
are still popular for the processing of small volume samples of biological fluids 
[6,71. 
A historical review of the advent of solid phase extraction (SPE) was 
presented by Liska in 2000 [8]. In the 1970's the first SPE procedures involved 
the use of activated carbon as a sorbent for the extraction of organic 
contaminants from water samples, chloroform was used as an eluent. However, 
the process was rather ineffective due to the low affinity of polar pollutants for the 
activated carbon sorbent and the inability of chloroform to elute high affinity 
compounds from the sorbent mass 181. The first successful SPE methods applied 
the use of porous polystyrene polymers, (XAD resins) whereby up to 150L of 
water sample could be passed through the sorbent and then eluted using 15 mL 
of diethyl ether which in turn was reduced in volume and analysed by GC [9]. 
Such a method allowed for the determination of previously unmeasured organic 
contaminants, e.g. polynuclear aromatic hydrocarbons at the low p g ~ - l  evels in 
the aquatic environment. The first reports of silica based SPE materials were 
also published in the 1970's [8]. The use of porous polymers was limited until the 
1980's and the advent of commercially available sorbents in pre-packed columns 
[9]. The 1990's saw the development of SPE disks and new sorbents based upon 
immunoaffinity interaction and molecularly imprinted polymer supports (MIPS), 
which offered increased levels of selectivity and specificity previously 
unachievable [a]. The progress of SPE continues with the development and 
commercialisation of hydrophilic lipophilic balanced polymers such as Waters 
Oasis HLB" that allow for the preconcentration of compounds displaying a broad 
spectrum of polarity in a single extraction [lo], along with the availability of fully 
automated and instrument compatible SPE systems like prospektTM and 
symbosism by Spark Holland [8] that allow for fast and more effective sample 
preparation. 
The change from LLE to SPE based sample preparation techniques arose 
due to the lower costs involved with both equipment and solvents, (SPE was 
considered a 'greener' option compared with LLE) and the ease at which the 
procedure could be performed or even automated. SPE also offered chemists the 
ability to extract samples in the field allowing for easier sample transport and 
storage [ I  I ] .  However, a number of limitations are also known. Because SPE 
involves the use of a synthetic sorbent, problems may arise with the batch-to- 
batch reproducibility of the product or the surface chemical modification. Also 
impurities present from the manufacturing process may adversely affect the 
performance of the sorbent [ I  I ] .  As the sorbent bed is of limited smaller capacity 
compared to a bulk liquid phase as used in LLE, the possibility of sample loss 
exists due to overloading and breakthrough. The particulate nature of the sorbent 
bed and the use of frits can be prone to blockage under certain conditions or may 
permit channelling and therefore, poor sample sorbent interaction leading to low 
analyte retention [12]. Despite these limitations SPE has emerged as a preferred 
sample preparation option due to economic and safety reasons. 
2.2.3 The four steps of SPE: 
Regardless of the intended application, each SPE procedure consists of four 
basic steps, i.e., conditioning, sample adsorption, washing and elution, Fig. 2.1 
following depicts the four steps of SPE in practice. Other sample pre-treatment 
procedures may also be necessary such as filtration to remove particulate matter 
and pH adjustment. 
Conditioning Sarrple Loading Washing Elution 
Component 
Analyte 
-* Matrix Component 1 
$ Matrix Component 2 
1 Direction of flow 
Concentrated Analyte 
Figure 2.1: The four steps of SPE. 
Each step of the SPE procedure is critically important in achieving a 
suitably concentrated and pure extract ready for instrumental analysis. 
Conditioning involves passing a water miscible solvent such as methanol or 
acetonitrile through the sorbent bed in order to prepare and 'wet' the active 
surface groups and therefore allow for efficient interaction with the sample [9]. 
The conditioning step also allows for the elution of any adsorbed organic 
impurities from the sorbent bed. The sorbent is then washed with water to 
remove the conditioning solvent prior to the introduction of the sample. Samples 
are passed through the sorbent bed usually under vacuum or pumped under 
pressure to allow for analyte retention by appropriate interaction with the sorbent, 
(types of sorbents and retention mechanisms will be reviewed later). The flow 
rate through the sorbent should be held constant over the course of sample 
introduction to avoid adverse affects on retention [9]. A washing procedure is 
then used to remove undesirable matrix components or excess salts and 
inorganics from the sorbent. The wash solvent conditions are usually optimised 
so that they remove the majority of matrix components without affecting the 
retention of the analyte of interest [2,9]. The last step of the SPE procedure 
involves elution of the analytes using a suitable solvent. The flow of the elution 
solvent is generally slower than the flow of the sample through the sorbent bed to 
ensure that all of the retained analyte is eluted. In order to maximise the 
preconcentration factor the volume of elution solvent required should be kept to a 
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minimum, usually three times the volume of the sorbent [I ]. However, larger 
volumes may be used with subsequent volume reduction to yield a concentrated 
extract suitable for instrumental analysis. It is desirable that the analytes of 
interest have a retention factor (k) as close as possible to zero under the elution 
conditions to ensure complete recovery [9]. 
2.2.4 Theoretical considerations: 
Solid phase extraction is a frontal chromatography whereby the sample, (acting 
as the mobile phase) is continuously fed into the stationary phase bed. In general 
the concentration of analyte present in the sample is quite low and therefore, the 
volume of sample that can be passed through the sorbent bed is determined by 
the breakthrough volume for the particular sorbent [Ill. The breakthrough 
volume for a particular sorbent is determined from the breakthrough curve, (that 
may experimentally determined and is analogous to determination of 
chromatography column capacity), see Fig. 2.2 [I 31. From Fig. 2.2 it can be seen 
that the analyte, of concentration X passing through the sorbent at a constant 
flow rate is quantitatively retained by the stationary phase until the capacity of the 
sorbent is exceeded. At this point the detection of analyte emerging from the 
sorbent is called the breakthrough volume; (VB). 
S a m p l e  V o l u m e  
Figure 2.2: Typical breakthrough curve for SPE sorbent, adapted from [I I]. 
It can also be seen that the resultant breakthrough curve is sigmoidal and 
a second point, Vc, represents the complete saturation of the sorbent analyte and 
therefore, the concentration of analyte entering the sorbent equals the 
concentration emerging from it [13]. The point of inflection of the breakthrough 
curve corresponds to the retention volume, VR, as the first derivative of the 
breakthrough curve can be assumed to be a Gaussian distribution analogous to 
the peaks observed in elution chromatography [14]. It is desirable to choose a 
sorbent with a large breakthrough volume thereby allowing for a greater analyte 
enrichment. 
The breakthrough volume may be mathematically related through the 
retention volume by the following equation [ I  1 , I  3,141: 
V, = V, + 20, (Eq. 2.1) 
Where a" is the standard deviation of the axial dispersion of the analyte through 
the sorbent bed and is calculated using: 
V (I + k ) / a  (Jv= o (Eq. 2.2) 
Where: 
V, is the inter particulate volume, 
k is the retention factor, 
N is the number of theoretical plates which is calculated using the following 
equation: 
2 N = V,(V, - oV )/av (Eq. 2.3) 
The values of N, k and VR can be determined using SPE coupled to LC. 
The pressure required to force the sample through the sorbent bed is 
described by the following equation [I I].  
APIL = pq(p/dp2 (Eq 2-41 
Where: 
APIL is pressure drop per unit length across the sorbent, 
p is the linear velocity of the sample, 
q is the viscosity of the sample solution, 
cp is the flow resistance parameter of the sorbent, (typically 1 03) and 
d, is the average sorbent particle diameter. 
It can be seen from the above equation that the size of the particles 
affects the pressure generated, i.e. the smaller the particles the higher the 
pressure generated and vice versa. 
The elution volume required for the recovery of greater than 99% of the 
analytes from the sorbent of bed volume V, may be calculated by [ I  31: 
V, = V,[l + k][I+ (2.3/fi] (Eq. 2.5) 
The volume of solvent required may be reduced by minimising the inter 
particulate volume of the sorbent or by minimising the value of k. 
2.2.5 Sorbent types and retention: 
The popularity of SPE is reflected by the large choice of commercially available 
sorbents for all manner of applications. As with chromatography columns the 
majority of SPE sorbents are either silica or polymeric based. The retention 
mechanism depends upon the sorbent used, although reversed-phase sorbents 
are by far the most common, normal phase, ion exchange and mixed mode 
formats also exist. In order for efficient extractions leading to concentrated pure 
extracts it is desired that the sorbent used have a high active surface area in 
order to shift the equilibrium in favour of the solid phase and therefore, promote 
analyte retention. The interaction between the analytes and the stationary phase 
should be suitably strong to allow for retention but easily reversed to guarantee a 
high degree of analyte recovery. The sorbent should be pure and free from 
impurities that may leach out and contaminate the extract and the sorbent should 
allow for good contact between the sample and active groups [9]. 
Normal phase sorbents are available using inorganic oxides like silica, 
alumina or Florisil and allow for the retention of polar analytes based upon 
dipole-dipole or hydrogen bonding interaction [ I  I ] .  Inorganic oxides offer a high 
active surface area for interaction and under pH conditions that promote the 
dissociation of surface hydroxyl groups allow the sorbent to be used as an ion 
exchanger [15]. However, drawbacks of inorganic oxides include pH instability 
and the possibility of irreversible adsorption or catalytic transformation of the 
adsorbed analyte [ I  I]. The majority of applications of normal phase SPE have 
reported its use for the clean up of complex matrices and the removal of polar 
interferants prior to instrumental analysis [ I  6,17,18]. 
Reversed-phase sorbents consisting of bonded phase silica, (alkyl silicas 
such as Cq8 or C8) or polymeric based materials are widely used for the 
extraction of organic pollutants from aqueous solutions [15]. Retention is based 
upon either van der Waals interactions or n-n interactions with available groups 
[19]. Silica based sorbents are widely used, however, they suffer from limited pH 
47 
stability. Residual silanol activity can cause problems with the elution of basic 
analytes and breakthrough volumes can be small for polar analytes [15]. 
Polymeric supports using styrene or methacrylate as monomers and divinyl 
benzene as cross linking agents offer pH complete stability compared to silica 
based materials and the increased interaction and retention involving n-n 
interactions [20]. However, reversed-phase polymers are generally hydrophobic 
and can shrink or swell in some organic solvents 1211. The hydrophobicity of 
polymeric supports can be reduced by the inclusion of a hydrophilic co-monomer 
during the polymerisation process; successful examples of such an approach 
includes Waters Oasis H L B ~ ~  which incorporates the water wettable N-vinyl 
pyrrolidone monomer and can be used directly with aqueous samples and 
without the need for a sorbent conditioning step [10,21,22]. Solvents used for the 
elution of reversed-phase sorbents include methanol, acetonitrile, acetone 
amongst others. Reversed-phase sorbents have been used for the extraction of a 
wide variety of organics from numerous sample matrices [23]. 
Ion exchange sorbents retain analytes based upon electrostatic 
interactions between oppositely charged groups on the analyte and the sorbent 
surface. In general sulphonic or carboxylic &acid groups are used as cation 
exchange groups while quaternary, secondary or primary amines are used as 
anion exchangers [24]. Both silica and polymeric based supports have been used 
in the preparation of ion exchange resins [ I  I ] .  Ion exchange sorbents may also 
contain some reversed-phase groups thereby allowing the retention of more 
bulky organics containing ionisable groups. Another application of ion exchange 
sorbents has focused upon the removal of interfering ionic species prior to 
analysis by ion chromatography (IC) or capillary electrophoresis (CE) [25,26]. 
Such processes allow for the removal of nitrate and hydroxide, chloride and 
sulphate by passing the sample through sulphonic acid sorbents in the hydrogen, 
silver or barium form, respectively. 
A rather underused alternative to ion exchange sorbents is to use ion-pair 
SPE whereby an ion pairing reagent is added 'to the sample in order to increase 
the retention of polar and ionic compounds using reversed-phase sorbents [27]. 
Typical ion pairing reagents used have included linear alkyl sulphonic acids for 
the extraction of basic analytes and amines or quaternary ammonium salts for 
the extraction of acidic analytes, concentrations used are generally in the milli- 
molar range [27]. Few reports of ion-pair SPE exist in the literature primarily due 
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to the extra uncertainty introduced by the inclusion of an ion pairing reagent, the 
extra extraction optimisation steps required and the possibility that the ion pairing 
reagent may negatively affect the chromatographic separation or may be 
incompatible with MS detection [27]. Reported applications of ion-pair SPE 
include the determination of naphthalene sulphonates in water using 
tetrabutylammonium bromide as the ion pairing reagent [28], the determination of 
pamoic acid in animal serum [29] and the extraction of the diabetes treatment 
metformin from plasma using sodium dodecyl sulphate as the ion-pairing reagent 
[30]. However, it is worth noticing that in each instance the ion-pair extraction 
was followed by determination using ion-pair HPLC with optical detection, 
thereby suggesting that the analytical method may have to be changed in order 
to facilitate the ion-pair extraction. 
2.2.6 The SPE approach used for the determination of PPCPs: 
As stated previously, due to the ultra trace levels of pharmaceutical compounds 
that may be present in the aquatic environment the preconcentration of samples 
prior to instrumental analysis is often a prerequisite and to facilitate this sample 
enrichment SPE has been the favoured approach reported to date. Reports of 
SPE in both the off-line format using disposable cartridges and in the on-line 
mode using short columns for the determination of drug residues have been 
reported in recent years. 
Of the reported methods, those that use reversed-phase disposable 
cartridges in the off-line mode are in the majority. Sorbents used for the 
enrichment of drug residues from environmental matrices have included silica C8 
and Cq8 [31,32,33], cross linked polystyrene divinyl benzene [34,35,36], phenyl 
[37], silica C2 for the extraction of antibiotics [38] and an immunosorbent for the 
extraction of sulfamethazine from soil and aquatic samples [39]. Passive 
sampling techniques have also been reported [40]. However, the greatest 
proportion of reported methods have focused upon hydrophilic lipophilic balanced 
polymers such as Waters Oasis H L B ~ ~  or strata-xTM by Phenomenex, 
[41 ,42,43,44,45,46,47,48149150151 ,52,53]. The popularity of such polymeric 
sorbents is reflected by the reasons discussed previously, i.e. the ability to 
extract compounds of varying polarity in a single extraction, increased retention 
and ease of use. Aguera et a/. favoured the use of CI8 over Oasis H L B ~ ~  for the 
extraction of Triclosan and biphenyl01 from sediment and wastewater due to 
increased rates of analyte recovery determined when using the silica based 
material, however, it was also reported that the initial elution solvent used, 
(methanol) for the evaluation of the SPE sorbents was later replaced with 
acetone due to excessive retention of biphenyl01 on the C18 sorbent, however, 
the other sorbents investigated were not re-evaluated under the revised 
conditions [33]. In some instances the use of tandem SPE was also reported 
whereby a sacrificial sorbent was included to selectively retain possible matrix 
interferences [54,55,56]. Although such an approach may be useful for the clean 
up of particularly matrix rich samples, the extra costs involved and possible loss 
of target analytes due to retention on the sacrificial sorbent may make tandem 
SPE an unfeasible procedure. 
A rather under investigated approach for the determination of ultra trace 
organic contaminants and particularly pharmaceutical residues is the use of on- 
line SPE. On-line met hods offer greatly increased levels of sensitivity compared 
to off-line methods as the entire enriched sample components can be analysed 
instead of a small proportion of the concentrated extract. On-line methods also 
offer reduced sample handling and the greater possibility for complete 
automation. Chen et a/. reported the use of on-line SPE using column switching 
for the determination of caffeine as an anthropogenic maker for the tracking of 
sewage effluent in natural waters 1571. Detection limits on the range of 0.1 pgL-' 
were attainable from 50 mL of sample. Endocrine disrupting chemicals such as 
estrogens and alkyl phenols were also determined using an on-line SPE 
approach [58,59,60] and method detection limits in the pgL-' range were 
frequently reported from moderate quantities of sample (250 mL) [59]. Sancho et 
a/. used on-line SPE for the determination of 50 compounds comprising 
pesticides and their transformation products from water samples [61] and again 
limits of detection in the low ngl-' range from just 1.3 mL of sample were 
attainable using LC-MSIMS. 
From a theoretical standpoint, on-line SPE allows for the easier 
determination of breakthrough volumes compared to off-line extractions thereby 
allowing for a rapid optimisation of the sorbent and extraction parameters. A 
notable limitation of on-line methods involves the quantity of sorbent that can be 
used. As stated previously the pressure generated is proportional to the particle 
size, as are the number of theoretical plates available and therefore, the retention 
efficiency of the sorbent. Therefore, the use of long columns of small particles for 
rapid extraction will be impractical due to the excessive backpressure generated 
as would the use of large particles for selective extractions due to low theoretical 
plate numbers consequently available. In order for on-line SPE to be a viable and 
successful process a careful examination of the sorbent material is essential. 
2.3 Analytical Separation: 
2.3.7 The importance of liquid chromatography: 
An efficient separation of all analytes targeted for environmental monitoring is a 
vital component of the overall analytical approach. Due to the complexity of 
extracted samples and the lack of detection mechanisms with the ability to 
confidently identify and quantitate the analyte of interest in the presence of all 
other matrix components, the need for a chemical separation is paramount. 
The concept of chromatographic separation was first introduced by Tswett 
in 1903 who reported the separation of plant pigments using calcium carbonate 
as an adsorbent [62]. Due to the inability of others to repeat the work of Tswett 
and language barriers, the method lay dormant for over thirty years until German 
scientists investigated and accepted its applicability for the purification of natural 
products [63]. A further problem with Tswetts work was the solubility of the 
adsorbent in water. However, in the 1940's. Martin and Synge developed an 
alternative using partition chromatography based upon the distribution of an 
analyte between two liquid phases and followed on with the invention of GC in 
the early 1950's [63]. GC developed and matured rather quickly as an analytical 
technique due to the influence of the petrochemical industry but a major 
drawback of GC was its limited applicability for the determination of analytes with 
low volatility or thermal stability. A solution to these problems was offered by 
liquid chromatography and many experts in the GC field turned their attention to 
a resurgence of liquid phase separations [64]. Modern LC evolved due to the 
advance of small porous silica particles, chemically modified stable supports and 
more reliable and user friendly instrumentation [63]. Smaller and more 
reproducible particles leading to more efficient separations and faster analysis 
times were reported through the late 1970's to the 1990's. Just as the 
petrochemical industry had played a critical role in the development of GC, the 
pharmaceutical industry and its associated regulatory authorities were similarly 
important in the development of modern LC. It is now estimated that modern LC 
instrumentation is the most important piece of equipment in analytical 
laboratories across the world after balances and pH meters [63]. The versatility 
and superior selectivity of LC along with the desire to perform faster and more 
efficient separations are the current driving forces for the continuous 
development and application of modern LC for the separation and determination 
of a wide variety of analytes. 
Methods for the determination of pharmaceutical residues in 
environmental samples have focused primarily on the use of liquid 
chromatographic separations rather than the use of GC that was previously 
employed for the determination of the majority of environmentally relevant 
analytes. The reason why LC is preferred to GC for pharmaceutical analysis is as 
previously mentioned; pharmaceuticals are polar molecules of moderate 
molecular weight and lack volatility [65]. Reported methods for the determination 
of pharmaceutical residues reflect the superiority of LC for the determination of 
polar analytes. 
2.3.2 Liquid chromatography - theoretical considerations: 
Chromatography may be defined as the distribution of analytes between two 
phases; a stationary phase and a moving mobile phase. The separation arises 
due to differential rates of migration of the analytes through the chromatographic 
column based upon their affinity for either the stationary or the mobile phase [66]. 
In liquid chromatography the mobile phase consists of a solvent or a mixture of 
solvents whilst the stationary phase is a solid support with or without chemical 
modification. Depending upon the polarity of the stationary phase the separation 
is termed either normal phase; whereby the stationary phase is a polar solid and 
the mobile phase is a nonpolar solvent, or reversed-phase; whereby the 
stationary phase is a nonpolar support and the mobile phase is a polar solvent 
[67]. As reversed-phase separations are the most common, indeed as all the 
reported methods for the determination of pharmaceutical residues to date are 
based upon reversed-phase LC, normal phase LC will no longer be considered in 
this review. 
The concept of analyte retention is demonstrated by Fig. 2.3. A three 
component mixture is injected onto the top of the column and is carried through 
the column by the continuous flow of mobile phase. The separation of the mixture 
arises due to differential migration through the column. 
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Figure 2.3: Hypothetical chromatographic separation adapted from [68]. 
The differential migration of analytes through the chromatographic column 
occurs as a result of the equilibrium distribution of each mixture component 
between the mobile and stationary phases [68]. Depending upon the position of 
the equilibrium, analytes with affinity for the mobile phase will elute earlier than 
those who show a greater affinity for the stationary phase as their path through 
the column is retarded due to interaction. The rates of differential migration can 
therefore be altered by changing either the composition of the mobile phase or 
the stationary phase [68]. The interactions that lead to retention are dependant 
upon the separation mode employed; see section 2.2.5 for a discussion of such 
interactions and mechanisms. In reversed-phase chromatography the most polar 
sample component will elute from the colum~ffjcs_t~\~ith_the~rn~st~n~ngnIa~sampk 
component being retained for the longest time. Therefore, by altering the polarity 
of the mobile phase using gradient elution, retention of polar components can be 
promoted by increasing the mobile phase polarity and in turn more hydrophobic 
components can be eluted by decreasing the polarity of the mobile phase. 
The eluted peaks are detected in time as they pass from the column and 
the resulting plot of detector response versus time is referred to as a 
chromatogram. The eluting peaks are generally bell shaped similar to the 
Gaussian distribution [69]. The amount of time it takes a component to elute from 
the column and be detected following injection is referred to as the retention time 
(TR) and is characteristic for that component under the specific conditions used. 
The time taken for the mobile phase to pass through the column is assigned (To). 
The retention factor (k) calculated using the following equation, is a numerical 
representation of the actual quantity of time a component spends in the 
stationary phase, 
(Eq. 2.6) 
Low values of k for a particular component indicate that the majority of its time is 
spent in the mobile phase and vice versa. It is generally desirable to have k 
values in the range of 1-5 which suggests that all analytes are suitably but not 
excessively retained on the column [67]. If two or more sample components have 
the same k value they will not be separated under the conditions used [69]. The 
ratio of retention factors of two sample components is called the separation factor 
(a), given as: 
k a = 2  (Eq. 2.7) 
kl 
The higher the value of a, the greater the degree of separation between the two 
components. If the value of a equals one, the two sample components will not 
separate and will therefore coelute [70]. 
The efficiency of the separation can be- evaluated from the degree of 
resolution between the separated components calculated using the following 
equation: 
(Eq. 2.8) 
Where W is the baseline width of peaks 1 and 2 respectively. 
The larger the value of Rs the more resolved the two peaks are. Rs value 
of 1.5 or greater suggests that the two components are completely baseline 
resolved [68]. A quantitative estimation of the efficiency of the column and 
therefore the separation is determined by calculating the number of theoretical 
plates (N) using the following equation: 
(Eq. 2.9) 
The concept of the theoretical plate was first presented by Martin and Synge in 
an attempt to elucidate the theory of the separation. The term arises from the 
theory of fractional distillation [67]. Each plate can be assumed to represent a 
single equilibrium distribution of the analyte between the mobile and stationary 
phases and therefore the higher the value of N, the greater the number of 
equilibrium distributions involved and consequently the more efficient the 
separation. The effective height of a theoretical plate (H) may be determined by 
dividing the length of the column by the theoretical plate count. The smaller the 
value of H the greater the efficiency of the peak. 
The resolution of the separation is dependant upon the above variables 
and can be calculated mathematically using the following equation: 
(Eq. 2.10) 
Where k2 is the retention factor of peak 2 and k,, is the average retention factor 
of the two components. 
From the above equation it can be seen that the resolution can be 
improved by increasing N, i.e. by increasing the column length, by altering the 
selectivity of the separation and increasing the retention of the analytes. 
2.3.3 Band broadening in liquid chromatography: 
Although samples are applied to chromatographic columns as discrete plugs the 
resultant peaks become distorted during their passage through the 
chromatographic system leading to the formation of bell shaped peaks similar to 
the Gaussian distribution. The diffusive variance associated with a Gaussian 
peak is described by the expression [70]: 
a2 = 2D,t (Eq. 2.1 1) 
Where: 
Dm is the diffusion coefficient and 
t is the time spent within the chromatographic system. 
From the above expression it can be deduced that the width of the 
chromatographic band is proportional to the square root of the retention time and 
therefore, increasing the retention time leads to the formation of broader peaks 
[70]. The actual processes that assist with the broadening of chromatographic 
peaks can be attributed to column and extra-column effects. 
Extra-column effects are processes that cause the spreading of 
chromatographic bands outside the column and arise primarily due to 
mismatches in tubing diameter or large sources of dead volume within the 
system, e.g. large volume detector flow cells etc. Extra-column effects can be 
minimised by choosing suitable lengths of tubing of appropriately small internal 
diameter in order to minimise the loss of the resulting separation or the 
dispersion of the injected sample within the mobile phase prior to entering the 
chromatographic column. 
The contribution of the chromatographic column to band broadening can 
be evaluated using the van Deemter equation which states that the separation 
efficiency, (in terms of H) is affected by the mobile phase flow rate and the 
column itself, [70]: 
(Eq. 2.12) 
Where: 
A, B and C are constants for a column and stationary phase and 
p is the mobile phase linear velocity. 
Therefore, from the above equation it can be seen that the mechanisms of 
band broadening are independent of, directly proportional and inversely 
proportional to the flow of mobile phase through the column [70]. 
The A term in Equation 2.12 is referred to as the multiple path term or 
Eddy diffusion and describes the multiple possible random paths of the molecule 
through the particulate bed leading to the distortion of the chromatographic band 
due to the fact that some molecules will take a shorter path than others and will 
consequently elute from the column earlier [69]. Such a fact is depicted pictorially 
in Fig. 2.4. 
The B term in the van Deemter equation represents longitudinal diffusion 
along the axis of the column. Longitudinal diffusion arises due to the random 
distribution of sample molecules in all directions due to the existence of a 
concentration gradient, from an area of high concentration inside the band to 
areas of low concentration on the edges of the band [68,70]. The net result as 
can be seen in Fig. 2.4 again leads to the spreading of the chromatographic 
band. 
The C term of the van Deemter equation accounts for the mass transfer of 
each analyte from the mobile phase to the stationary phase and back again. 
From Fig. 2.4 it can be seen that there is a layer of mobile phase surrounding 
each particle that is essentially stagnant when compared to the mobile phase in 
the inter particulate spaces. Therefore, this stagnant layer of mobile phase may 
contribute to band broadening as molecules present in this layer are not moving 
at the same velocity when compared to molecules in the 'bulk' mobile phase [68]. 
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Figure 2.4: A pictorial representation of band broadening mechanisms, adapted from [68,69,70]. 
The stagnant mobile phase is also important as it impedes the interaction 
of molecules in the bulk mobile phase with the stationary phase, i.e. sample 
molecules must diffuse from the bulk into the stagnant layer and then from the 
stagnant layer onto and into the stationary phase and then back out again [68]. 
The net effect leads to a retardation of molecular movement again leading to a 
distortion of the chromatographic band. As these processes are continuously 
occurring as the sample passes long the length of the column it can be seen that 
the longer the column residence time the greater the effect of band broadening. 
Therefore the effects of band broadening need to be minimised in order to 
maximise the efficiency and resolution of the separation and also to avoid 
problems with quantitation. A plot of H versus p should in theory yield a minimum 
value of H that suggests the optimum linear velocity for maximum efficiency. 
Another alternative is offered by capillary or monolithic columns which reduce the 
A and C terms of the van Deemter equation allowing for more efficient 
separations. 
2.3.4 LC Instrumentation: 
Instrumentation for LC consists of basic but integral parts, i.e. a pump capable of 
delivering solvents steadily at high pressures, a sample injection system, the 
chromatography column, a detector to monitor the column output and a data 
handling system. It is essential that all components of the system operate 
efficiently and reproducibly, e.g. disturbances in solvent delivery will manifest 
themselves as baseline noise in the detector output and therefore, cause a 
reduction in the sensitivity of the analysis. 
A variety of pumping systems for LC have been developed ranging from 
displacement pumps whereby the solvent is forced out of the reservoir by 
external pressure to syringe pumps, however, the majority of modern LC pumps 
use double head reciprocating pumps, a schematic of which is shown in Fig. 2.5. 
Such a pump operates using sinusoidal dual piston movements that are 180' out 
of phase and allows for a constant flow of solvent with minimal pulse disturbance 
[71]. Dual head reciprocating pumps also allow for the performance of flow 
gradients as the volume delivered can be changed rapidly be adjusting the 
displacement stroke volume or the stroke frequency [68]. 
The introduction of samples into a high pressure mobile phase as a 
discrete plug to avoid band broadening and also to avoid disturbing the mobile 
phase flow is usually performed using sample loop type injectors, e.g. Rheodyne 
injectorsTM [71], (see Fig. 4.1). Injection is performed by loading the sample into a 
loop of defined volume when the valve is in the load position, by switching the 
valve to the inject position the mobile phase is redirected through the sample 
loop and carries the loaded sample onto the chromatographic column 1721. Loop 
injectors are also easily automated and are incorporated into autosamplers by 
many manufacturers. Column switching and selection can also easily be 
performed using sample loop type injectors. 
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Figure 2.5: Dual head reciprocating pump, adapted from [73]. 
Detection of separated bands as they emerge from the chromatographic 
column is normally performed by monitoring a bulk property of the mobile phase, 
i.e. a change in refractive index due to the presence of dissolved solute or more 
selectively by monitoring a property of the solute itself, e.g. its UV absorption as it 
elutes from the column [68]. Detectors have been developed and commercialised 
that exploit some property of the analyte. However, regardless of the detector 
type there are a number of characteristics that a detector should ideally fulfil. 
These include; sensitivity, linearity, stability and reproducibility, a rapid response, 
selectivity and the detector must not contribute significantly to band broadening 
[72,74]. The detector used must also be compatible with the separation 
conditions, e.g. electrochemical detectors cannot be used with gradient elution or 
only volatile mobile phase modifiers may be used in conjunction with mass 
spectrometry [70]. Due to its versatility and fulfilment of many of the above 
conditions the UV detector is the most commonly used for the detection of 
pharmaceutical analytes, e.g. it is estimated that approximately 95% of all 
separations of pharmaceuticals using LC employ UV as the detection mechanism 
~ 5 1 .  
UV detection monitors the absorption of monochromatic light by the 
various solutes present in the mobile phase. The absorption of light is 
proportional to the concentration of analyte present according to the Beer- 
Lambert law which states [75]: 
(Eq. 2.13) 
Where: 
A is the absorbance, 
E is the molar absorption coefficient, (~rnol~~crn~') ,  
c is the concentration,  OIL-I), 
L is the light path, (cm), 
I, is the initial light intensity and 
I is the sample attenuated light intensity. 
A schematic of a UV detector is depicted in Fig. 2.6 following, the principle 
components include a light source such as deuterium (D2) lamp for UV 
wavelengths or a tungsten halogen lamp for visible wavelengths, a 
monochromator for the selection of the appropriate wavelength, a flow cell that 
usually uses 'Z' type geometry to maximise the light path, light detectors such as 
photodiodes or photomultiplier tubes and electronic components to convert the 
resulting signal [74]. 
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Figure 2.6: Schematic of UV detector, adapted from [73]. 
The popularity of UV detectors is due to their versatility. The majority of 
analytes contain some chromophoric moiety or indeed can be tagged with a 
chromophore to aid with their detection. UV detectors are quite sensitive with 
detection limits in the range of 100 pg - I ng achievable [72]. 
The use of photodiode array detectors adds an extra degree of selectivity 
to the analysis with the ability to record complete UV spectra over the course of 
the elution of the peak. Therefore, qualitative information may be obtained using 
spectral matching. Other advantages of the use of photodiode array detectors 
includes the assessment of peak purity and deconvolution of unresolved peaks. 
However, for such an approach to be successful it requires the unresolved 
components to have different UV spectra [74]. 
2.3.5 Column chemistry & monolithic silica: 
Most modern forms of LC are performed using stationary phases consisting of a 
particulate support that may or may not be chemically modified. This is especially 
true in reversed-phase chromatography whereby columns are usually based 
upon silica functionalised via siloxane bonds with nonpolar hydrophobic organic 
chains such as C8, CI8 etc. The preparation of such reversed-phase materials is 
performed by reacting organochlorosilanes with silanol groups on the silica 
surface, for a detailed review see that of Kirkland [76]. The widespread use of 
silica as the support material is due to the ability to manufacture silica particles 
with suitably small diameters and a controlled pore distribution. Silica also has 
high mechanical strength and provides a large active surface area that promotes 
mass transfer [77]. However, the biggest limitation to the use of silica as a 
chromatographic support is its pH instability at acidic and basic pH values and 
also the presence of un-functionalised and un-endcapped silanol groups on the 
surface that interfere with the chromatographic process, leading to poor peak 
shapes [77]. Recent trends in LC have been driven by the need for fast and 
efficient separations in the fields of pharmaceutical and combinatorial chemistry 
research, metabolomics and proteomics [78]. To fulfil these aims columns with 
smaller particles and narrower internal diameters have been developed. 
However, limitations in the form of excessive backpressure generation or 
incapability with standard LC instrumentation can be encountered [78]. 
A relatively new development in the field of LC separations is the use of 
monolithic based stationary phases. Monoliths consist of a single piece of 
homogenous phase and have been reportedly constructed using polymeric, (e.g. 
polymethacrylates) or silica based materials [79]. The history of polymeric 
monoliths has recently been reviewed by Tennikova and Reusch [80]. Monolithic 
silica was first reported as a chromatographic support by Japanese scientists at 
the 22"d International Symposium on High Performance Liquid Phase 
Separations and Related Techniques 1998, however, the technology was 
subsequently further developed and commercialised by Merck KGaA [79]. The 
preparation of monolithic silica columns is based upon sol-gel technology, which 
involves the hydrolysis and condensation of metal alkoxides to form ceramic like 
materials. A detailed account is beyond the scope of this text and therefore, the 
reader is referred to the reviews of Collinson [81] and lshizuka et a/. [82]. The 
commercially available monolithic columns are imparted a unique bimodal pore 
structure consisting of macropores of -2 pm internal diameter and mesopores of 
-13 nm internal diameter [83,84,85]. The macropores act as flow through pores 
whilst the mesopores provide a large active surface area on which the separation 
may occur. The bimodal pore structure also imparts a significantly higher 
permeability to the monolith when compared with particle packed columns [85]. 
The increased level of permeability may be attributed to the absence of inter 
particulate voids and pools of stagnant mobile phase that lead to the generation 
of higher backpressure in particle packed columns [86]. Therefore, monoliths 
generate less backpressure and allow for increased rates of mass transfer and 
as a consequence higher separation efficiencies compared to particle packed 
columns may be achieved [87,88]. Such properties allow for monolithic columns 
to be operated at high flow rates without compromising the separation efficiency. 
The adsorption capacity of monolithic columns may also be higher than their 
particle packed counterparts which allows for increased analyte stationary phase 
interaction and therefore, efficiency and selectivity on monolithic columns is often 
equivalent to that attainable on 3.5 ym particulate columns 1891. To date 
monolithic silica columns are only commercially available in either bare silica, C8 
or CI8 phases whilst polymeric monoliths such as C I M ~ ~  disks are available in a 
choice of chemistries allowing for easy column coupling for multidimensional 
chromatography [86]. 
2.3.6 The LC separation approach used for PPCP determination: 
As stated previously in section 2.1, all reported methods for the determination of 
pharmaceutical residues in environmental samples have focused upon the 
development of reversed-phase separation methods prior to MS with either 
electrospray (ESI) or atmospheric pressure chemical ionisation (APCI). In the 
vast majority of methods a CI8 column was used along with a mobile phase 
consisting of water and either methanol or acetonitrile. Modifiers used for 
adjusting the pH or ionic strength have included acetic or formic acids or 
ammonium formate and ammonium acetate [38,45,48,49,50,90]. Blackwell et a/. 
published two methods for the determination of three antibiotics again using a 
CI8 column [55,56], a mobile phase consisting of tetrahydrofuran, acetonitrile and 
water containing trifluoroacetic acid (TFA), was used. In one instance, UV 
detection was used with multiple wavelength monitoring, i.e. 285, 355, 260 and 
370 nm for extra selectivity whilst on the other occasion pre-column fluorescence 
derivatisation using fluorescamine as a fluorophore was employed [56]. Two 
reports concerning the use of C8 phases were presented by Augeura et a/. [33] 
for the determination of Triclosan and biphenyl01 in marine sediments and also by 
Miao et a/. for the determination of carbamazepine and its metabolites. Augeura 
et a/. used a mobile phase of ammonium hydroxide at pH 10.5 along with 
acetonitrile to promote the dissociation of Triclosan prior to ESI-MS 
determination, [33], however, it is worth recalling that the upper recommended 
pH limit of silica based materials is pH 7.5, (section 2.2.5). A complex mobile 
phase was used by Miao et a/. [43] consisting of 2:3 methanol acetonitrile and 
ammonium acetate in water. Vandetford et a/. employed a CIS column with a 
methanol water mobile phase modified with formic acid for the separation of 
acidic and basic pharmaceuticals, personal care products such as Triclosan and 
hormones. Detection was performed using ESI-MS, however, the mobile phase 
flow rate was 0.70 m~min",  with no adverse affects on the ESI intensity as a 
result of the high flow rate being reported. Other detection mechanisms have 
also been reported, although, reports of such are scarce. Santos et a/. report the 
use of fluorescence detection for the determination of pharmaceutical residues in 
treated wastewater [91]. 
Capillary LC-MS was used by van der Ven et a/. for the determination of 
diazepam in aquatic samples [92]. The limit of detection for the analysis was 
approximately 0.1 n g m ~ '  for a 5 pL injection of un-preconcentrated sample into 
the CIS capillary LC-MS system, as with normal and microbore methods a mobile 
phase consisting of ammonium acetate and methanol was employed but with a 
flow rate of only 15 p~min".  Another alternative approach was reported by 
Quintana and Reemtsma [93] who employed ion-pair LC with tandem MS 
detection for the determination of acidic pharmaceuticals. Tributylamine was 
used as the ion-pairing agent in a methanol water mobile phase and a phenyl- 
hexyl column. The ion-paring agent was indeed found to aid retention of acid 
drugs such as salicylic acid but its affects were less pronounced with decreasing 
analyte polarity and an incomplete separation of the analytes was reported. An 
ion chromatography approach was also reported by Sacher et a/. who used anion 
exchange chromatography in conjunction with inductively coupled plasma mass 
spectrometric detection (ICP-MS) [94]. Reports of capillary electrophoretic 
separations are also rare, Buchberger et a/. report the use of CE-MS for the 
determination of antidepressants in wastewater and surface water in association 
with SPE [95]. Detection limits reported concern only an instrumental validation; 
however, low p g ~ - l  levels were easily achieved in a relatively fast run, less than 
20 minutes per sample. It should be noted that the majority of published methods 
lack complete separation of the target analytes and in many cases excessive 
runtimes or unsuitable conditions are employed. Therefore, further research to 
improve the chromatographic performance of many monitoring methods needs to 
be undertaken. 
2.4 Selective Detection usins Mass Spectrometrv: 
2.4. I The power of mass spectrometry: 
Mass spectrometry; (MS) is the separation and identification of gaseous ions 
based upon their mass to charge ratio (mlz) [96]. MS is one of the most powerful 
tools available to the analytical chemist as it permits elemental and isotopic 
analysis, structural elucidation of molecules and surfaces and when used in 
conjunction with an analytical separation technique, a wealth of qualitative and 
quantitative data may be obtained for complex mixtures [96]. MS was pioneered 
through the research of Thomson and Aston, both Nobel Prize winners in physics 
and chemistry respectively for their work investigating the separation of non 
radioactive isotopes using electric and magnetic fields [97]. The technique 
received much attention and developed rapidly with the first commercial mass 
spectrometer becoming available in 1948 [98]. Other significant developments in 
MS were the introduction of GC-MS instrumentation in 1956 followed by the 
development of liquid phase introduction techniques in the 1980s [98]. The most 
recent Nobel Prize winners for pioneering research in the MS field were Fenn 
and Tanaka in 2002 for the development of ionisation methods for the mass 
spectrometric analyses of biological macromolecules [98]. 
The importance of MS in environmental analysis, especially for the 
identification of pharmaceutical residues has been discussed by Daughton [99] 
who noted the necessity for highly sensitive and selective analytical methods 
when attempting to evaluate the sources of, and risks posed by drugs and also 
for the forensic identification of other previously unknown environmental organic 
micro contaminants. It is therefore, not surprising that the majority of published 
methods for determining the extent of environmental contamination with 
pharmaceutical residues report the use of either single or tandem MS detection 
based upon the ability to unambiguously identify compounds using mass spectral 
data. 
Mass spectrometers consist of the following components, a sample 
introduction system, an ionisation source, a mass analyser and a detection 
system. A discernible operating characteristic of MS is the need for the 
instrument to be kept under high vacuum in order to ensure that ions reach the 
detector without undergoing unwanted gas phase collisions. Therefore, the 
incompatibility with LC that uses significant quantities of solvents over the course 
of the separation is clearly apparent. Other notable incompatibilities are that LC 
is suited to the analysis of polar non-volatile compounds, while MS requires the 
formation of gaseous ions and also the use of unsuitable mobile phase modifiers. 
The development of suitable interfaces to remove the mobile phase and convert 
dissolved solutes into gaseous ions was a necessity for the coupling of LC with 
MS. The inte'rface serves two purposes; it facilitates the use of LC as a sample 
introduction technique for MS and also the use of MS as a chromatography 
detector. As a consequence MS must fulfil the requirements of a suitable LC 
detector [loo]. Initial attempts to interface the two techniques focused upon the 
use of a moving belt interface. However, the technology rapidly improved with 
each new available interface superseding the previous [loo]. Today only two 
interfaces are commonly used in LC-MS analjlses, ESI and APCI. Both of these 
have been applied to the determination of pharmaceutical residues and will now 
be reviewed. 
2.4.2 Atmospheric pressure Interfaces for LC-MS; ESI & A PC/: 
As said previously in section 2.4.1, there is an apparent mismatch in the coupling 
of LC with MS and therefore, an interface is required not only to remove the 
mobile phase but also act as a link between the atmospheric pressure output of 
the LC and the high vacuum MS. The design of suitable interfaces must therefore 
include components to allow for liquid introduction, an atmospheric pressure 
region wherein the ionisation occurs, ionic sampling apertures, a vacuum 
interface and finally ion optics to ensure the ionised analytes reach the mass 
analyser [ l o l l .  The two interfaces currently used for the vast majority of LC-MS 
applications are the ESI and APCl interfaces. 
The concept of ESI was first described by Fenn and co-workers in 1984 
for the mass spectrometric analysis of proteins and macromolecules from the 
liquid phase [97]. ESI involves the transitory of ionised species from the liquid 
phase into the gas phase as individual entities [102]. The mechanism of 
electrospray can be seen in Fig 2.7. ESI involves passing a solution of the 
analyte, i.e. the column effluent, through a capillary to which a high potential is 
applied, the effect of the applied electric field causes the generation of a fine mist 
of highly charged droplets as the solution emerges from the capillary [102]. The 
charged droplets are attracted towards the endplate electrode due to the 
influence of both the potential difference and the pressure gradient that exists 
within the source, during this time the droplets reduce in size as a result of 
solvent evaporation and also due to 'coulomb explosions' that occur due to the 
build up of ions of one polarity on the surface of the drop, creating coulomb 
forces of repulsion that are greater than the surface tension of the liquid, (i.e. the 
Rayleigh limit) [100,103,104,105]. The net result is the formation of a smaller 
droplet rich in one ion polarity and the process reoccurs until the formation of 
extremely small droplets in the range of 3-10 nm diameter that are capable of 
producing gas phase ions upon fission [I 02,103,104,105]. The formed ions are 
then sampled using skimmer cones and transported through the ion optics to the 
mass analyser. 
ESI is an extremely soft ionisation technique and yields the production of 
gaseous ions with the same charged state as was present in the liquid phase, the 
process is also non energetic and as a consequence none or very little molecular 
fragmentation will occur [102]. The mechanism can be perceived to involve a 
step-wise removal of solvent molecules from the analyte without detrimentally 
affecting the confirmation of the analyte. As a result the technique is important in 
the investigation of biologically important macromolecules [ I  03,1041. 
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Figure 2.7: The mechanism of electrospray ionisation, adapted from [loo]. 
Choosing suitable LC separation parameters is also extremely important 
when using ESI-MS as a chromatography detector. The flow rate used must be 
compatible with ESI as it affects the size distribution of the aerosol droplets and 
therefore, the level of charge on each droplet [104]. Mobile phase modifiers that 
are suitably volatile must be used to avoid build up of residues on the source 
components. Accordingly, it is worth recalling that the approach used by the 
majority of analysts for the determination of pharmaceutical residues has focused 
upon the use of microbore LC columns with mobile phases containing acetic or 
formic acids or their volatile ammonium salts (section 2.3.6 previous). 
The production of ions by ESI is often heavily dependant upon solution 
chemistry and is highly suited to the analysis of ionic compounds, polar and 
neutral compounds that may be readily protonated or deprotonated by altering 
the solution conditions, e.g. pH and compounds that can be oxidised or reduced 
under the applied electric field at the capillary tip [104]. Pharmaceuticals are 
therefore suited to ESI-MS analysis as they are often weak acids or bases and 
contain polarisable groups, e.g. carbonyl moieties etc. 
For compounds that do not fulfil the above requirements APCl may be 
used as an alternative. In APCl the column effluent is nebulised and heated to 
form an aerosol. lonisation is then achieved using a corona discharge (i.e. the 
ionisation of the nebuliser gas using a high applied voltage to the tip of a metallic 
electrode) [ I  00,104,106,107]. The corona discharge ionises both analyte and 
eluent molecules and both species can react by gas phase ion molecule 
interactions such as proton transfer etc. as shown in Fig. 2.8, leading to 
ionisation of the analyte which is then sampled in an analogous manner to ESI 
[100,104,106,107]. As with ESI, APCl is a rather 'soft' process leading to the 
formation of molecular ions via protonation, deprotonation or adduct formation 
with mobile phase modifiers. [ I  041. 
A significant difference between the two interfaces is the LC flow rates that 
can be accommodated. As mentioned previously ESI demands lower flow rates 
in order to be efficient, however, APCl is compatible with flow rates normally 
used in conjunction with standard bore chromatography columns, even up to 
2.00 m~min- '  [IOO]. Higher flow rates help prevent damage to the corona needle 
and the stability of the discharge. APCl is extremely useful for the ionisation of 
nonpolar to moderately polar compounds that posses a degree of volatility and 
thermal stability as common APCl performance temperatures are in the region of 
350-500°C [loo]. APCI-MS has also been applied to the determination of drug 
residues in environmental samples, particularly for analytes that exhibit no ESI 
response, e.g. Loffler and Ternes used LC-APCI-MS for the determination of 
acidic analgesics and the parasiticide ivermectin in river sediments [34] and 
Vanderford et a/. employed LC-APCI-MS for the analysis of hormones in aquatic 
samples, [41]. Other reported applications of LC-APCI-MS include the 
determination of antifouling agents [ I  081, narcotics [I091 and pesticides [ I  101. 
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Figure 2.8: The mechanism of APCI, adapted from 1981. 
2.4.3 Mass analysers used in LC-MS: 
After the interface has ionised the sample molecules or transferred them into the 
gas phase, they are then swept into the mass analyser as a result of potential 
dfferences and a vacuum gradient. The mass analyser separates ions based 
upon their mlz ratio. Mass analysers frequently reported in conjunction with liquid 
chromatography include the quadrupole, the ion trap and the time of flight mass 
analysers. 
Quadrupole mass analysers consist of four rods that are arranged in a 
perfectly parallel orientation as depicted in Fig. 2.9. The rods are oppositely 
charged and have a fixed direct current (DC) potential and an oscillating radio 
frequency (RF) potential applied to them [I 1 I]. Introduced ions are passed along 
the centre of the quadrupole and by varying the RF potential ions of different mlz 
can be selectively allowed to pass through and reach the detector thereby 
permitting the collection of the mass spectrum [I 1 I]. 
u 
Figure 2.9: The quadrupole mass analyser, adapted from [I 121. 
The equations describing the trajectory of an ion through the quadrupole 
field are extremely complex and beyond the scope of this text, however, the field 
experienced by ions as the travel through the quadrupole comprise both the 
constant and the alternating potentials described by the following equation [ I  131. 
cp = +(U - Vcoswt) and -cp = -(U - Vcoswt) (Eq. 2.14) 
Where: 
cp is the total applied potential, 
U is the DC potential, 
Vcoswt is the applied RF potential of amplitude V and frequency w. 
Ions will resonate at particular values of Vcoswt and will have a stable 
trajectory as shown in Fig. 2.9 therefore reaching the detector, whilst unstable 
ions collide with the rods, lose their charge and are removed from the mass 
analyser by the vacuum system [I 131. 
Quadrupole mass analysers are widely used as mass analysers in both 
GC and LC-MS instruments due to their relatively low cost and their simplicity of 
operation, with single mass resolution readily achievable. Quadrupoles can also 
be coupled in series quite easily allowing for tandem MS measurements to be 
performed, i.e. QqQ instruments. In such an instance the first quadrupole acts as 
a mass filter allowing ions of particular mlz to pass through to the second 
quadrupole where they are fragmented by collisions with a gas. Fragmented ions 
70 -. 
then pass into the third quadrupole where the fragmented ions are measured and 
identified [ I  1 I ] .  Tandem MS measurements can be used to increase selectivity, 
sensitivity and structural elucidation, approaches frequently used in the articles 
cited previously for the determination of pharmaceutical residues, (section 2.3.6). 
The ion trap mass analyser is a form of quadrupole and consists of two 
end-cap electrodes and a ring electrode as shown in Fig. 2.10. 
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Figure 2.10: The ion trap mass analyser, adapted from, [98]. 
The ion trap operates using the same principles as the quadrupole mass 
analyser by the creation of a three dimensional quadrupole field upon the 
application of stable and variable potentials across the electrodes which allows 
for the trapping of all ions within the trap cavity. By ramping the RF potential ions 
of increasing mlz are ejected from the trap and detected [ I  131. Ions of similar 
charge will naturally repel each other inside the trap with a detrimental effect 
upon their trajectory, to avoid such an effect the trap is filled with helium at 
pressure of 10" torr which acts as a 'shock absorber' and removes excess 
energy by collision [ I  131. ton traps are also widely used as mass selective 
chromatographic detectors as they are small and relatively inexpensive and offer 
unit mass resolution [ I  1 I ] .  The ion trap also allows for tandem MS 
measurements to be performed by isolating the ion of interest within the trap 
during the first mass analysis, fragmenting it using an excitation pulse and helium 
collisions and then analysing the product ions in the normal scanning manner 
during the second mass analysis [ I  1 I ] .  
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The time of flight; (ToF) mass analyser as shown in Fig. 2.1 1 operates on 
a much simpler principle than the previously discussed mass analysers. With 
ToF-MS ions are introduced directly from the source or if in a tandem instrument 
from the previous mass analyser as a controlled pulse, which imparts the same 
kinetic energy to all ions [ I  11 ,I 131. As they pass through the drift tube the ions 
separate based upon their mass, i.e. light ions travel faster than heavier ions and 
therefore, reach the detector first [98]. 
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Figure 2.1 1 : The time of flight mass analyser, adapted from [I 041. 
Equation 2.15 describes the relationship between the flight time and ionic 
mass, [I 131: 
(Eq. 2.15) 
Where: 
t is the time it takes to reach the detector, 
d is the length of the drift tube, 
V, is the applied pulse potential and 
e is the charge on an electron. 
Therefore, from the above equation it can be seen that mlz can be 
calculated from the drift time as the values in brackets are constant. However, 
this also requires accurate time measurements for accurate mass measurement 
and fast electronics. The ToF analyser has no mass limits and high mass 
accuracy is readily achievable with extremely high sensitivity. 
Few reports exist of the application of ToF-MS for the determination 
pharmaceutical residues in environmental samples. Marchese et a/. examined 
the use of QqQ-MS and Q-ToF-MS for the LC-MSIMS determination of non 
steroidal anti inflammatory compounds in surface water [ I  141 and it was found 
that the QqQ system was more sensitive with calculated detection limits lower 
than the Q-ToF system by a factor of 3. However, the Q-ToF system was more 
selective for the analysis of real samples as it was not as prone to matrix 
interference as the QqQ-MS [ I  141. Ferrer and Thurman reviewed the application 
of LC-ToF-MS for the determination of emerging environmental contaminants 
including pharmaceuticals and remarked that only two articles concerning drug 
residue analysis were reported, both of which were submitted for review [ I  151. It 
was however, noted that LC-ToF-MS is a powerful tool for the elucidation of 
previously unknown organic micro pollutants. Such an approach was further 
employed by Aguera et a/. who demonstrated the ability to identify photo 
transformation products of the non steroidal anti-inflammatory drug diclofenac 
using ToF-MS. It was possible to perform accurate mass measurements with 
very low mass error and consequently identify thirteen previously unknown 
photoproducts of the drug [ I  161. Perez et a/. performed a similar study using ion 
trap MS to determine and characterise metabolites of the x-ray contrast agent 
iopromide in activated sludge. Although ion trap MS lacks the same mass 
accuracy as ToF-MS it was still possible to identify four possible biodegradation 
products of iopromide in activated sludge using hydrogen deuterium exchange in 
order to increase the accuracy of the measurements [ I  171. 
2.4.4 Ion detectors: 
Detection of the separated ions is the final parameter in the collection of mass 
spectral data. Typical ion detectors include electron multipliers, Faraday cups 
and array detectors. Electron multipliers operate in an analogous fashion to 
photomultiplier tubes in optical spectroscopy with signal multiplication arising due 
to the enhancement of charged particles across dynodes [113]. Electron 
multipliers consist of a SnISnO or PbIPbO doped glass funnel that acts as a 
continuous dynode under a voltage gradient to attract electrons to the bottom of 
the multiplier, a gain of l o 7  electrons per ion is readily achievable [I 131. 
With Faraday cup detectors the ion exiting the mass analyser strike a 
collector electrode that is surrounded by a Faraday cage, which captures 
reflected ions or ejected secondary electrons [ I  121. The collector electrode and 
the Faraday cage are connected to a resistor and the analytical signal is 
recorded as the feedback current required across the resistor in order to maintain 
a base level potential [112]. Faraday cups are not as sensitive as electron 
multipliers and also exhibit a slower response and as a consequence are not 
suitable for rapid analysis, they are, however, relatively inexpensive. 
Array detectors consist of a plate into which parallel cylindrical channels 
have been drilled and a potential difference is applied across the plate (inlet to 
outlet) [113]. Channels are coated with a semiconductor that acts as the 
continuous dynode, readily allowing gains of l o 5  to l o 8  per incident ion at a 
metallic collector anode. The plate can be used to detect ions of various mlz in 
different channels over the course of a single scan [ I  131. 
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3.0 Development of Dual Gradient Monolithic HPLC for 
the Determination of Pharmaceutical Residues in 
Environmental Samples. 
3.1 Introduction: 
A large number of HPLC methods have been published in the peer-reviewed 
literature for the determination of pharmaceutical substances spanning across 
analgesics [1,2,3,4,5,6], antibiotics [7,8], antifungal agents [9], lipid regulating 
agents [ I  0,l I ] ,  preservatives [ I  21, personal care products [ I  3,141, prospective drug 
candidates [I51 to narcotics and banned or forensically interesting substances 
[16,17]. Stereo specific methods have also been reported but to a much lesser 
degree than standard assays [18,19,20]. The majority of reported methods have 
focused upon the use of reversed-phase particle packed columns and UV 
absorbance detection with the primary aims of the above studies being 
pharmacokinetic monitoring or finished and commercial product analysis. Many of 
the reported methods, while suited to the task at hand and often fully validated, are 
unsuitable for application to environmental monitoring or incompatible with MS due 
to the use of inorganic buffers in the mobile phase such as large amounts of 
phosphate, unsuitable flow rates, (flow rates of up to 0.7 m~min-' were reportedly 
used with ESI [8]), lack of sensitivity and often lengthy runtimes for single 
compound analysis. Very few reports of the use of microbore columns exist, not 
even in conjunction with MS. 
Pharmaceutical residues have been detected in a variety of environmental 
matrices, in both aqueous and terrestrial compartments, i.e. soils and sludge 
[21,22,23,24]. In contrast with the previous methods, the developed procedures for 
environmental pharmaceutical residue analysis are primarily based upon the use of 
small particle high resolution; (3-5 pm), microbore column LC-MS or LC-MSIMS to 
increase the sensitivity and specificity of the method. As a consequence of the use 
of MS detection, complete chromatographic separation of all analytes is no longer 
crucial, however, in order to avoid adverse or unwanted effects upon the ESI 
intensity a suitable separation of the chosen analytes is still desired. A shortcoming 
of many of the reported methods is poor analytical separation. For example, four 
individual methods were required by Milton and Thomas [21] for the separation of 
thirteen pharmaceuticals leading to a single sample analysis time of greater than 
two hours, excluding re-equilibration time. In the case where a single 
chromatographic method was used it was often observed that a significant number 
of analytes were noticed to coelute [22,24]. In the case of Aguera et a/. [23] the 
mobile phase employed was adjusted to pH 10.5 with hydroxide prior to use with 
an octyl silica column (it is worth remembering that the upper limit of silica based 
chromatography columns is usually pH 7.5 in order to prevent the stationary phase 
from dissolving, section 2.3.5). Therefore, it can be seen that although the methods 
published to date are suitably sensitive and fit for the purpose intended, an efficient 
chromatographic separation of the chosen analytes is often overlooked. 
Monolithic silica columns are a relatively underused concept in 
environmental and pharmaceutical analyses. To date the majority of published 
reports have focused upon the use of monolithic silica columns to reduce analysis 
times and therefore, increase sample throughput [25,26,27]. However, monolithic 
silica columns also allow for more efficient separations with theoretical plate counts 
often far superior to those obtainable with 3.5 pm particulate columns due to higher 
permeability and increased rates of mass transfer [28,29]. Therefore, monolithic 
columns unlike their particle packed counterparts allow for highly efficient 
separations at high flow rates. The increased rate of column permeability, >80% 
compared to -65% in a particle packed column, also allows for the use of 
significant flow gradients that are not possible due to excessive backpressure 
production in particle packed supports [30]. 
The aim of this initial research was to develop a high efficiency separation of 
chosen environmentally relevant pharmaceuticals using monolithic silica columns 
and to apply the developed method for the preliminary determination of 
pharmaceutical residues in environmental samples. A SPE procedure was also 
incorporated into the method in order to lower detection limits. In order to select a 
suitable sorbent various commercially available SPE cartridges based upon silica 
or polymeric supports were evaluated. Photodiode array detection was used for the 
80 
determination of sample extracts in an attempt to increase the specificity of the 
developed method. 
3.2 Experimental: 
3.2.1 Analyte test group: 
Analytes chosen for monitoring include those that showed prevalence in both the 
published literature and also the list of the most prescribed pharmaceuticals in 
Ireland for the year ending December 31'' 2003 [31]. The chemical structures of 
the selected analytes are depicted in Table 3.1. 
Table 3.1: Chemical structures of the pharmaceuticals and metabolites selected for study, 
Analyte Chemical Structure Analyte Chemical Structure 
Acetaminophen lndomethacin 
HO 
0 
Salicylic acid 
Trimethoprim Mefenamic acid 
I 
4'2N 
Clotrimazole 
O I 
Caffeine 
Propranolol Gemfibrozil 
0 
Clofibric Acid Triclosan 
I 
C! 
Ketoprofen d",H Flurbiprofen F 
OWOH 
Bezafi brate o-Toluic acid 
Naproxen 2-Naphthoic acid 
Warfarin 
lvermectin 
3.2.2 Chemicals and reagents: 
Reagent water used throughout, unless otherwise stated was obtained from a 
Millipore Milli-Q water purification system (Millipore, Bedford, MA, USA) and was 
18.2 M a  or greater. Methanol (MeOH) was purchased from Labscan (Dublin, 
Ireland), acetone and ethyl acetate were obtained from Aldrich (Gillingham, UK). 
All solvents used were HPLC grade. Dichlorodimethylsilane, ammonium formate 
and formic acid were also purchased from Aldrich. BDH Analar grade sulphuric 
acid was used for sample pH adjustment (Poole, UK). Metformin hydrochloride, 
acetaminophen, salicylic acid, o-toluic acid, propranolol hydrochloride, clofibric 
acid, ketoprofen, diclofenac sodium salt, clotrimazole and 2-naphthoic acid were 
obtained from Aldrich (Steinheim, Germany). Trimethoprim, caffeine, naproxen and 
Triclosan were received from Fluka (Buchs, Switzerland). Bezafi brate, warfarin, 
flurbiprofen, indomethacin, ibuprofen sodium salt, meclofenamic acid sodium salt, 
mefenamic acid, gemfibrozil and ivermectin were all obtained from Sigma 
(Steinheim, Germany). All analytes were of a purity >95%. 
Stock 1000 m g ~ ~ '  solutions of each analyte were prepared in MeOH and 
were stored as described on the material safety data sheets (MSDS) sheets for 
maximum stability, i.e. refrigerated if necessary and in the dark. In the case of 
salts, standards were prepared in terms of the parent analyte. These standards 
were periodically replaced. Working standards were prepared from these stock 
standards by appropriate dilution using MeOH. 
3.2.3 Glassware preparation: 
Prior to use all glassware was silanised by rinsing thoroughly with a 10% vlv 
solution of dichlorodimethylsilane in dichloromethane, followed by rinsing twice with 
dichloromethane and twice with MeOH. 
3.2.4 Sample extraction: 
A variety of sorbents were investigated as suitable stationary phases for sample 
extraction. These included Phenomenex Strata 200 mg I3 mL, 
Phenomenex strata-xTM; 200 mg 16 mL, (Phenomenex, Macclesfield, UK), Merck 
LiChrolut  EN^^; 200 mg 13 mL, (Merck, Darmstadt, Germany), Waters Oasis H L B ~ ~ ;  
200 mg 16 mL and Waters Oasis MAX"; 150 mg 16 mL, (Waters, Milford, MA, 
USA). From initial investigations the Phenomenex strata-xTM and Oasis HLB'~ 
sorbents demonstrated high analyte recovery and were therefore chosen for further 
study. Prior to extraction, 1 L water samples were filtered through Whatman GFIC 
glass micro fibre filters to remove particulate matter, (Whatman, Maidstone, UK). 
The filtrate was then spiked with surrogate standards (to yield an overall 
concentration of 2 p g ~ - '  of both o-toluic acid and meclofenamic acid) to assess 
extraction performance and adjusted to pH 4.0 with concentrated sulphuric acid. 
The SPE cartridge was conditioned with 6 mL of MeOH and 6 mL of water 
respectively. Samples were introduced by vacuum through Teflon tubing and 
extracted under an operating pressure of 20" Hg on a vacuum manifold. After 
complete sample introduction but without letting the cartridge run dry, the sorbent 
was washed with 1 mL of water that was discarded. The sorbents were then dried 
by vacuum aspiration for a minimum of 30 minutes. Elution was then performed 
using 10 mL of a 50% v/v solution of ethyl acetate in acetone [20]. The eluate was 
collected and reduced in volume to near dryness under a stream of N2. The 
residue was reconstituted in 1 mL of internal standard solution (1 m g ~ - '  naphthoic 
acid in MeOH) and transferred to an autosampler vial for LC analysis. 
3.2.5 Liquid chromatography: 
A Hewlett Packard HP 1050 Series HPLC was used throughout and consisted of a 
quaternary pump with online vacuum degasser, a variable wavelength detector 
model 79853C and an autosampler. Agilent ChemStation for LC systems version 
84 
A.09.03 was used for system control and data analysis, (Agilent Technologies, 
Palo Alto, CA, USA). The analytical column used consisted of two Chromolith 
Performance RP18e; 100.0 x 4.6 mm monolithic octadecyl silica columns 
combined in series using a Chromolith column coupler. A 10.0 x 4.6 mm 
Chromolith RPI Be guard cartridge was also incorporated to prevent spoilage of the 
analytical columns, (Merck, Darmstadt, Germany). A multi-step binary gradient, 
(Table 3.2) in conjunction with a flow gradient was employed for analyte elution 
using a mobile phase consisting of MeOH and 1 mM ammonium formate I formic 
acid buffer at pH 4.5. The temperature was held at 25OC throughout. A 20 pL 
injection volume was employed for both samples and standards. The total analysis 
time per injection was 70 minutes followed by a 10-minute re-equilibration period. 
Absorbance was monitored at 225 nm. At lower wavelengths the mobile phase 
itself showed significant absorbance and at higher wavelengths detector sensitivity 
for the majority of the pharmaceuticals was reduced. 
Table 3.2: Liquid chromatographic method parameters. 
Time Flow 
solvent A' solvent B~ (minutes) (m~min-') 
- -- - 
35 52.5 47.5 
40 65 3 5 
c c C T CaE 
1 
9 Can 
- - 
70 90 10 2.30 
Solvent A was MeOH. 
2 Solvent B was 1 mM ammonium formate buffer, pH 4.5. 
3 .3  Results and Discussion. 
3.3.1 Methanol gradient: 
Using an initial mobile phase consisting of MeOH and water adjusted to pH 3.0 
using formic acid, simple linear gradients were investigated. Initial experiments 
involved starting conditions of 40% MeOH that was held isocratically for 10 minutes 
and then raised to 70%. However, results showed that for polar analytes such as 
trimethoprim, caffeine and paracetamol the initial percentage of MeOH in the 
mobile phase was too high, leading to subsequent poor retention. A number of 
peak pairs were also found to coelute, these included ketoprofen and clofibric acid, 
warfarin and bezafibrate and gemfibrozil and Triclosan. 
Therefore, the starting percentage of MeOH was reduced in order to 
promote retention of polar analytes. It was found that at 10% MeOH, polar analytes 
like paracetamol could be retained for approximately 8 minutes. A series of 
individual linear gradients were then investigated to reduce the retention of all other 
less polar species and avoid the co-elution of the above mentioned peak pairs. To 
facilitate the complete elution and separation of all of the pharmaceuticals 
investigated, including ivermectin, the MeOH concentration had to be gradually 
increased over three individual linear gradients to 90% over a 75 min 
chromatographic run. 
Fig. 3.1 depicts a 10 m g ~ - '  standard chromatogram (excluding ivermectin) 
recorded under optimum conditions, a near complete separation of all analytes is 
observable with the exception of gemfibrozil and Triclosan. The dashed line 
describes the % MeOH gradient used. 
3.3.2 pH and buffer strength: 
Using the previously optimised organic modifier the pH and the buffer strength of 
the aqueous proportion of the mobile phase was systematically varied to evaluate 
selectivity effects. 
Buffers considered included ammonium formate and ammonium acetate for 
compatibility with possible MS detection. Of the buffered phases ammonium 
acetate demonstrated considerable absorbance at 225 nm and caused baseline 
disruption over the course of the gradient. Ammonium formate demonstrated a 
considerably lower absorbance and although baseline disturbance was observed it 
was considerably less. Based on the above ammonium formate was chosen as the 
most suitable modifier. 
Time, (mins) 
Figure 3.1: Optimised MeOH gradient separation of 19 pharmaceuticals on 20 cm reversed-phase 
silica monolithic column (pH 3.0 formic acid). Peak identification: 1 paracetamol; 2 trimethoprirn; 3 
caffeine; 4 salicylic acid; 5 o-toluic acid; 6 clotrimazole; 7 2-naphthoic acid, (internal standard); 8 
ketoprofen; 9 clofibric acid; 10 naproxen; 11 warfarin; 12 bezafibrate; 13 flurbiprofen; 14 diclofenac; 
15 ibuprofen; 16 meclofenamic acid; 17 mefenamic acid; 18 & 19 gemfibrozil and Triclosan. 
For optimisation, an experimental space was designed, governed by the 
buffering activity of formate, (pK, = 3.75) and the desire to keep the ionic strength 
low enough to prevent salt precipitation at high proportions of organic solvent. 
Therefore, mobile phases containing ammonium formate concentrations of 1 to 5 
mM, over the pH range of 2.5 to 5.5 were investigated. Twelve individual 
experiments were run within the above concentration and pH range. The resulting 
chromatograms were assessed using the resolution product criterion, R, calculated 
according to Equation 3.1 [32]. 
(Eq. 3.1) 
Where: 
n is the number of analytes present. 
RS(ili-I) is the resolution between peaks i and i + I. Calculated using, 
(Eq. 3.2) 
Where: 
Tri+, is the retention time of peak i + 1. 
Tri is the retention time of peak i. 
Wi+, is the baseline width of peak i + 1. 
Wi is the baseline width of peak i. 
R has values in the range of OeRcI. A value of 1 indicates that the 
resolution between all peaks is evenly distributed over the span of the separation 
and conversely a value of 0 indicates co-elution of two or more peaks somewhere 
within the chromatogram. From the calculated R-values a response surface was 
constructed, which is shown as Fig. 3.2. The optimum combination of pH and 
buffer strength was determined from the apex of the response surface within the 
experimental space. 
The response curve depicts a mobile phase condition where all analytes 
were optimally resolved, this being 1 mM ammonium formate at pH 4.5. Fig. 3.3 
depicts a standard chromatogram recorded under the optimised pH and buffer 
strength. 
Figure 3.2: Resolution response surface for pH and buffer strength optimisation. Standard mixture 
as in Fig. 3.1. 
A complete separation of all chosen analytes can be observed in the 
optimised chromatogram, including the previously co-eluting peak pair. It is also 
notable that a change in the retention order of certain basic compounds is also 
observable, for example clotrimazole is now retained for -58 minutes as opposed 
to -28 minutes at pH 3.0, and increase in retention of some 30 minutes due to the 
higher pH of the mobile phase, attributable to the deprotonation of the nitrogen 
atoms of the imidazole group leading to a neutral moiety as opposed to the cationic 
moiety that exists at the lower pH. 
Time, (mins) 
Figure 3.3: Optimised MeOH gradient separation of 19 pharmaceuticals on 20 cm reversed-phase 
silica monolithic column (pH 4.5, 1 mM formic acid). Peak identification: 1 paracetamol; 2 salicylic 
acid; 3 trimethoprim; 4 caffeine; 5 o-toluic acid; 6 clofibric acid; 7 2-naphthoic acid, (internal 
standard); 8 ketoprofen; 9 bezafibrate; 10 naproxen; 11 warfarin; 12 flurbiprofen; 13 diclofenac; 14 
ibuprofen; 15 meclofenamic acid; 16 mefenamic acid; 17 clotrimazole; 18 gemfibrozil; 19 Triclosan. 
3.3.3 Combined solvent and flow gradients: 
Although a complete separation of all pharmaceuticals in the optimisation standard 
is shown in Fig. 3.3, the overall analysis time is quite long at 90 minutes per 
injection (including re-equilibrium time). The high permeability of the porous 
monolithic columns is ideally suited for use at elevated flow rates. In this case 
operation under constant (isofluentic) elevated flow conditions were not suitable 
due to the desire to maintain resolution of early eluting peaks. Therefore, an 
approach first used by Paci et a/. was investigated [33]. Paci et a/. utilised a flow 
gradient combined with an elution gradient to reduce the retention of the anti- 
malarial agents chloroquine and proguanil on a 250.0 x 4.0 mm particulate C18 
column. However, due to the pressure constraints of the particulate packed column 
used in the study, the flow could only be increased by 0.3 mlmin-I. More recently, 
Paull et a/. have reported more significant reductions in analysis times, together 
with increased efficiency, when a 'dual gradient' was applied to the separation of 
UV absorbing anions on short monolithic column coated with a zwitterionic reagent 
[34]. In this case flow gradients from 1.0 to 6.0 mlmin-' were applied. 
A number of flow gradient programs were investigated in combination with 
the optimised mobile phase gradient. Comparison of resultant separations showed 
that a continual linear flow gradient from I to 3 mlmin-' over the course of the run 
provided the best distribution of peaks across the entire chromatogram (with no 
detrimental effect upon resolution), combined with an approximate reduction in 
analysis time of 40 to 45%. Fig. 3.4 depicts a standard chromatogram obtained by 
separation using the dual gradient. Although not shown in Fig. 3.4, the dual 
gradient approach also allowed for the inclusion of iverrnectin to the test mixture, 
which eluted after 65 minutes. lvermectin is moderately lipophilic but it was found 
that an extremely high quantity of MeOH was required to elute it from the column 
under normal conditions. 
Time, (mins) 
Figure 3.4: As Figure 3.3 with applied linear flow gradient from 1 mlmin" at ~FO to 3 mlmin-' at t 
=75 minutes. Peak identification: 1 metlormin; 2 paracetamol; 3 salicylic acid; 4 trimethoprim; 5 
caffeine; 6 o-toluic acid; 7 propranolol; 8 clofibric acid; 9 2-naphthoic acid, (internal standard); 10 
ketoprofen; 11 bezafibrate; 12 naproxen; 13 warfarin; 14 flurbiprofen; 15 diclofenac; 16 
indomethacin; 17 ibuprofen; 18 meclofenamic acid; 19 mefenamic acid; 20 clotrimazole; 21 
gemfibrozil; 22 Triclosan. 
3.3.4 Temperature effects: 
Temperature is an important parameter in chromatographic separations that 
requires optimisation as fluctuations in temperature can drastically affect analyte 
retention. Temperature governs both the viscosity of the mobile phase and also the 
mobility of the analyte through the analytical column. For initial method 
development studies the column was kept isothermally at 25OC. The separation 
temperature was optimised over the range of 25 to 45OC in 5OC increments using a 
column oven. 45OC was chosen as the upper temperature limit as upon referral to 
the Chromolith column information, it is recommended not to heat the column 
greater than 45OC as higher temperatures can lead to strain and even breakage of 
the bond between the monolithic silica surface and the C18 ligand [35]. The 
resolution product was calculated for each resulting chromatogram. 
0 I I I I I I 
20 25 30 35 40 45 50 
Separation Temperature, (OC) 
Figure 3.5: Investigation into the effect of increasing the operational separation temperature on the 
overall resolution product, (R). Separation conditions were as per those previously described in 
Table 3.2. 
It can be seen that the resolution decreases as the temperature at which the 
separation is performed increases as demonstrated by Fig. 3.5. This can most 
probably be attributed to decreased analyte retention at elevated temperatures. 
The chromatographic efficiency was also observed to decrease as the separation 
temperature increased, theoretically it would have been expected to increase as 
often by raising the operating temperature the kinetics of interaction are improved 
[36]. As the flow rate is constantly increasing, a uniform distribution of heat may not 
occur at elevated temperatures that may also lead to band distortion and therefore, 
decrease the efficiency of the separation. 
3.3.5 Method validation: 
Having developed and optimised the dual gradient separation the performance of 
the method was then investigated. In all instances method validation was 
performed according to the 'ICH Harmonised Tripartite Guidelines for the 
Validation of Analytical Procedures' [37]. The method was validated for linearity, 
reproducibility and repeatability and the instrumental limits of detection (LOD) and 
quantitation (LOQ) were calculated. The results for the validated parameters are 
presented in Table 3.3. 
Table 3.3: Dual gradient HPLC method performance data. 
Analyte Linearity LOD LOQ Reproducibility Repeatability 
(R2) (rngcl) (rng~-') (%RSD) (%RSD) 
Metformin 0.9999 0.02 0.07 0.42 2.10 
Paracetamol 0.9967 0.14 0.46 9.30 5.32 
Salicylic acid 0.9999 0.22 0.72 2.37 7.97 
Trimethoprim 0.9999 0.02 0.07 - 0.35 1.30 
Caffeine 0.9982 0.09 0.29 1.91 3.41 
o-Toluic acid 0.9999 0.06 0.19 0.75 1.03 - - 
Propranolol 0.9973 0.03 0.10 2.30 1.38 
Clofibric acid 0.9955 0.02 0.06 3.28 3.59 
2-Na~hthoic - - - 
acid; (I.S.) 
Ketoprofen 0.9931 0.08 0.26 4.17 7.03 
Bezafibrate 0.9954 0.06 0.21 1.09 7.17 
Naproxen 0.9999 0.01 0.04 0.35 1.52 
Warfarin 0.9999 0.24 0.81 7.49 10.24 
Flurbiprofen 0.9999 0.24 0.81 0.91 11.10 
Diclofenac 0.9998 0.15 0.49 9.70 15.09 
lndomethacin 0.9997 0.10 0.33 2.02 9.31 
Ibu rofen 0.9999 5.94 7.85 
Meclofenamic 0.9999 0.04 0.13 0.61 2.47 
acid 
Mefenamic acid 0.9999 0.05 0.1 5 2.10 3.68 
Clotrimazole 0.9998 0.1 1 0.37 1.81 7.05 
Gemfibrozil 0.9999 0.25 0.84 1.58 2.18 
Triclosan 0.9999 0.12 0.40 2.74 3.70 
lvermectin 0.9996 0.12 0.40 4.20 3.52 
Linearity was determined at five individual concentration levels within the 
range of 0.1 to 20 mg~- ' .  A linear response was observed for each analyte as 
demonstrated by the regression coefficients that were all greater than R~ = 0.99. 
The limit of detection was defined as a signal three times the standard deviation of 
the baseline noise and the limit of quantitation was defined as ten times the 
standard deviation of the baseline noise. Using the ChemStation software, version 
A.09.03, the 'peak-to-peak' baseline noise was measured for a triplicate blank 
injection, (HPLC grade MeOH) over a window of twenty times the peak width either 
side of each peak. The peak heights of a combined 0.5 m g ~ - '  standard were 
measured and from these measurements the LOD and LOQ for each analyte were 
determined. The reproducibility of the method was determined by performing six 
replicate injections of the same standard at the LOQ level using the same mobile 
phase. Reproducibility is acceptably low for most analytes, generally lower than 5% 
relative standard deviation (RSD) [37]. Repeatability was determined by the 
injection of six individual standards at the LOQ level using six fresh preparations of 
mobile phase for the separation. The calculated repeatability values are also quite I 
I 
low, ~ 1 0 %  RSD for all analytes with the exception of flurbiprofen and diclofenac. I 
Paci et a/. [33] acknowledge that dual gradient separations suffer from lower 
precision due to the more complex dynamic processes occurring during the 
separation, however, the observed reproducibility and repeatability values were 
within acceptable limits in this study. 
3.3.6 Solid phase extraction: 
3.3.6. I Sorbent selection. 
The chosen group of pharmaceuticals displayed a range of chemical properties, 
ranging from very hydrophilic to hydrophobic, and acidic to basic. Due to these 
distinct differences the selection of an extraction sorbent that showed good 
recoveries for all species was not trivial. Sorbents examined included those based 
upon standard octadecyl silica, hyper cross-linked styrene divinyl benzene, 
hydrophilic lipophilic balanced polymers and mixed functionality reversed-phase 
anion exchangers. Five commercial SPE phases were evaluated using recovery 
performance data for a 5 c (~L- '  test mix of all analytes listed in section 3.2.1. The 
resultant data is presented in Table 3.4. 
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Table 3.4: Sorbent selection performance data (calculated O/O recoveries). 
Merck Waters Waters 
Phenomenex Phenomenex 
Analyte LiChrolut Oasis Oasis 
strata-CI 8~~~ strata-xTM 
 EN^^ HLB'"  MAX^^ 
Paracetamol - 11 76 19 15 
Salicylic acid - 79 49 70 58 
Trimethoprim 20 98 44 89 65 
Caffeine 14 90 82 - 76 289 
o-Toluic acid, 
_o6 62 53 57 47 
Propranolol 13 78 36 72 54 
Clofibric acid 66 89 83 77 65 
2-Naphthoic 
- - - - 
acid, (I.S.) 
Ketoprofen 7 1 85 77 79 23 
Bezafibrate 7 1 86 81 78 46 
Naproxen 66 83 76 78 22 
Warfarin 74 89 9 5 90 27 
Flurbiprofen 83 9 1 85 90 45 
D~clofenac 63 75 80 72 15 
lndomethacin 6 1 56 238 
Ibuprofen 69 88 69 86 38 
Meclofenamic 85 83 75 65 
acid, (S2) 
Mefenamic acid 45 78 74 76 63 
Clotrirn-nlo - 711 41 59 30 
Gemi .-. . - 
Triclosan 66 79 79 7 5 45 
From initial studies the hydrophilic lipophilic balanced sorbents, i.e. Waters 
Oasis H L B ~ ~  and Phenomenex strata-xTM showed the greatest promise as 
relatively high recovery was observed across the range with these sorbents. The 
CI8 sorbent demonstrated poor ability to extract and retain the more polar analytes. 
Recovery was generally good using the Merck LiChrolut EN" sorbent, however, 
indomethacin was completely unretained on the styrene divinylbenzene resin, 
although it was retained on all of the other polymeric sorbents investigated in Table 
3.4. As the majority of the pharmaceuticals were acidic, a mixed functionality 
reversed-phase anion exchange sorbent, Oasis MAX'" was investigated. The 
extraction was performed at pH 6.0 so as to promote the dissociation of carboxyl 
functionalities. Recovery for acidic analytes was low, generally <5O0/0 and recovery 
of basic and neutral analytes was also lower than that calculated from the 
reversed-phase sorbents, suggesting ion exclusion based upon electrostatic 
repulsion. 
As the Oasis H L B ~ ~  and the Phenomenex strata-xTM were chemically similar 
and share common retention chemistry, a t-Test was performed using the 
calculated percentage recovery values for a 5 pgL-' spike standard to determine 
whether the two sorbents were significantly different using Microsoft E X C ~ I ~ ~ .  It was 
discovered that at the 95% confidence interval that there was no significant 
difference between the two sorbents (t-Experimental = 0.31 < t-Critical = 2.03, two 
tailed assuming equal variances). 
3.3.6.2 Extraction pH. 
A subset of six analytes was chosen to optimise extraction pH. The selected 
analytes were salicylic acid, clofibric acid, ketoprofen, diclofenac, ibuprofen and 
mefenamic acid. These solutes were selected as they span across the 
chromatographic separation. Buffer solutions were prepared within the pH range of 
2-8 and spiked with 5 p g ~ - '  of each. Samples were extracted using the Oasis HLB 
cartridges and eluted with 10 ml MeOH, reduced in volume, reconstituted and 
analysed using the HPLC method. It was observed that an extraction pH of 4.0 , 
1 
provided optimum analyte recovery for all compounds. 
3.3.6.3 Elution solvent. 
Within the literature many SPE procedures recommend elution with MeOH. 
However, MeOH is difficult to reduce in volume under N2 without significant sample 
loss and so alternative solvents were investigated. These included; acetone, 
acetonitrile, ethyl acetate, isopropyl alcohol (IPA), 50% v/v ethyl acetate in acetone 
[38], and 10% v/v MeOH in methyl t-butyl ether (MtBE) [39]. Using the Oasis H L B ~ ~  
sorbent, a 5 p g ~ - '  mixed standard was extracted and eluted using each of the 
above solvents and solvent mixtures. Recovery from cartridges eluted with ethyl 
acetate and acetonitrile were unacceptably low, ~ 5 0 %  for the test solutes. 
Recovery was in the range of 70-90% with IPA and acetone. For the mixed 
solvents, recovery was -50% or less for cartridges eluted with 10% vlv MeOH in 
MtBE, however, 50% v/v ethyl acetate in acetone provided near quantitative 
recovery for all analytes, >go%. Of all the solvents examined the 50% v/v ethyl 
acetate in acetone mixture provided the highest recoveries, (due to increased 
solvent strength) and it is also easily reduced in volume under N2 with minimal 
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splashing and sample loss. The recovery of salicylic acid was low in all extraction 
experiments, however, it is the most polar of the compounds examined (pK, -3.0). 
At this stage in the study it was noted that during the SPE procedural development 
that there was significant batch-to-batch variability with the Oasis H L B ~ ~  sorbent, 
reflected in some cases by large reductions in solute recovery. Such batch 
variability was not apparent with the Phenomenex strata-x"" phase and therefore 
these cartridges were preferred in further sample extractions. 
3.3.6.4 Elution volume. 
The optimum volume of elution was determined by eluting an extracted 5 p g ~ - l  
standard with ten 2 mL portions of 50 % vlv ethyl acetate in acetone. Each 2 mL 
fraction was collected, reduced in volume and reconstituted in 100 pL of MeOH. 
The relative recovery of each analyte was determined and plotted against the 
elution volume, Fig. 3.6. It was observed that 10 mL of elution solvent was 
sufficient to completely elute all compounds from the sorbent bed. It was also 
observed that as expected the more polar the solute the less solvent was required 
for complete elution. 
3.3.6.5 Surrogate Performance. 
Two surrogate standards were also included in the method at a concentration level 
of 2 p g ~ - l  to assess the extraction procedure. The recovery of o-toluic acid is quite 
low and outside the acceptable limits, (i.e. 70-130%, [37]) at 56%, while the 
recovery of meclofenamic acid is more acceptable at 80%. o-Toluic acid is the 
more polar of the pair and although it is not in itself a pharmaceutical compound, it 
was chosen as it shares a common functionality with many of the more polar 
pharmaceuticals. Meclofenamic acid was previously used as a surrogate standard 
by Clara et a/. [40]. 
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Figure 3.6: Plot of relative % recovery versus SPE elution volume, (mL) using strata-X~ SPE 
cartridges and elution with 50 % vlv ethyl acetate in acetone. Key: black trace; ibuprofen, green 
trace; clofibric acid, pink trace; ketoprofen, orange trace; diclofenac, blue trace; mefenamic acid, red 
trace; salicylic acid. 
3.3.6.6 Overall method performance data. 
Using the optimised parameters six 1 p g ~ '  spikes prepared in water collected from 
the River Boyne near Navan, Co. Meath, Ireland were extracted using the 
Phenomenex strata-xTM cartridges and analysed using the dual gradient method. 
From the six replicate extractions the overall level of method precision was 
estimated (as the percentage RSD for the six replicate extractions). Unspiked 
aliquots of estuarine and river water were also extracted and analysed. The overall 
levels of sensitivity, (LOD and LOQ) were then calculated by determining the 
baseline noise in the unspiked extracts. Overall method performance data is 
presented in Tables 3.5 and 3.6. 
Table 3.5: Extraction repeatability and overall method precision calculated using 1 CIg~-l spikes in 
river water, (*actual spiking level was 2 pg~-l).  
% Recovery Repeatability, Method Precision, 
Analyte (n=6) (% RSD, n=6) 
Metformin - - 
Paracetamol - 
Salicylic Acid 67 f 19.8 29.38 
Trimethoprim - - 
Caffeine - 
o-Toluic Acid 45 f 12.3 27.27 
Propranolol - 
Clofibric Acid 77 f 18.4 23.90 
Keto~rofen 81 f 15.6 19.32 
Warfarin 97 f 18.2 18.86 
~lurbiarofen 77 + 16.0 20.83 
Diclofenac 73 f 15.2 20.63 
Meclofenamic Acid 72 f 13.0 17.95 
Mefenamic Acid 75 + 13.9 18.42 
Clotrimazole- . 
Gemfibrozil 72 + 7.3 10.20 
Triclosan 104 f 24.4 23.57 
lvermectin 42 f 5.3 12.65 
Table 3.6: Overall method sensitivity data calculated in two different sample matrices (1 L 
extraction volume), values quoted are in vg~ - ' .  
Estuarine Water River Water 
Analyte 
LOD LOQ LOD LOQ 
Metformin 0.35 1.17 - 
Paracetamol 0.33 1.09 - 
Salicylic Acid 0.66 2.21 0.18 0.62 
Trimethoprim 0.03 0.1 1 - - 
Caffeine 0.27 0.91 - - 
o-Toluic Acid 0.13 0.44 0.17 0.58 
Propranolol 0.04 0.13 - + 
Clofibric Acid 0.12 0.41 0.07 0.23 
Ketoprofen 0.16 0.53 0.1 1 0.38 
Bezafibrate 0.13 0.45 0.08 0.28 
Na proxen 0.02 0.08 0.02 0.08 
Warfarin 0.73 2.42 0.55 1.85 
Flurbiprofen 0.41 1.36 0.32 1.06 
Diclofenac 0.29 0.96 0.18 0.62 
lndomethacin 0.09 0.31 0.15 0.49 
Ibuprofen 0.19 0.64 0.33 1.12 
Meclofenamic Acid 0.1 1 0.36 0.12 0.39 
Mefenamic Ac~d 0.1 1 0.38 0.12 0.39 
Clotrimazole 0.24 0.80 
Gemfibrozil 0.46 1.52 0.37 1.24 
Triclosan 0.23 0.78 0.14 0.46 
lvermectin 0.32 1.08 0.43 1.42 
The determined recovery data from the Strata-X sorbent was generally in 
the acceptable range of 70-130% and for many analytes is near quantitative. As 
expected from the LC method development, the water solubility of the analytes 
limits its retention on the polymeric sorbent, i.e. the more hydrophilic the analyte 
the less retention. This fact is clearly demonstrated by metformin that shows little 
retention. The retention of basic analytes was generally lower than their acidic 
counterparts, which was due to the low pH at which the extraction was performed. 
Repeatability was generally in the range of 10-20% RSD for the six replicate 
extractions which is acceptable considering the complexity of the method and the 
number or steps involved before achieving a concentrate extract. The levels of 
precision achievable will depend upon the influence of the sample matrix, i.e. 
interference from component of the matrix present, possible co-elution etc. Analyte 
recovery was also noted to be higher from estuarine water samples compared to 
fresh water samples, this is attributed to the increased ionic strength of the 
estuarine sample and resulting 'salting out' effects. The homogeneity of the 
extraction material is also important in providing repeatable recovery values. Based 
upon the levels of repeatability calculated it can be deduced that the Strata-X 
sorbent is quite homogenous with acceptable inter batch repeatability and the 
sample matrix is not excessively preconcentrated under the method conditions 
allowing for clear identification of the target analytes. 
The calculated LOD and LOQ values in a real sample matrix are on average 
in the low to sub p g ~ - l  range therefore suggesting that the developed method is 
suitably sensitive for its intended purpose. It can be observed that components of 
the sample matrix that are extracted along with the target analytes reduce the 
sensitivity of the method, this is particularly visible for trimethoprim and propranolol 
amongst others which exhibit strong responses under standard conditions but were 
completely obscured by co-extracted matrix components. It is also interesting to 
note that the calculated detection and quantitation limits are lower in estuarine 
water than in river water. This may be due to lower matrix content or the influence 
of increased ionic strength on the extraction compared to river water. The 
calculated sensitivity data also compares well with other methods developed for 
the determination of pharmaceutical residues from complex environmental 
samples. For example Blackwell et a/. reported detection limits in the range of 
0.25-0.35 p g ~ - '  for the determination of three antibiotics in surface water samples, 
however, a much more complicated extraction procedure was employed and 
detection was performed at longer wavelengths that would not be expected to 
suffer as much from matrix interference [41]. Similarly Gonzalez-Barreiro et a/. 
employed photochemically induced fluorescence for the determination of ten 
pharmaceuticals in wastewater and detection limits were in the region of 2-120 
p g ~ - '  [42]. It can therefore, be seen that the developed method compares 
favourable with other reported LC procedures with optical detection. 
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3.3.7 Application to environmental samples: 
Grab samples were collected in silanised 2 L amber glass bottles from areas in 
north Co. Dublin and Co. Meath, Ireland namely the Malahide Estuary (which 
receives treated effluent from sewage treatment plants in north Co. Dublin), in the 
vicinity of sewage sea outfalls near Howth and Portmarnock, and from the River 
Boyne downstream of the Navan Wastewater Treatment Centre in Co. Meath 
(>40,000 population equivalents). A sample of potable water from the laboratory 
was also analysed. Samples were filtered and extracted as previously described in 
section 3.2.4 and analysed using the dual gradient method, Table 3.2. A 1 L 
portion of each sample was also spiked with 1 p g ~ - '  of each pharmaceutical and 
extracted and analysed using the dual gradient method. None of the chosen 
analytes were detected in any of the samples collected. However, the spiked 
samples showed very clear peaks for all of the pharmaceuticals added at the 
expected retention times. Fig. 3.7 depicts the resulting chromatogram of extracted 
spiked Malahide Estuary sample. 
30 40 
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Figure 3.7: Chromatogram of the extracted 1 p g ~ - '  spiked Malahide Estuary sample. Separation 
conditions as in Figure 3.4. Peak identification: 1 metformin, 2 paracetamol, 3 salicylic acid, 4 
bimethoprim, 5 caffeine, 6 o-toluic acid, 7 propranolol, 8 clofibric acid, 9 2-naphthoic acid, (internal 
standard, 10 ketoprofen, 11 bezafibrate, 12 naproxen, 13 warfarin, 14 flurbiprofen, 15 diclofenac, 16 
indomethacin*, 17 ibuprofen, 18 meclofenamic acid, 19 mefenamic acid, 20 cloirimazole*, 21 
gemfibrozil*, 22 Triclosan, 23 ivermectin*, (*Actual spiking level: 2 ppb). 
Samples and spikes were also analysed using a photodiode array detector 
and a portion of an extracted contour plot is displayed in Fig. 3.8. It can be seen 
that distinguishable UV spectra can be obtained even from ultra trace levels on 
complex matrices when suitable preconcentration is employed. Preliminary 
qualitative data can be achieved by UV library searching if available and therefore 
the method may be of use in environmental laboratories where LC-MS 
instrumentation is not available. 
2-Naphthoic Acid, (1,s.) 
Propranolol 
Figure 3.8: Partial contour plot of spiked Malahide estuary sample, distinguishable UV spectra can 
be obtained even for ultra trace residues with sample preconcentration using SPE. 
3.4 Conclusions: 
A simple method has been developed that allows for the preconcentration and 
determination of acidic and basic pharmaceuticals. Using monolithic columns a 
highly efficient separation is achievable with calculated theoretical plate counts far 
superior to those attainable using particulate columns. Acceptable SPE recoveries 
for the majority of analytes permit the lowering of instrumental detection limits by 
one thousand fold thereby allowing low p g ~ - '  levels to be determined using LC-UV. 
When combined with photodiode array detection preliminary qualitative information 
is achievable especially if a spectral library search function is available. The 
method has been applied to a variety of environmental waters. The method may 
become useful to those who wish to determine the selected pharmaceuticals in 
environmental samples but who do not have access to LC-MS instrumentation. 
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4.0 On-line Preconcentration of Pharmaceutical 
Residues from Large Volume Water Samples using 
Short Reversed-Phase Monolithic Cartridges Coupled 
to  LC-UV-ESI-MS. 
4.1 Introduction: 
Within the last decade pharmaceuticals and personal care products have emerged 
as a new class of organic micro contaminants that are frequently detected in the 
aquatic environment [1,2]. As a result, the number of methods appearing in the 
peer-reviewed literature for their determination has increased. Due to the ultra 
trace levels of pharmaceuticals that may be present, normally sub parts per billion 
[3] a sample enrichment procedure is necessary in order to attain the desired 
levels of analytical sensitivity. The foremost approach reported to date has been 
the use of solid phase extraction (SPE) techniques predominantly using disposable 
cartridges in the off-line mode [4,5,6]. A drawback of off-line SPE procedures is 
that they can be quite cumbersome to perform, often requiring many steps before 
reaching a concentrated extract suitable for instrumental analysis, of which only a 
small proportion is actually injected onto the chromatographic column. In contrast 
on-line SPE techniques offer increased sensitivity with reduced sampling handling 
as all the extracted components can easily be introduced to the analytical column. 
Reported detection limits in the p g ~ '  range are not uncommon [7,8]. One of the 
driving forces for on-line SPE methods is higher throughput and faster analysis as 
required for pharmacokinetic and metabolomic studies [9]. The formats of on-line 
SPE reported in the literature vary from column switching techniques 
[ I  0,11,12,13,14,15,16,17,18] to automated SPE instruments coupled to liquid 
chromatographs [8,19,20,21]. With automated systems only a small portion of the 
extract is actually injected onto the analytical column compared with complete 
introduction b.y mobile phase back flush when column switching is employed. 
Therefore it would be more appropriate to refer to such procedures as automated 
SPE rather than true on-line SPE. Although on-line SPE is an attractive prospect it 
is not without limitations. Extraction columns are generally quite small and 
therefore can only contain a limited quantity of sorbent leading to problems with 
analyte retention [lo]. Sorbents are generally particulate in nature and small 
particles with a large active surface area may be required. However, the speed of 
the extraction may then be limited due to the excessive backpressure generated. 
Sorbents must also be chosen with high analyte affinity thereby allowing higher 
volumes of sample required for increased sensitivity to be extracted without the 
possibility of analyte breakthrough. Application of on-line SPE and automated SPE 
include the preconcentration of pharmaceuticals [ I  0,181, estrogens and endocrine 
disruptors [8,20] and nonylphenol [I41 with subsequent LC and photodiode array or 
MS detection. 
Monolithic silica consists of a unique bimodal pore structure, (macropores of 
-2 pm and mesopores of -13 nm, section 2.3.5) which imparts high porosity and a 
higher available active surface area to the column [22]. Such high porosity also 
allows monolithic columns to be used at elevated flow rates without the generation 
of excessive backpressure. The approach taken with this research has focused 
upon the use of short reversed-phase monolithic silica columns for the on-line SPE 
of acidic, basic and neutral pharmaceutical residues from aquatic samples. The 
monolithic column allows for the rapid extraction of a large sample volume at 
relatively low pressure. A longer reversed-phase monolithic column was employed 
for the analytical separation using the method developed in Chapter 3.0. Coupling 
the on-line SPE-LC procedure with ion trap MS increased the selectivity of the 
method. 
4.2 Experimental: 
4.2. I Analyte selection: 
Analytes chosen for monitoring include those that showed prevalence in both the 
published literature and also the list of the most prescribed pharmaceuticals in 
Ireland for the year ending December 31'' 2003 [23]. In addition to the analytes 
mentioned in Chapter 3.0 Table 3.1, the pharmaceuticals depicted in Table 4.1 
were also included. 
Table 4.1: The chemical structures of the additionally included pharmaceuticals. 
Analyte Chemical Structure Analyte Chemical Structure 
Atenoiol 
Furosemide Carbamazeplne 
A 0 NH, 
Sulfamethoxazole 
Suffamethazine 
Salbutamol 
4.2.2 Chemicals and reagents: 
Chemicals and reagents used in this study were as per section 3.2.2 unless 
otherwise stated. Ciprofloxacin was received from Fluka, (Buchs, Switzerland). 
Atenolol, salbutamol, amoxicillin, sulfamethoxazole, sulfamethazine sodium salt, 
furosemide, carbamazepine, nimesulide and fluoxetine were all obtained from 
Sigma, (Steinheim, Germany). All pharmaceuticals were of a purity >95%. 
Stock 1000 m g ~ - '  solutions of each pharmaceutical were prepared in MeOH 
with the exception of ciprofloxacin which was prepared in water. In the case of 
salts, standards were prepared in terms of the parent analyte. These standards 
were periodically replaced. Working standards were prepared from these stock 
standards by appropriate dilution using MeOH. 
Buffer solutions used for the optimisation of the extraction pH were prepared 
by mixing appropriate amounts of acid and its conjugate base for formate and 
acetate, respectively. In the case of MES and HEPES weighed proportions of salt 
were dissolved in -900 mL Milli-Q water and titrated to the desired pH using either 
1 M HCI or 1 M NaOH. 
4.2.3 Glassware preparation: 
Silanisation was performed as described in section 3.2.3. 
4.2.4 On-line SPE: 
On-line SPE was performed using a Rheodyne 7000 six-port column-switching 
valve (Cotati, CA, USA). The extraction column was a Merck Chromolith RP18e 
guard cartridge; 10.0 x 4.6 mm i.d. monolithic silica (Merck, Darmstadt, Germany). 
The experimental set-up is depicted in Fig. 4.1 following. 
Sample Loading 
tRheodme Switching Vdv 
Figure 4.1: On-line SPE experimental set-up. 
A Merck Hitachi LaChrom L-7100 pump was used for sample delivery. Prior 
to extraction the short monolithic column was conditioned with 20 mL of MeCN and 
20 mL of water at flow rates of 5 mlmin-'. Samples were filtered through Whatman 
GFIC glass fibre filters to remove suspended matter and a 500 mL aliquot was 
transferred to a silanised glass bottle and adjusted to pH 4.0 using concentrated 
sulphuric acid. Samples were pumped through the extraction column at a rate of 10 
mlmin-'. Following complete extraction the column was washed with 20 mL of 10% 
v h  acetonitrile (MeCN) in water at a rate of 10 mlmin". Elution was performed by 
back flushing with mobile phase for 25 minutes of the chromatographic dual 
gradient run. After such time the valve was switched back to the load position for 
the next extraction. 
4.2.5 LC-UV & LC-MS Analysis: 
HPLC instrumentation unless otherwise stated was as per section 3.2.5. LC-MS 
analysis were performed using an Agilent 1100 series HPLC consisting of a binary 
pump with on-line vacuum degasser and a photodiode array detector, model 
G1315B. The LC system was coupled to a Bruker Daltonics esquireLC ion trap MS 
complete with an atmospheric pressure ESI interface. Agilent ChemStation version 
A.06.01, (Agilent Technologies, Palo Alto, CA, USA) and Bruker Daltonics esquire 
control version 6.08, (Bruker Daltonics, Coventry, UK), were used for LC-MS 
system control, Bruker Daltonics DataAnalysis version 3.0 was used for data 
processing. For ESI optimisation solutions of analyte were directly infused into the 
MS using a Cole Parmer 74900 series syringe pump at a rate of 300 p~h' l  (Cole 
Parmer, Vernon Hills, IL, USA). 
Analytical separations were performed using two Merck Chromolith 
Performance RP18e; 100.0 x 4.6 mm i.d. monolithic silica columns joined in series 
using a Chromolith volumeless column coupler (Merck KgaA, Darmstadt, 
Germany). Details of the dual gradient separation parameters were previously 
reported, (Table 3.1). Prior to entering the ESI interface the flow was split -1120 
using an UpChurch Scientific graduated micro splitter valve, model P-470, 
(UpChurch Scientific, Oak Harbor, WA, USA). 
4.3 Results & Discussion: 
4.3.1 Liquid chromatography: 
The chosen set of pharmaceutical analytes is quite chemically diverse spanning 
across acidic, neutral and basic chemicals. The pK, values and both 
experimentally determined and theoretical octanol water partition coefficients (Log 
P and XLog P), data of the selected pharmaceuticals can be seen in Table 4.2 
following. 
During previous LC method development it was observed that the pH of the 
mobile phase exhibited the most pronounced effect on the selectivity of the 
separation. It was found that a pH of 4.5 provided sufficient separation of all 
chosen analytes. Additional pharmaceuticals have been included because a 
complete separation of all analytes is not completely necessary when 
accompanied by MS detection. Fig. 4.2 depicts the separation of a 5 mgL" mix 
standard of the chosen pharmaceuticals with UV detection at 225 nm, for the 
purposes of clarity the set of chosen analytes was subdivided and each resulting 
chromatogram is offset to easily permit the resulting peaks to be identified. 
Table 4.2: pK, and Log P data for the selected pharmaceutical analytes, 
Analyte PK, 1241 Log P and theoretical (XLog P) [25]. 
Metformin 12.40 1261 -, (0.56) 
Atenolol 9.1 6 [27] 0.16, (0.46) 
Salbutamol 5.90 [28] -, (1.44) 
Paracetamol 9.50 [29] 0.46, (0.45) 
Salicylic Acid 3.50 2.36, (2.43) 
Amoxicillin 2.40 0.87, (0.03) 
Trimethoprim 6.60 0.91, (0.65) 
Sulfamethazine 2.65 0.89, (0.46) 
Caffeine 14.00 [30] -0.07, (-0.50) 
Sulfamethoxazole 5.70 0.89, (0.68) 
Ciprofloxacin 6.38 -, ( I  .94) 
Furosemide 3.90 [27] 2.03, (1.41) 
Propranolol 9.49 3.48, (3.03) 
Clofibric Acid - 2.58, (2.58) 
Carbamazepine 13.90 2.45, (2.30) 
Ketoprofen 4.45 3.12, (3.22) 
Bezafibrate 3.60 -, (3.85) 
Nimesulide 6.50 [31] -, (2.51) 
Meclofenamic Acid -, (4.32) 
Mefenamic Acid 4.20 [34] 5.12, (4.16) 
Clotrimazole 6.12 -, (6.14) 
Gemfibrozil - -, (3.56) 
Triclosan 8.10 1351 4.76, (4.96) 
lvermectin - -, (3.41) 
Naproxen 4.20 3.18, (2.84) 
From Fig. 4.2 it can be observed that the use of simultaneous organic 
Warfarin 5.05 
Fluoxetine 8.70 
Flurbiprofen 4.33 
solvent and flow gradients allows for the efficient separation of a broad spectrum of 
analytes within a reasonable amount of time (65 minutes per injection). The 
Diclofenac 4.1 5 -, (3.91) 
lndomethacin 4.50 [26] 4.27, (4.1 8) 
Ibuprofen 4.51 3.97, (3.64) 
[32: 
:33: 
127: 
previously optimised mobile phase conditions are also expected to be readily 
2.60, (2.96) 
-, (3.82) 
4.16, (3.76) 
adaptable to ESI as Ahrer et a/. reported that concentrations of mobile phase 
additives greater than 2 mM can often lead to a decrease in mass spectral intensity 
[36]. The peak shape of the early eluting peaks is attributed to band distortion as a 
result of solvent effects, as the standard was prepared in a stronger reversed- 
phase solvent, i.e. MeOH, than the conditions encountered by the analytes under 
initial mobile phase conditions. The polarity of pharmaceutical compounds is 
clearly observable from Fig. 4.2 with the majority of analytes being eluted from the 
reversed-phase column within the first twenty minutes of the chromatographic run, 
suggesting perhaps that other stationary phase chemistries such as C8, phenyl or 
even ion exchange sorbents may warrant investigation to improve the retention 
and increase selectivity for such early eluting analytes. 
30 40 
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Figure 4.2: Standard separation of chosen pharmaceuticals. Peak identification: 1; Metformin, 2; 
Atenolol, 3; Salbutarnol, 4; Acetaminophen, 5; Amoxicillin, 6; Salicylic acid, 7; Trimethoprim, 8; 
Sulfarnethazine, 9; Sulfamethoxazole, 10; Caffeine, 11; Ciprofloxacin, 12; Furosemide, 13; 
Propranolol, 14; Clofibric acid, 15; Carbamazepine, 16; Ketoprofen, 17; Bezafibrate, 18; 
Nimesulide, 19; Naproxen, 20; Fluoxetine, 21; Warfarin, 22; Flurbiprofen, 23; Diclofenac, 24; 
Indornethacin, 25; Ibuprofen, 26; Meclofenarnic acid, 27; Mefenarnic acid, 28; Clotrirnazole, 29; 
Gemfibrozil, 30; Triclosan, 31; Iverrnectin. The blue trace is offset by 2.5 minutes in time and 5 
rnAU, the red trace is offset by 5 minutes in time and 10 mAU for the purposes of clarity, separation 
conditions as per Table 3.1. 
4.3.2 On-line SPE - optimisation of the sample loading flow: 
The unique bimodal pore structure of monolithic silica allows for the use of 
elevated flow rates without the generation of excessive backpressure normally 
encountered when using particulate-based media under the same conditions. In 
this study, the use of a short monolith as an on-line concentrator column with LC 
was investigated, configured as shown in Fig. 4.1. On-line SPE using short 
monolithic trap columns offers the following potential advantages over using an off- 
line SPE approach. Firstly, despite the surface area of the short monolith being 
-350 m2g" compared to higher surface areas for commercial packed SPE 
cartridges (Oasis HLB = 700 m2g", LiChrolut EN = 1000 m2g-'), it was envisaged 
the relatively small dead volume within the monolithic phase and the comparatively 
small flow through channels would result in equal or improved extraction 
efficiencies for analytes exhibiting some reasonable degree of hydrophobicity. 
Secondly, the system would permit rapid sample loading, equivalent to the loading 
rates used with off-line SPE using commercial cartridges, but also permit 
automated washing and elution steps. Thirdly, the elution of the retained analytes 
would be possible using the LC mobile phase and the direct back flushing of the 
analytes and sharp sample bands onto the analytical column possible, without any 
analyte loss. Finally, the system allowed for simultaneous loading of the next 
sample during the chromatographic separation of the previous sample. Such a 
feature allows for the reduction of analysis times significantly, in this instance the 
desire was to use short monolithic columns for the rapid extraction of reasonably 
large volumes of sample. In order to determine the maximum possible flow rate, 
reagent water was pumped through the extraction column at various flow rates and 
the resultant backpressure was measured. Fig. 4.3 depicts the average of ten 
replicate backpressure measurements at each of the different flow rates. 
From the Fig. 4.3 it can be seen that the backpressure generated increases 
linearly as the flow rate increases. The maximum recommended operating 
pressure according to the product literature is not more than 200 bar [37] and 
therefore, from Fig. 4.3 it is estimated that the maximum possible flow rate is -19 
mlmin-' via linear extrapolation. However, the maximum flow rate possible with the 
Merck Hitachi pump was 10 m~min- '  thereby limiting the minimum possible 
extraction time. The inserted error bars indicate acceptable flow reproducibility that 
suggests that the flow of sample through the column should be homogenous. 
The effect of flow rate on analyte recovery was measured by extracting 500 
mL portions of 200 ngL-' mixed analyte standards prepared in Milli-Q water and 
adjusted to pH 4.0 with sulphuric acid. Flow rates investigated were as in Fig. 4.3 
above and all extractions were performed in duplicate. Table 4.3 following lists the 
calculated recovery values at each of the investigated sample loading flow rates. 
Recovery was calculated based upon peak area comparison with the direct 
injection of a 5 rng~-'  standard. 
0 I I I I 1 1 
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Figure 4.3: Extraction column backpressure generated at various flow rates of Milli-Q water. 
Table 4.3: The effect of sample loading flow rate upon analyte recovery, sample size 500 mL. 
% Recovery at different sample loading flow rates, (m~min-I) 
Analyte 
2.00 4.00 6.00 8.00 10.00 
Metformin 0 0 0 0 0 
Atenolol 0 0 0 0 0 
Salbutamol 0 0 0 0 0 
Paracetamol 0 0 0 0 0 
Salicylic Acid 0 0 0 0 0 
Amoxicillin 0 - 0 0 0 0 
Trimethoprim 4 3 4 5 3 
Sulfamethazine 8 4 3 5 3 -
Caffeine 0 9 5 5 4 
Sulfamethoxazole 8 5 4 8 7 
Ci rofloxacin 12 16 15 
Furosemide 20 19 29 16 20 
Pro~ranolol 24 34 49 50 48 
Fluoxetine 69 92 97 101 92 - ~~ - -
Flurbiprofen 64 126 95 >I 30 82 
Diclofenac 30 28 85 90 65 
lndomethacin 103 85 100 96 112 
Ibuprofen 106 118 83 99 130 
Meclofenamic Acid 57 103 75 83 63 
Mefenamic Acid 80 84 87 84 92 
Clotrimazole 43 98 28 14 20 
Gemfibrozil 75 109 87 72 69 - - 
Triclosan 54 55 61 60 66 
lvermectin - 
From Table 4.2 it can be observed that there is little recovery of the more 
polar analytes from the extraction column suggesting that there is insufficient 
interaction between these polar compounds and the reversed-phase sorbent. This 
also suggests that the pH at which the extraction is performed will be of critical 
importance in attempting to promote retention of such analytes. However, as was 
observed in Fig. 4.2, these analytes also elute extremely early from the analytical 
column, within starting mobile phase conditions of maximum aqueous modifier. 
Therefore, as previously suggested, the use of more polar or ionic stationary 
phases may be needed to sufficiently retain and extract these compounds. This is 
an unfortunate observation as it is expected that these analytes that clearly 
demonstrate high aqueous affinity are those that are expected to show prevalence 
in discharged wastewater effluent and the receiving aquatic system. 
In a number of instances the percentage analyte recovery was greater than 
130%, particularly in the case of warfarin. Such excessive recovery is attributed to 
co-adsorbed trace organic contaminants present in the reagent water. Based upon 
a mass balance approach there is a 25000-fold magnification of both analytes and 
matrix and therefore, impurities that are normally at such minute levels suddenly 
become significant interferants and leading to problems with peak integration. Such 
effects were particularly prevalent at lower flow rates. It was also observed that due 
to the increased path through the on-line SPE system retention times slightly 
increased when compared to those recorded by direct standard injection. In most 
instances such an effect caused no problems except in the case of ivermectin that 
elutes just before a system peak, (later identified using ESI-MSIMS to be diethyl 
hexyl phthalate, mlz 391 . I ,  a plasticizer contaminant present in the MeOH used) 
during standard injection and was observed to coelute with the system peak in the 
chromatograms of on-line SPE extracts. 
Analyte recovery, with the exception of the aforementioned polar analytes 
was quite high, on average >70% and near quantitative in many cases. For the 
majority of analytes recovery was unaffected by increasing the rate of extraction, 
thereby allowing for reduced extraction times. Practicality must also be taken into 
consideration and therefore, it was decided to use a flow rate of 10 mlmin-' for 
sample extraction for all further development. 
4.3.3 On-line SPE - optimisation of the sample pH: 
In an attempt to increase the retention of the more polar pharmaceuticals the 
extraction pH was optimised. As the extraction column is a silica-based material 
and according to the product literature is only stable within the range of pH 2 - 7.5 
[37], pH values in the range of 3 - 7 were investigated using appropriate buffer 
solutions prepared in Milli-Q water. Table 4.4 lists analyte recovery at each of the 
experimental pH values. 
Table 4.4: Analyte recovery as a function of sample pH, sample size 500 mL. 
% Analyte recovery 
Analyte PH 3 PH 4 PH 5 PH 6 PH 7 
(formate) (formate) (acetate) (MES) (HEPES) 
Metformin 0 0 0 0 0 
Atenolol 0 0 0 0 0 
Salbutamol 0 0 0 0 0 
Paracetamol 0 0 0 0 0 
Salicvlic Acid 0 0 0 0 n 
Amoxicillin 0 0 0 0 0 
Trimethoprim 4 6 9 25 33 
Sulfamethazine 5 3 3 3 1 
Caffeine 5 8 7 7 n 
Sulfamethoxazole 7 9 6 4 2 
Ciprofloxacin 36 77 40 15 0 
Furosemide 48 36 16 5 0 
Pro~ranolol 58 40 49 82 71 
Clofibric Acid 40 11 4 0 n 
Carbamazepine 88 97 84 84 75 
Ketoprofen 93 82 98 51 28 
Bezafi brate 92 94 87 83 100 - - 
Nimesulide 83 104 123 85 32 
Naproxen 73 78 73 16 11 
W~arfarin 73 112 99 90 0 
Fluoxetine 46 58 77 58 70 
Flurbi rofen 92  0 0 
Diclofenac 100 105 98 46 0 
lndomethacin 70 67 107 110 79 
Ibuprofen 110 93 101 35 5 1 
Meclofenamic Acid 58 - 70 90 85 0 
Mefenamic Acid 68 68 85 87 71 
Clotrimazole 24 35 48 93 60 
Gemfibrozil 75 96 92 86 87 
Triclosan 59 57 59 91 74 
lvermectin - 
As was noticed during the flow rate study no appreciable recovery of early 
eluting analytes was observed. These analytes may require more extreme acidic or 
alkaline conditions in order to exhibit retention on the CI8 phase. However, 
because of the chemical diversity of the analytes, extractions at acidic pH would 
promote the protonation of both acidic and basic analytes and thereby convert 
alkaline compounds into the BH' cationic form reducing their interaction with the 
reversed-phase sorbent. The opposite would be expected at more alkaline pH 
values. An example of such effects is demonstrated by clotrimazole, the imidazole 
ring of the compound is protonated at acidic pH values but as the pH is increased 
the percentage recovery is also observed to increase due to the conversion of 
clotrimazole to a neutral moiety. 
From Table 4.4 it was decided to extract all samples at pH 4.0 as at this pH 
an acceptable balance between all analyte recovery was observed, e.g. small but 
distinguishable peaks for some of the polar analytes such as caffeine were 
observable whilst for most other analytes including basic compounds recovery was 
quite high. Compounds that are more hydrophobic demonstrate a greater tolerance 
to changes in the pH. For example, the recovery of gemfibrozil varies only slightly 
as the pH at which the extraction was performed changed. As was previously 
observed ivermectin could not be distinguished due to co-elution with the diethyl 
hexyl phthalate contaminant peak. 
4.3.4 Matrix removal: 
For any on-line extraction technique, preconcentration of matrix components is an 
important factor. In an attempt to examine the suitability of the method, laboratory 
tap water was spiked with 200 n g ~ "  of the chosen analytes and extracted at pH 
4.0. However, the recorded UV chromatogram displayed a rather large broad peak 
(-20 minutes wide). This peak is attributed to excessive preconcentration of the 
sample matrix, (natural organic matter, humic and fulvic acid, tannins etc.) and was 
observed to totally swamp all analyte peaks and also cause suppression of the ESI 
signal during initial MS work. Previously reported methods for matrix removal in the 
literature have focused upon changing the pH at which the extraction is performed 
1381, sample dilution 1391, or the addition of cationic surfactants to the sample prior 
to extraction [40]. However, such approaches are impractical in this instance. 
Traditionally in off-line SPE methods the sorbent is washed with water containing 
small portions of organic solvent and this procedure was further investigated due to 
the ease at which it could be performed on-line. 
For the development of the wash solvent composition 500 mL aliquots of tap 
water were extracted under the previously optimised conditions. Upon complete 
sample introduction the short monolithic trap column was linked directly to the UV 
detector and analytes were desorbed using a linear gradient of 100% water to 
100% solvent in 30 minutes. Both MeCN and MeOH were investigated but 
preliminary data showed that MeCN removed a larger proportion of the matrix in a 
smaller period of time than MeOH and was therefore, preferred for further 
development. Upon examination of the ChemStation solvent profile it was 
observed that at 20% MeCN the majority of the matrix components had been 
desorbed see Fig. 4.4 (A). However, as the experiment was performed under 
gradient conditions it was necessary to repeat it under isocratic conditions with a 
defined lower proportion of organic solvent, in this case 10% MeCN was 
investigated. Again a 500 mL aliquot of tap water was extracted and this time the 
extraction column was washed with 10% vlv MeCN in water at 1 m~min-', see Fig. 
4.4 (B). From this investigation it was observed that the majority of the adsorbed 
matrix components were removed directly upon the introduction of the wash 
solution and that after a period of 20 minutes of washing nearly all the retained 
matrix components were completely removed, from the extraction column. The 
effect of the washing procedure on the retention of the analytes was also 
investigated by preconcentrating a 200 n g ~ "  standard prepared in reagent water. 
Upon complete introduction the extraction column was washed with 10% vlv MeCN 
for 20 minutes, after such time the percentage of MeCN was increased in a linear 
step to ensure complete analyte elution, Fig. 4.5 depicts the resulting UV trace. 
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Figurn 4.4: Malrix removal using MeCN washes; (A) depicts the determination of the % MeCN 
required for the removal of the sample matrix. (B) depicts the removal of the preconcenlrated matrix 
under the chosen isocratic solvent wash conditions (1 0% MeCN). 
From Fig. 4.5 it can be observed that the retention of some analytes is 
indeed affected by the washing procedure with peaks present at the beginning of 
the chromatogram. These analytes that are observed to elute in the early stages of 
the chromatogram elute in the same region as the majority of the matrix and as a 
result are omitted from further study. However, a significant proportion of the 
analytes is completely retained and was only observed to elute as the percentage 
of organic solvent was increased. The higher the degree of hydrophobicity of the 
compound the higher its tolerance to the washing procedure, it is expected that the 
wash solvent lacks sufficient strength to elute nonpolar analytes from the 1 cm 
extraction column. The volume of wash solvent required can also be estimated 
from Fig. 4.5, it is clear that analyte retention is unaffected for at least 20 minutes 
under conditions of 10% MeCN pumped through at a rate of 1 mlmin-'. Again 
considering the porosity of the monolithic extraction column it was possible to 
perform the washing procedure at an elevated flow rate of 10 mlmin-I, thereby 
allowing for a reduction in the analysis time. 
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Figure 4.5: On-line SPE wash development, depicting the effect of the matrix removal wash 
procedure upon the retention of the analytes on the short monolithic extraction column, a MeCN 
gradient (dashed line), was used to completely remove the retained components from the trap 
column. The black trace de icts the matrix profile, the blue trace depicts the elution profile of the rp retained analytes, (200 ngL- ) and the red irace depicts a 'blank extraction' of reagent water. 
4.3.5 Extraction to extraction carryover: 
Due to the high rate of matrix magnification, problems with extraction to extraction 
carryover may be expected, leading to contamination or matrix build up and 
surface spoilage within the monolithic trap column. The possibility of such 
carryover was investigated by extracting a 500 mL portion of tap water without a 
matrix removal wash step, i.e. a 'worst case scenario' approach. The sample was 
eluted by mobile phase back flush onto the analytical column. At the end of the 
chromatographic run the analytical column was analysed for residual matrix using 
the dual gradient method without injection while the extraction monolith was 
conditioned as normal and then examined for any residual contamination also 
using the dual gradient method. Fig. 4.6 is an overlay of the resulting UV traces. 
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Figure 4.6: Extraction to extraction carryover. The black trace depicts the elution of the 'unwashed' 
sample matrix from the extraction and analytical columns. The red trace depicts the resulting UV 
irace and shows that there is no residual matrix contamination on the analyhcal column. The blue 
irace is the resulting UV trace of the reconditioned monolithic trap. 
From the above figure it is clear that extraction to extraction carryover is 
negligible with no residual matrix peaks being observed in either the analytical or 
extraction column traces. No residual matrix canyover is expected as during the 
separation the percentage MeOH is increased to 90% at a flow rate of 2.3 mlmin-' 
while the extraction column is conditioned with 20 mL of MeCN prior to extraction 
suggesting that both sets of solvent conditions are sufficient to completely remove 
any adsorbed sample or matrix from both the Cq8 phases. 
4.3.6 Method performance: 
The performance of the on-line SPE dual gradient LC method was evaluated using 
two distinct sample matrices, river water taken from the River Boyne in Co. Meath, 
Ireland and potable water obtained from the tap in the laboratory. The levels of 
natural organic matter present in these sample types is expected to be quite 
different with a greater proportion expected in the river water samples. Overall 
method detection limits were determined in each sample matrix, LODs are quoted 
as three times the standard deviation, (n = 3) of the peak-to-peak baseline noise 
while the LOQs are quotes as ten times the standard deviation, (n = 3) of the peak- 
to-peak baseline. Method performance data quoted was calculated from UV 
chromatograms as preliminary attempts to couple the method with ESI-MS using 
the flow splitter showed that there was a rather high degree of variability with the 
MS signal and therefore the method is semi quantitative using UV detection and 
qualitative when accompanied by ESI-MS. The calculated LOD and LOQ values 
calculated by comparison with 200 n g ~ - '  spikes also prepared in both river and 
potable water samples are presented in Table 4.5 following. 
The calculated detection and quantitation limits are rather low suggesting 
that the on-line SPE procedure imparts much greater sensitivity to the method due 
to the higher levels of preconcentration obtainable and complete sample 
introduction when compared to levels observed when off-line SPE methods are 
employed. It can also be observed that the matrix of the sample exhibits a 
pronounced effect on sensitivity, limits are lower in potable water compared to river 
water and also components of the river water matrix were observed to coelute and 
mask the responses of carbamazepine, fluoxetine and warfarin making their 
detection at such ultra trace levels impossible by UV alone. Detection limits are in 
some instances greater than two orders of magnitude lower than those previously 
reported by other researchers for similar pharmaceutical analytes in similar 
matrices using optical detection [41,42,43] and comparable if not superior to many 
limits quoted using LC-MS and LC-MSIMS methods with off-line SPE [44]. 
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Table 4.5: Overall method sensitivity using on-line SPE, values in Clg~" ,  sample size 500 mL. 
River Water Potable Water 
Analyte 
LOD LOQ LOD LOQ 
Carbamazepine - - 0.01 0.03 
Ketoprofen 0.05 0.17 0.05 0.16 
Bezafi brate 0.06 0.21 0.02 0.07 
Nimesulide 0.07 0.24 0.02 0.07 
Naproxen 0.01 0.03 0.004 0.01 
Fluoxetine - 0.05 0.01 
Warfarin - - 0.04 0.12 . -
Flurbiprofen 0.20 0.68 0.06 0.19 
Diclofenac 0.1 1 0.38 0.04 0.12 
lndomethacin 0.17 0.56 0.03 0.09 
Ibuprofen 0.09 0.30 0.03 0.08 
Meclofenamic acid 0.03 0.09 0.01 0.03 
Mefenamic acid 0.03 0.09 0.01 0.04 
Clotrimazole 0.15 0.48 0.08 0.27 
Gemfibrozil 0.14 0.46 0.05 0.17 
Triclosan 0.09 0.29 0.03 0.1 1 
lvermectin 0.32 1.06 0.17 0.55 
Overall method precision was determined by performing ten replicate 
extractions of 200 ngL-' analyte spikes prepared in both river and potable water 
samples. Method precision data is presented in Table 4.6 and is quoted as the 
%RSD based upon peak area measurement for the ten replicate extractions in 
each matrix. The average analyte recovery was also determined in each matrix by 
comparison with the direct injection of a 5 mgL-' standard. 
Overall method precision shows higher variability with increased levels of 
sample matrix, the %RSD values are higher in river water when compared to those 
for the potable water spikes. Precision is ~ 2 0 %  RSD for the majority of analytes in 
both matrices with some exceptions, notably clotrimazole in river water and 
naproxen in potable samples. The levels of precision attainable with on-line SPE 
are expected to be dependant on the homogeneity of the sample matrix, analytes 
with small responses such as warfarin and clotrimazole demonstrate this fact and 
are more affected by the presence of small matrix peaks than analytes that exhibit 
a larger UV response. 
Table 4.6: Overall method precision and analyte recovery from two different sample matrices, (n = 
lo), sample size 500 mL. 
River Water Potable Water 
Analyte Precision Precision 
Recovery Recovery 
(O/o RSD) (% RSD) 
Carbamazepine - 14.42 9f1 
Ketoprofen 20.92 71 f 15 15.90 18f 3 
Bezafibrate 16.35 64f11 21.42 42 f9 
Nimesulide 18.17 96f 17 7.12 107 f 8 
Naproxen 13.02 88f11 47.60 41 f 19 
Fluoxetine - 37.94 52 f 20 
Warfarin - - 25.62 100 + 26 
Flurbiprofen 16.05 65f 10 9.08 86k8 
Diclofenac 22.02 60 f 13 5.72 75k4 
lndomethacin 34.57 56k 19 24.57 74f 18 
l buprofen 17.08 89f 15 4.55 73 k 3 
Meclofenamic acid 30.13 68 f 20 6.02 77f 5 
Mefenamic acid 20.31 79f 16 3.13 86f 3 
Clotrimazole 44.55 37+ 17 9.31 58 f 5 
Gemfibrozil 11.09 86k 10 10.53 81 +9 
Triclosan 10.51 102f11 6.61 78 f 5 
lvermectin 38.41 23f 9 18.78 19f4 - 
The calculated rates of recovery are acceptably high for the majority of 
analytes. Interestingly ivermectin that was indistinguishable from the system peak 
is again completely resolved with the inclusion of the matrix removal step allowing 
for its unhindered determination. There does not appear to be a trend when 
correlating the calculated recovery to the type of sample matrix with some analytes 
exhibiting higher rates of recovery in matrix rich river water than in tap water and 
vice versa. The recovery of naproxen from tap water was much lower with higher 
variability when compared to the rate calculated for the same spiking level in river 
water. A possible explanation for the lower recovery and variability may include the 
reaction of naproxen with residual chloride present from the drinking water 
disinfection process. Boyd et a/. [45] investigated the removal of naproxen during 
water chlorination and reported that naproxen is highly reactive with residual 
chlorine to form a range of chlorinated disinfection by-products. The recovery of 
ketoprofen and bezafibrate are also considerably lower from tap water than from 
the river samples perhaps resulting from elution during the matrix removal wash. 
From the ten replicate extractions the reusability of the extraction column 
was estimated by examining the stability of analyte peak areas. It was found that 
the column displays excellent stability for the extraction of potable water samples 
with no significant variation of peak area for the majority of analytes over the 
course of the ten extractions with the exception of naproxen as previously 
discussed. For the extraction of the river water samples the column displayed no 
great disparity for the first eight extractions but decreases in peak area were 
observed for extraction numbers nine and ten respectively. Therefore, it is 
concluded that the maximum column usage for the extraction of matrix rich 
samples such as river water should not exceed eight extractions but for samples 
with lower natural organic matter content the column can be used a minimum of 
ten times with no noteworthy problems. This makes the on-line SPE method 
economically viable, as the extraction columns are similar in price to SPE 
cartridges. The superior sensitivity levels also make the method more attractive. 
4.3.7 Direct infusion mass spectrometry: 
Prior to coupling the on-line SPE-LC method with MS detection an optimisation of 
the ESI and ion trap focusing parameters was performed by directly infusing 
solutions of each individual analyte prepared in 1:l MeOH 1 mM ammonium 
formate pH 4.5 into the MS. These parameters were automatically fine tuned using 
the Bruker esquire software, version 6.08, for stated mlz values. Analytes were 
infused using both negative and positive ion polarity; that which provided the 
highest intensity was selected for further study. Optimised parameters under both 
polarities are presented in Table 4.7. An average of the optimised focusing 
parameters under each ion polarity was then taken for use with the coupled SPE- 
LC-UV method. 
Table 4.7: Tuned ESI-MS method parameters, (optimisation was performed using a nebuliser 
pressure of 55 psi, dry gas flow of 8 ~ m i n - '  and a drying temperature of 300°C). 
Parameter (+) ESI (-) ESI 
Determined Value Determined Value 
Caoillarv Voltaae (V) -4500.00 4500.00 
- . . .. . . . . . 
Skim 2 (V) 6.20 -6.50 
Octopole (V) 2.50 -1.80 
Octopole A (V) 2.10 -2.00 
Octo p ole RF ( V pp) 138.50 -1 75.00 
Trap Drive 34.10 35.20 
Lens 1 (V) -2.60 2.30 
Simple spectra were recorded in most instances, under positive ion polarity 
the majority of analytes exhibited a [M+H]' pseudomolecular ion, e.g. 
carbamazepine, ketoprofen, bezafibrate, naproxen and fluoxetine while for 
clotrimazole no significant pseudomolecular ion response was observed. The 
predominant ion for clotrimazole was recorded at mlz 277.0 suggesting the loss of 
the imidazole moiety from the molecule. Ibuprofen also exhibited no 
pseudomolecular ion response, the most intense signal being present at mlz 251 .I 
suggesting the formation of a formic acid adduct of ibuprofen [M+HCOOH]'. The 
monitoring of ketoprofen, bezafibrate and naproxen using positive ion conditions is 
also unusual, these compounds are acidic in nature and have more usually been 
reported under (-)ESI conditions and under the mobile phase conditions used 
these analytes are expected to be partly deprotonated (pK, values of 4.45, 3.6 and 
4.2 respectively [24]), thereby the formation of positive pseudomolecular ions 
seems strange. The intensity of the pseudomolecular ions was higher in (+)ESI 
than when the same standard was infused under (-)ESI and therefore (+)ESI was 
chosen for further study. Under negative ion polarity again all analytes exhibited a 
pseudomolecular [M-HI- ion with the exception of flurbiprofen whose most intense 
signal corresponded to the decarboxylation of the molecule, [M-COOHI-. For 
diclofenac and indomethacin the [M-COOHI- ion was significantly more intense 
than the [M-HI- ion and was therefore more suitable for extracted ion 
chromatogram (EIC) generation. Gemfibrozil was produced two distinct ions 
corresponding to a [M-HI- molecular ion at mlz 249.1 and a [M-C7HI2O2]- ion at mlz 
121 .I with the latter displaying higher intensity and therefore being chosen as more 
suitable for EIC generation. Both Triclosan and ivermectin exhibited no response 
when infused under both negative and positive ion polarity as these analytes are 
neutral and nonpolar. Previous reports of ivermectin analysis by LC-MS have 
focused upon the use APCl [46] which is more suitable for the determination of 
higher molecular weight non-polar organics. Triclosan has been determined using 
negative ion ESI-MS but requires the use of high pH mobile phases, (> pH 7.5) for 
significant ion formation [47,48]. 
Due to the flow mismatch between the on-line SPE-LC method and ESI-MS 
the volume of column effluent must be reduced prior to entering the ESI source, 
this was performed using a variable flow splitter. To optimise the flow splitter 
injections of a 10 mgLml mixed analyte standard were performed at various splitter 
settings using the dual gradient LC method now complete with MS detection. The 
resulting EIC peak areas were monitored at each splitter setting until a maximum 
was recorded. At this optimum splitter setting the volume of eluent entering the ESI 
source at both the initial and final flow rates was determined by weight allowing for 
an approximate split ratio to be calculated. It was determined that the split ratio 
was approximately 1120 at both flow rates. The reproducibility of the splitting 
process was also investigated by performing six replicate injections of a 10 m g ~ - '  
standard at the optimised splitter setting. The % RSD for the six replicate injections 
was quite high (max. 25.5% for bezafibrate) and therefore there is a significant 
degree of variability introduced by the requirement to split the eluent flow from the 
monolithic analytical column. Due to this high degree of variability mass spectral 
measurements were only used for qualitative determinations to complement any 
peaks observed in the UV chromatogram. 
The previously unoptimised conditions of nebuliser pressure and dry gas 
flow rates along with the drying temperature were then determined from values 
recommended by the esquire software now knowing the approximate volumes of 
mobile phase entering the ESI source. The values adopted were a nebuliser 
pressure of 30 psi with a dry gas flow of 8 ~min- I  and a drying temperature of 
32S°C. These parameters were used for all further LC-MS analyses. 
4.3.8 Analysis of samples using on-line SPE-DG-LC-MS: 
Samples of water were collected from the River Boyne in Co. Meath, Ireland in the 
vicinity downstream of the Navan Wastewater Treatment Centre that caters for a 
population equivalent of -40,000 along with samples of potable water from the 
laboratory were analysed using the developed on-line SPE-LC-MS method. 
Aliquots of each sample were spiked with 200 ngL-' of the chosen pharmaceuticals 
and also analysed (Table 3.1 and Table 4.1). None of the chosen analytes were 
detected in either sample type however, clear sharp distinguishable peaks are 
observed for each analyte in the UV chromatograms of both spiked sample types. 
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Fig. 4.7 depicts the resulting UV traces for 200 n g ~ - '  spikes in both river and 
potable water samples. The expanded region of the chromatogram illustrates the 
sensitivity if the developed method and also shows the resolution of the spiked 
pharmaceuticals from a number of unknown peaks present within the river water 
and to a lesser extent the potable water sample. The excellent retention 
reproducibility between the two sample types is also clear from the overlaid sample 
chromatograms. 
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Figure 4.7: Overlay chromatogram of 200 n g ~ - '  analyte spikes in river, (red trace) and potable 
water, (blue trace). Peak Identification: 1; ketoprofen, 2; bezafibrate, 3; nirnesulide, 4; naproxen, 5; 
fluoxetine, 6; warfarin, 7; flurbiprofen, 8; diclofenac, 9; indomethacin, 10; ibuprofen, 11; 
meclofenarnic acid, 12; mefenamic acid, 13; clotrimazole, 14; gemfibrozil, 15; Triclosan, 16; 
ivermectin. Separation conditions as per Table 3.1. 
Fig. 4.8 depicts the total ion current chromatogram (TIC) and EIC traces for 
blank and spiked river water. The excellent selectivity imparted by MS is clearly 
visible with defined analyte peaks clearly visible even in regions of high matrix 
interference in the EIC chromatograms. Both fluoxetine and warfarin can be 
detected without matrix interference unlike with UV detection where the 
identification of these analytes was obscured. The ability to obtain such clear mass 
spectra in regions of simultaneous matrix elution illustrates the success of the 
washing step that reduces this background to acceptable levels. The advantage of 
the simultaneous use of UV and ESI-MS detection as shown in Figs. 4.7 and 4.8 in 
overcoming problematic background interferences incurred during ultra trace 
analyses is clear in this case. 
4.4 Conclusions: 
A highly sensitive and selective LC-MS method has been developed for the 
determination of acidic, neutral and basic pharmaceuticals in complex 
environmental samples using monolithic silica columns. The short monolithic 
extraction column allows for the rapid extraction of rather large sample volumes 
with acceptably high analyte recovery. The method was found to be repeatable and 
detection limits were in the low n g ~ - '  range. In order to avoid excessive matrix 
preconcentration and subsequent ESI signal a simple solvent wash step that could 
easily be performed on-line was developed. It was found that such a procedure 
effectively reduced the matrix signal by -90% therefore minimising the matrix effect 
upon the ESI signal. Due to the necessity to split the column effluent prior to 
entering the ESI interface the method is semi-quantitative using UV detection and 
qualitative by MS. The method was successfully applied to environmental waters. 
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Figure 4.8: TIC and EIC traces of t i e r  water spiked with 200ng~- '  using (A) positive and (B) 
negative ESI polarity. m/z Values: ketoprofen (255.0); bezafibrate (362.1); naproxen, (231.0); 
fluoxetine (310.0); ibuprofen (251 . I ) ;  clotrirnazole (277.0); gernfibrozil (121 .I); rnefenarnic acid 
(240.0); rneclofenarnic acid (294.0); indornethacin (31 2.0); diclofenac (250.0); flurbiprofen (1 99.0); 
nirnesulide and warfarin both (307.0). 
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5.0 Column Switching Liquid Chromatography with 
Atmospheric Pressure Chemical Ionisation Mass 
Spectrometry for the Determination of Zinc Pyrithione 
and its Fate in the Aquatic Environment. 
5.1 Introduction: 
5.7.1 Background information: 
From January lSt 2008 the use of antifouling paints containing organotin biocides 
will be completely banned in accordance with the International Marine Organisation 
(IMO), Convention on the Control of Harmful Anti-fouling Systems [I]. In Europe, 
from the same date, under Regulation 78212003, ships registered, operating under 
the authority of, or entering the port of Member States will be legally required to 
bear a certificate stating that they have no coating containing organotin compounds 
or must possess a secondary coating which acts as a protective barrier to prevent 
organotin compounds from leaching into the surrounding waters, [I]. As 
replacements for organotin compounds a number of organic booster biocides have 
appeared on the market. These organic booster biocides have attracted increased 
analytical attention due to their inherent environmental toxicity and the ability of 
some chemicals such as lrgarol 1051 and diuron to persist in the environment and 
perhaps bioaccumulate [2]. 
However, one particular organic booster biocide; zinc pyrithione; (bis-(N- 
oxopyridine-2-thionato) zinc(l1)) has received little attention due to the lack of 
sufficient analytical methods for its determination. Originally synthesised by Shaw 
et a/. in 1950 as a functional analogue of the antibiotic aspergillic acid the 
pyrithione ligand was found to be considerably more potent against 
Staphylococcus, Klebsiellia and Bacillus species than was aspergillic acid [3,4]. 
Pyrithione exists as a tautomeric pair, (see Fig. 5.1) and reacts with some transition 
metal ions via both the sulphur and the oxygen atoms to form complexes with five 
membered chelation rings [5]. 
Figure 5.1: The structures of the pyrithione ligand tautomeric pair; (A) 2-mercaptopyridine-N-oxide 
and (B) N-hydroxypyridine-2-thione, (C) the structure of zinc pyrithione (ZnPT) and (D) the structure 
copper pyrithione (CuPT). 
The use of zinc pyrithione (ZnPT) as an organic booster biocide is a 
relatively new concept, to date the majority of ZnPT produced has been used as 
either the active ingredient in anti-dandruff shampoo or as an additive in cosmetics 
and dermatitis treatments. In Sweden for example it was estimated that at least 10 
tonnes of ZnPT were consumed in the anti-dandruff shampoo sold in 2003 while 
only 2.4 tonnes of ZnPT were used as an organic booster biocide in marine anti- 
fouling paints [6]. The permitted levels of ZnPT usage are a maximum of 4% wlw in 
marine paints and a maximum of 1% wlw in anti-dandruff shampoo [7]. 
Pharmacologically ZnPT acts upon the cell membrane causing 
depolarisation via inactivation of the primary proton pump and other membrane ion 
channels due to the interaction of ZnPT with, and consequent disaggregation of, 
the membrane phospholipid phosphatidyl ethanolamine [8,9,10]. Also Guthery et 
a/. note that the dipole structure of the molecule creates pseudoquaternary 
ammonium groups capable of providing another, mode of antimicrobial activity and 
therefore due to the multimodal activity of ZnPT, microbial resistance is unlikely to 
occur [8]. As a consequence the use of personal care products containing ZnPT 
would be expected to increase. 
5. I .  2 Environmental entry and fate ZnPT: 
Two distinct routes into the aquatic environment exist for ZnPT that depend 
principally upon the mode of usage. In the case of marine antifouling paints ZnPT 
may leach directly from a painted ship surface into the surrounding water. The rate 
of ZnPT leaching has been estimated by Turley et a/. to be 1-3 ~gcrn-~d- '  for long 
-2 -1 lasting paint formulations or 3-1 1 pgcm d for self-polishing paints [ I  I ] .  Using this 
information further, Turley et a/. modelled a PEC of 0.04 p g ~ - '  for ZnPT. Based 
upon the above leach rates, coated ship surfaces would be expected to act as 
continuous diffuse sources of ZnPT and other booster biocides into the 
environment. However, it was noted by Thomas et a/. that the rate of introduction of 
booster biocides into the environment significantly increased during high pressure 
cleaning of painted ship surfaces [12]. Such practices can account for a significant 
proportion of the total quantity of biocide introduced into the surrounding water over 
the course of the cleaning event, but could, however, be minimised by adopting 
improved cleaning practices [12]. 
In two separate studies Thomas et a/. report that paint particles released 
into the environment during high pressure cleaning operations may . . act as further 
sources of booster biocides into the aquatic environment [13,14]. It was found that 
booster biocides introduced to sediment in the form of paint particles persisted for a 
longer period than those introduced as a result of direct leaching [13]. The paint 
particle was also observed to release booster biocides during dissolution and 
therefore, cause "hot spots" of biocide pollution in docks and marinas etc. 
As stated previously in section 5.1 . I ,  the primary use of ZnPT is in anti- 
dandruff shampoo and other personal care products and therefore, ZnPT and free 
pyrithione may be introduced into the aquatic environment via municipal household 
wastewater where such products are used. It would also be expected due to the 
topical only administration and short contact times of such products that metabolic 
conversion would not occur. Galvin et a/. estimate that based upon a rate of 
production of 100-200L wastewater per person per day, possible resulting 
concentrations of pyrithione being introduced into the aquatic environment are in 
the region of 1 x M, (-0.32 P ~ L - ' )  and consequently household wastewater is a 
significant source of pyrithione with possible pollution of receiving waters [ I  51. 
Once introduced into the environment the question is posed as to the fate of 
ZnPT, ideally it should readily degrade and therefore, pose minimal risk to aquatic 
biota. Reports concerning the environmental fate of ZnPT are mixed, however, a 
general consensus exists within the published literature that photochemical 
attenuation is by far the most important removal process for ZnPT and other 
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pyrithiones. Maraldo and Dahllof examined the photolytic behaviour of both ZnPT 
and CuPT in seawater [I61 and reported that the photolytic half-lives for the 
aforementioned complexes were -8.3 and -7.1 minutes respectively. A loss in the 
toxicity of the two complexes to the test bacterial species was also noted upon 
exposure of sample solutions to light. Biotic degradation was also examined during 
the study but it was noted that compared to photochemical attenuation biotic 
degradation was an insignificant process for the removal of the pyrithione 
complexes [16]. Maraldo and Dahllof concluded that wavelengths in the region of 
320-355 nm were the most efficient in the removal of the pyrithione complexes. 
However, in environmental systems the dept of penetration of such wavelengths, 
i.e. the turbidity of the water, and also the photon flux will be the limiting factors 
governing the overall removal of the pyrithione complexes from the water column, 
[16]. Turley et a/. also examined the photochemical behaviour of ZnPT and CuPT 
in the environment [17]. It was determined that the pyrithione complexes rapidly 
degraded upon exposure to light accompanied with a resultant loss in toxicity. The 
photochemical products of both ZnPT and CuPT were identified as 2-pyridine 
sulphonic acid and C02. Based upon available toxicity data for 2-pyridine sulphonic 
acid it was concluded that little environmental risk was posed by the photoproducts, 
(no observed effect concentration (NOEC) for 2-pyridine sulphonic was 5460 M g ~ - ' )  
[171. 
Pyrithione released into the aquatic environment in . either - a free or 
complexed form would be expected to interact with endogenous metal ions. Galvin 
hypothesised that free pyrithione introduced into surface water might accumulate 
as the manganese (11) complex (MnPT) [15], however, it was previously reported 
that pyrithione forms its most stable complex with Cu(ll) and therefore, all 
pyrithione introduced into the aquatic environment may complex with or 
transchelate to form CuPT, i.e. pyrithione complex formation follows Irving-Williams 
behaviour [I 81. Formation constants for pyrithione metal complexes can be found 
in Ref. [I 81. 
With a reported Log KO, of 9.33 it would be expected that ZnPT would 
accumulate in sediments due to very low aqueous solubility [19]. However studies 
to determine the extent of the adsorption of ZnPT onto sediments are scarce. In 
contrast to what would be expected, Turley et a/. proposed that free or complexed 
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pyrithione will not persist or accumulate in sediment due partly to rapid 
photochemical attenuation in the water column but also through anaerobic 
degradation of any pyrithione adsorbed to the sediment via reduction of the N- 
oxide group [ I  I ] .  It was also proposed that the reason for sediment detoxification of 
pyrithione was due to either a high microbial population within the sediment or 
sediment surface catalysed degradation [ I  I ] .  Similarly Galvin et a/. hypothesised 
that pyrithione might associate with suspended natural organic matter (NOM) within 
the water column [15]. It was thought the carbonaceous NOM surface may play a 
part in the adsorptive oxidative detoxification of pyrithione and that such a process 
might be important in waters where photochemical attenuation did not efficiently 
occur [ I  51. 
5.1.3 Toxicity of ZnPT: 
Although mentioned previously that ZnPT introduced into the aquatic environment 
is expected to be rapidly degraded, concern still exists due to the inherent toxicity 
of ZnPT. As was the case with its environmental fate, published reports concerning 
the toxicity of ZnPT vary from declaring that the highest risk posed by ZnPT arises 
solely from the Zn(ll) ion due to the photochemical instability of the pyrithione 
ligand [20], to those that claim that ZnPT poses a more significant ecotoxicological 
risk than organotin compounds [21]. However, a large proportion of published 
toxicity studies have noted that ZnPT may adversely affect aquatic biota at 
environmentally relevant concentrations. Most studies have focused upon 
determining the toxicological risk posed to single species using laboratory based 
tests. For example, Kobayashi and Okamura determined the effect of ZnPT and 
CuPT upon the development of the sea urchin [21]. It was discovered that the 
NOEC levels for ZnPT and CuPT were O.0,l f g ~ "  and 1 p g ~ - I  respectively 
compared with tributyl tin oxide that was found to exhibit a NOEC level of 10 n g ~ - '  
[21], with significant teratogenic effects noted upon fish larvae at levels of 5 pg~- ' .  
Teratogenic effects were also reported in sea urchin and mussel by Bellas et a/. at 
similar concentrations [22]. Goka determined the effect of ZnPT using commercial 
anti-dandruff shampoo samples upon the development of fish species [23]. It was 
found that exposure to ZnPT resulted in embryotoxic and teratogenic 
abnormalities, namely curved vertebral columns. The author also concluded that 
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fish exposed to domestic wastewater containing ZnPT from anti-dandruff shampoo 
were highly at risk [23]. Other studies conducted also found ZnPT and CuPT to be 
the most toxic of all compounds currently in use as booster biocides in marine 
paints [24,25]. A field study was also performed by Sanchez-Bayo and Goka to 
determine the effect of ZnPT on Japanese medaka fish in an experimental rice 
field, unlike the previous laboratory tests chronic teratogenic effects were not 
observed, presumably due to loss of ZnPT to the environment, prompting the 
authors to believe that the actual risk posed by ZnPT may be overestimated by 
laboratory based studies [ I  91. 
The effect of ZnPT and CuPT upon the bacterial community of sediment 
was examined by Groth Petersen et al. who noted that in particular nitrogen cycling 
was effected with an increase in nitrification and a decrease in denitrification [26]. It 
was thought that the changes in the nitrate flux occurred due to the effect of ZnPT 
on nitrifying bacteria, which are mostly Gram negative species and are more 
susceptible to the membrane activity of pyrithione [26]. Other endpoints 
investigated included a phosphate flux, which was observed to increase upon 
exposure to ZnPT and also DNA content that was also observed to increase. The 
reason for the increase of both endpoints was thought to be due to death and 
degradation of cells as a result of pyrithione exposure [26]. 
Structural activity relationship (SARs) testing was also investigated by 
Doose et a/. [27], who examined the toxicological effects of ZnPT and a number of 
structural analogues to rat leukemic cells. It was discovered that analogues 
containing the N-hydroxythioamide group exhibited similar toxicity to ZnPT and 
therefore, it was noted that deactivation of this functionality was necessary to 
ensure the toxicity threat was fully removed [27]. Based upon the results of the 
SARs study it was decided that the environmental fate and effects of ZnPT, CuPT, 
iron (Ill) pyrithione (FePT) and a decomposition product bis-(2-pyridiny1)- 
disulfide,l ,I1-dioxide (PT2) should also be investigated prior to the recommendation 
of ZnPT as a safer and greener option to organotins [27]. 
5.1.4 Analytical methods for the determination of ZnPT: 
In many of the aforementioned studies a concluding remark noting the absence of 
suitable analytical methods for the determination of ZnPT in both cosmetic and 
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environmental matrices has been made and indeed analytical procedures in the 
published literature are few and far between. Chromatographic techniques for 
pyrithione and ZnPT determination are not commonplace due to problems that will 
be discussed here. Instead, researchers have focused upon the use of 
electrochemical techniques such as polarography, voltammetry and amperometry. 
However, such methods are unsuitable for the determination of ZnPT in 
environmental samples due to the lack of analytical sensitivity and also problems 
with electrode fouling [28,29,30,31,32]. 
Difficulties have been reported concerning the chromatographic analysis of 
pyrithione complexes due to problematic unwanted interactions with the silica 
stationary phase. The majority of researchers have reported that ZnPT readily 
transchelates with metallic impurities present in the silica stationary phase such as 
~ e * " ~ '  leading to severe peak tailing or adsorption of the pyrithione complex on to 
the silica stationary phase [33]. The effect of silanol activity on the chromatography 
of pyrithione complexes has, however, been overlooked and would be expected to 
be of high significance due to the presence of the pyridyl moieties of the ligand. 
Attempts to avoid such unwanted interactions have focused upon the derivatisation 
of ZnPT with fluorescent reagents such as 5-dimethylaminonaphthalene-l- 
sulphonylaziridine (DNS-A) or 7-Chloro-4-nitrobenzo-2-oxa-I ,3-diazole (NBD-CI), 
which apparently stabilise the pyrithione complex and aid with detection [34]. More 
commonly ZnPT is converted to the more stable CuPT by the addition of Cu(l1) that 
thereby facilitates easier chromatography [33,35]. Due to the higher formation 
constant for CuPT it is expected that the transchelation of ZnPT to CuPT should be 
rapid and efficient [18]. Other problems noted with the chromatographic analysis of 
pyrithione complexes have included the oxidation of pyrithione by the silica 
stationary phase yielding PT2 over the course of the chromatographic run [36]. 
To date only one method has appeared in the literature with the desired 
levels sensitivity for the determination of ZnPT in the aquatic environment. Using 
LC-APCI-MS Thomas determined the levels of ZnPT in marinas in the southern 
United Kingdom [37]. However, in all instances no ZnPT was detected above the 
limit of detection (20 ng~") .  Sample preparation was performed using copper 
chelation LLE to extract any ZnPT present as CuPT thereby facilitating more 
efficient chromatography. Recently another method based upon LC-APCI-MS has 
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appeared that claims to allow for the direct analysis of ZnPT using a phenyl 
stationary phase [38]. However, the method is limited to concentrations in the 
range of 3.5-10 m g ~ - '  and therefore is not directly applicable to the determination 
of ZnPT in the environment. 
This research therefore aims to do the following: 
The development of a suitably sensitive validated analytical method using LC- 
APCI-MS for the determination of ZnPT in the environment. 
lnvestigate cleaner preconcentration chemistries based upon SPE for the 
trace enrichment of ZnPT prior to LC-APCI-MS analysis and, 
lnvestigate the fate of ZnPT when exposed to common environmental 
constituents. 
5.2 Experimental: 
5.2. I Chemicals and reagents: 
Chemicals and reagents unless otherwise state were as per section 3.2.2. Zinc 
pyrithione (95%) was received from Sigma-Aldrich, (Steinheim, Germany) as was 
copper sulphate pentahydrate (99%), copper (11) acetate (98%), 2,6-pyridine 
dicarboxylic acid (99%), sodium chloride (ACS reagent grade), formic acid (95- 
97%), ammonium formate (99.995%), ammonium acetate (99%), disodium 
hydrogen phosphate (99%), MES (98%), pyridine (99%) and phenol (ACS reagent 
grade). Ferric nitrate nonahydrate, hydrochloric acid, nitric acid, sulphuric acid, 
glacial acetic acid and ammonia solution (33%) all AnalaR grade were received 
from BDH Chemicals Ltd. (Poole, UK). Copper (11) nitrate trihydrate and anhydrous 
sodium sulphate were both received from Riedel de Haen, (Seelze, Germany). 
Potassium nitrate was purchased from Merck KGaA, (Darmstadt, Germany). 
Stock 1000 m g ~ - '  solutions of ZnPT were prepared in dichloromethane and 
stored in the refrigerator in darkness. These stock standards were replaced 
monthly. Buffer solutions used for the optimisation of the extraction pH were 
prepared by mixing the appropriate amounts of acid and its-conjugate base for 
formate and acetate respectively. In the case of MES weighted proportions of salt 
were dissolved in -900mL Milli-Q water and titrated to the desired pH using either 
1 M HCI or I M NaOH. 
5.2.2 LC-A PC/-MS analysis: 
LC instrumentation unless otherwise stated was as per section 3.2.5 for method 
development and section 4.2.5 for LC-MS analyses. The LC system was coupled 
to a Bruker Daltonics esquireLC ion trap mass spectrometer complete with an 
atmospheric pressure chemical ionisation source. For APCl optimisation, solutions 
of analyte in dichloromethane were infused using a Cole Parmer 74900 series 
syringe pump at a rate of 600 p~h - ' ,  (Cole Parmer, Vernon Hills, IL, USA) into a 
flow of MeOH at a rate of 190 p~min- I  from the LC pump through a mixing tee and 
then into the APCl source. Gradient separations were performed on a Merck 
Chromolith Performance RP18e; 100.0 x 4.6 mm i.d. monolithic silica column, 
(Merck KGaA, Darmstadt, Germany) with a mobile phase of MeOH and 10 mM 
ammonium acetate. Quantitation was performed upon the extracted ion 
chromatogram (EIC) mlz 316.0 traces while the ratio of EIC rnlz 316.0 to EIC mlz 
31 8.0, (-1 00:45) was used for qualitative confirmation. 
5.2.3 On-line SPE: 
On-line SPE was performed as previously described in section 4.2.4. Extraction 
columns investigated included a 10.0 x 4.6 mm i.d. column packed with 
imminodiacetic acid; (IDA) functionalised silica, (Nucleosil 7pm, pore size 100A, 
prepared and packed by Prof. Pavel N. Nesterenko) and a Phenomenex Onyx CI8 
guard cartridge; 10.0 x 4.6 mm i.d. monolithic silica, (Phenomenex, Macclesfield, 
UK). The experimental set-up was previously described in Fig. 4.1. A Merck Hitachi 
LaChrom L-7100 isocratic pump was used for sample delivery at flow rates of 
either 6 m~min- '  for the IDA column or 10 m~min- '  for the Cq8 monolithic column. 
Prior to use the IDA column was washed with 200 mM HN03 to remove any 
retained metallic impurities followed by conditioning with 10 mM ammonium 
acetate 1 acetic acid buffer pH 4.7 to promote dissociation of the acidic 
functionalities. Depending on the desired choice of extraction chemistry the IDA 
column was used directly after buffering or was modified with a solution of 20 mM 
cu2' to facilitate the use of immobilised metal affinity interaction. The C18 
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monolithic column was conditioned with 20 mL MeCN and 20 mL of water 
respectively prior to use. From initial investigations only the C18 monolithic column 
demonstrated any applicability and was therefore, used for all further study. 
Environmental samples were filtered through Whatman GFIC glass fibre filters to 
remove particulate matter and adjusted to pH 7.0 prior to extraction. A 200 mL 
portion of sample was extracted using the c-18 monolithic column and elution was 
performed using mobile phase back flushing onto the analytical monolithic column. 
Methods for the removal of matrix interference will be discussed later. 
5.3 Results & Discussion: 
5.3. I Liquid chromatography: 
Central to the development of a chromatographic method for the determination of 
ZnPT was the correct selection of the analytical column. As previously mentionedin 
section 5.1.4, is was necessary to identify a stationary phase that was essentially 
free from metallic impurities and also exhibited very low silanol activity. Of these 
two parameters the activity of residual silanol groups was deemed to be the more 
critical as metallic contamination could either removed by washing or suppressed 
by the addition of additives to the mobile phase. In order to assess the silanol 
activity of possible analytical columns a pyridine phenol test was performed 
according to Ref. [39]. Ideally, pyridine should elute from the column before phenol, 
symmetrically with minimal tailing. Active silanols cause excessive retention and 
tailing of the pyridine peak. Co-elution of pyridine and phenol, although undesirable 
indicates an acceptable level of silanol activity [39]. Fig. 5.2 displays the resulting 
traces for the pyridine phenol test performed upon a Chromolith Performance 
RP18e 100.0 x 4.6 mm monolithic silica column, a Waters Symmetry 50.0 x 2.1, 
3.5 pm ODs column, a Hypersil ODs 50.0 x 2.1, 3 pm column and a Hypersil BDS 
250.0 x 3.0 mm, 5 pm column. 
As can be seen from Fig. 5.2 the Chromolith Performance RP18e monolithic 
column out performs all the particle packed columns with a narrow co-eluting peak 
observed for pyridine and phenol. Of the particle packed columns the Waters 
Symmetry column appears to be the most inert, again a single peak was observed 
for pyridine and phenol with more tailing present when compared with the 
monolithic column. The effect of uncapped silanol groups is clearly depicted in the 
trace of the Hypersil ODs column whereby an extremely broad peak can be 
observed for pyridine. A similar observation was noted for the Hypersil BDS 
column, which surprisingly showed quite high silanol activity considering the 
column is marketed for the separation of basic analytes. Due to these results the 
monolithic column and the Waters Symmetry column were selected for further 
study. 
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Figure 5.2: Overlaid pyridine phenol test chromatograms to examine the silanol activity of 
perspective analytical columns. Test conditions: mobile phase 50% MeCN in water with UV 
detection at 254 nm, column temperature 40°c, concenlrations; 0.5 C t ~ m ~ - l  pyridine and 4 mgrn~-' 
phenol. Peak Identification: 1 Phenol, 2, Pyridine. 
Initial gradient method development was performed using the Waters 
Symmetry column but metallic contamination within the silica substrate was 
encountered. Fig. 5.3 demonstrates the effect of metallic impurities within the silica 
substrate upon the ZnPT peak, i.e. the ZnPT peak is diminished in size and is 
fronted. Metallic contamination was removed by washing the stationary phase with 
a selective chelating agent, in this case a solution of 10 mM 2,6-pyridine 
dicarboxylic acid (dipicolinic acid) pH 4.0 as was used as previously by Elefterov et 
a/. for the elution of excessively retained transition metals from an IDA modified 
silica column [40]. The dipicolinic acid wash successfully removed metallic 
contamination from the silica substrate of the Waters Symmetry column as upon 
re-injection of the same ZnPT standard solution a large sharp symmetrical peak 
was observed. Therefore, a dipicolinic acid wash was performed whenever a 
change in the response of ZnPT was observed. No such effects were observed 
when using the Chromolith column presumably due to the high purity monolithic 
silica substrate and also the superior level of endcapping, thereby minimising the 
number of available silanol groups to interact with and retain metal ions via ion 
exchange. It is also worth noting that the Chromolith column contains no metal 
components. 
10 
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Figure 5.3: The effect of stationary phase metal conhrnlnation upon ZnPT, the bottom trace depiGts 
a 20 m g ~ '  ZnPT injection prior to washing the st&tionary phase wifh dlpicolinic acid, he upper trace 
depicts an injection of the same 20 mg~" standard ZnPT solution after washing the stationary 
phase with dipicolinic acid. The MeOH gradient used b depicted by the black line, TR ZnPT = 16.60 
minutes. 
Initial investigations into the LC analysis of ZnPT suggested that a rather 
high proportion of organic solvent was required to elute the complex from the 
column. This observation correlates well with the reported Log Kw of ZnPT = 9.33. 
[19]. Using a mobile phase consisting of MeOH and acetate buffer pH 4.7 simple 
linear gradients were examined and in each instance >70% MeOH was required to 
elute the ZnPT peak. Of the gradients examined a rapid linear sweep changing 
from 30% MeOH to 90% MeOH in one minute was initially chosen as it produced a 
sharp ZnPT peak with a retention time of approximately 8.3 minutes. However, it 
was later found when using MS detection that the rapid linear gradient was a 
significant source of ion suppression as the sharp increase in MeOH caused a 
focusing effect of retained matrix components and therefore, a shallower multi-step 
gradient was developed as shown in Fig. 5.4. 
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Figure 5.4: A 5 m g ~ "  injection of ZnPT on the Chromolith Performance RP18e monolithic column 
using the multi-step gradient, TR ZnPT = 9.2 minutes. 
From the above figure it can be seen that the multi-step gradient still allows 
for the relatively rapid determination of ZnPT with a sharp peak observed at 
approximately 9.2 minutes. However, when the LC method was later used in 
conjunction with APCI-MS detection it was observed that the acetate buffer MeOH 
mobile phase on the monolithic column yielded a peak that was slightly fronted as 
shown in Fig. 5.5. The reason for the fronting was unclear. However, upon 
changing the acetate buffer to a solution of ammonium acetate the fronting was 
completely removed, most probably due to an increase in the conditional stability 
constant of the complex with the increased pH of the aqueous modifier of the 
mobile phase, i.e. pH 6.5 as compared to pH 4.7 when using the ammonium 
acetate / acetic acid buffer. Therefore, the optimised LC conditions used for the 
determination of ZnPT in environmental samples were a mobile phase of MeOH 
and 10 mM ammonium acetate with a step-wise gradient on the Chromolith 
Performance monolithic column. 
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Figure 5.5: 5 m g ~ - '  ZnPT standard injections using LC-APCI-MS on the Chromolith Performance 
RP18e monolithic column. The blue bace was recorded using a mobile phase of MeOH and 10 mM 
ammonium acetate 1 acetic acid buffer pH 4.7, the red trace was recorded using 10 mM ammonium 
acetate pH 6.5. The calculated USP asymmetry value for the red trace was 0.95. 
5.3.2 APCI-MS study of transition metal pyrithione complexes: 
In order to determine the optimum ionisation and ion focusing parameters a 
solution of 1000 m g ~ "  ZnPT in dichloromethane was split 1/20 with MeOH from the 
LC pump and infused into the mass spectrometer. These parameters were 
automatically fine tuned using the Bruker esquire software for the ZnPT 
pseudomolecular ion; m/z 317.0. The ZnPT solution was infused using both ESI 
and APCl in both positive and negative modes, however, ZnPT gave no ESI 
response with either positive or negative ion polarity, only positive polarity APCl 
gave an appreciable signal. The optimised ion focusing parameters are listed in 
Table 5.1. 
Table 5.1: Optimised ion focusing APCI-MS parameters for ZnPT, (the optimisation was performed 
using a nebuliser pressure of 50.0 psi, a dry gas flow of 10.0 Llmin, a drying temperature of 32S°C, 
a corona voltage of +3200 V and an APCl temperature of 500°C). 
Parameter Measured Value 
Capillary Voltage (V) -4500.00 
End Plate Offset 01) -684 .OO 
Capillary Exit Offset (V) 50.00 
Skim 1 (V) 1 5.00 
Skim 2 (V) 5.90 
Octopole (V) 2.64 
Octopole A (V) 1.48 
Octopole RF (Vpp) 201.60 
Trap Drive 40.30 
Lens 1 (V) -2.90 
Lens 2 (V) -49.50 
The resultant APCI-MS spectrum for ZnPT is depicted in Fig. 5.6, which depicts 
two significant ions, the pseudomolecular [M+H]' ion at mlz 317.0 and another ion 
at m/z 221.2. 
Figure 5.6: APCI-MS spectrum of ZnPT showing the [M+H]+ pseudomolecular ion at mlz 317.0 and 
a decomposition product ion at mlz 221 .l. lnset A shows the expanded isotopic pattern of the 
pseudomolecular ion and lnset B depicts the thecretical isotopic pattern as calculated by the 
Sheffield Chemputer re-plotted using Microsoft Excel [41]. 
The expanded isotopic pattern for the pseudomolecular ion at mlz 317.0 is 
inserted as Insert A in Fig. 5.6 and clearly shows the isotope pattern of elemental 
zinc with [M+H]', [M+H+2]' and [M+H+4]' ions in the approximate ratio of 
100:60:40, it can also be seen that the recorded experimental spectrum correlates 
well with the expected theoretical spectrum as calculated using the University of 
Sheffield on-line Chemputer [41], which again shows an isotope pattern 
characteristic of the central zinc atom. The ion at mlz 221.2 was also observed by 
Thomas [37] although no definitive molecular structure was assigned. In an attempt 
to elucidate the identity of the species at mlz 221.2 tandem mass spectrometry was 
performed that yielded MSIMS daughter ions at mlz 11 1.2 and rnlz 187.1, with the 
ion at rnlz 111.2 being significantly more intense. Upon studying the isotope 
patterns for all the ions it was concluded that the complex at rnlz 221.2 did not 
contain a metallic element and the daughter ion at rnlz 11 1.2 suggests that the 
molecule fragments by splitting in half. From a literature search for possible 
decomposition products of pyrithione it is proposed that the species at rnlz 221.2 is 
pyridine disulfide and the daughter ion at mlz 221.2 arises from a-cleavage of the 
disulfide bond as shown in Fig. 5.7. 
Figure 5.7: Proposed structure of the ion at mlz 221.2 and the MSIMS daughter ion at m h  11 1.2. 
Other metal pyrithione complexes were prepared by LLE of ZnPT with 
solutions of CU*', ~ e ~ '  and ~ n ~ *  and dichloromethane, the APCI-MS spectra of the 
formed complexes, of which CuPT (golden) and FePT (violet) were strongly 
coloured, were then recorded in a similar manner as described for ZnPT. Fig. 5.8 
depicts the recorded spectrum of CuPT. Again as was observed for ZnPT, the only 
significant ion present is the pseudomolecular CuPT [M+H]' ion at mlz 316.0, the 
decomposition product at rnlz 221.1 can also be observed although at a much 
lower intensity than was present in the ZnPT APCI-MS spectrum. Inserted into Fig. 
5.8 are the experimentally recorded and theoretical Chemputer isotopic pattern of 
the pseudomolecular ion, both of which clearly show the characteristic copper 
isotopes with [M+H]' and [M+H+2]' ions in the approximate ratio of 100:45. In the 
case of FePT no pseudomolecular ion was observed in the resulting spectrum, the 
only significant ion present was at mlz 127.2 that corresponds to [pyrithione+H]', 
therefore, suggesting that the FePT complex is quite labile and readily 
decomposes within the APCl source. A similar observation was observed for 
MnPT, whereby the only significant ions present in the spectrum were rnlz 127.2, 
221.1 and 317.0 which correspond to [pyrithione+H]', pyridine disulfide and the 
ZnPT pseudomolecular ion respectively, suggesting that the manganese complex 
does not readily form in solution and therefore accumulation of MnPT in the 
environment as proposed by Galvin et a/. would not be expected to occur [ I  51. 
Figure 5.8: APCI-MS spectrum of CuPT showing the [M+H]' pseudornolecular ion at rnlz 316.0. 
lnset (A) shows the expanded isotopic pattern of the pseudomolecular ion and lnset (B) depicts the 
theorGical isotopic pattern as calculated by the Sheffield Chernputer re-plotted using Microsoft 
Excel [41]. 
Based upon the APCI-MS study it was concluded that only ZnPT and CuPT 
were of relevance for further study due the lability or instability of the FePT and 
MnPT complexes. It is worth noting that the CuPT and ZnPT pseudomolecular ions 
only differ by one mass unit and also co-elute under the chosen LC conditions and 
therefore, in an attempt to find exploitable differences between the complexes 
MSIMS was performed. Under tandem conditions ZnPT yielded a daughter ion at 
rnlz 192.0 that corresponds to the loss of a pyrithione ligand from the molecule and 
an ion at rnlz 127.2, i.e. [pyrithione+H]+. Further tandem transitions of the ion at mlz 
192.0 yielded another daughter ion at rnlz 174.0 suggesting dehydration of the 
species at rnlz 192.0. CuPT did not yield any daughter ions of significant intensity 
under MSIMS, therefore, suggesting the greater stability of CuPT, which correlates 
well with previously reported data [18]. It was therefore concluded that tandem MS 
was a viable option for distinguishing ZnPT and CuPT even with co-elution on a LC 
column. 
An optimisation of the APCl source ionisation parameters, i.e. applied 
corona voltage and APCl reaction temperature was performed upon linking the LC 
method with APCI-MS detection using repeat injections of a 5 m g ~ - '  solution of 
ZnPT. The corona voltage was optimised in the region of +I000 V to +3400 V and 
a sigmoidal relationship was observed between the resulting intensity and the 
applied voltage, see Fig. 5.9 (A). Insignificant intensity was observed below +I000 
V whilst above +3400 V excessive current was generated within the source. The 
optimum applied voltage was deemed to be +2600 V above which point no 
significant increase in intensity was recorded. Therefore, +2600V was used as the 
optimum applied corona voltage for all subsequent analysis. The APCl temperature 
was optimised in the range of 200 to 500°C using 25OC intervals, see Fig. 5.9 (B). A 
linear increase in intensity with increasing APCl temperature was observed up to 
-325OC followed by a linear decrease in intensity with further increases in the APCl 
temperature, suggesting that at temperatures exceeding 325OC ZnPT may begin to 
decompose. A temperature of 325OC was ad,opted as both the optimum APCl 
reaction temperature and also the dry gas temperature set point in order to 
maintain isothermal conditions within the source. 
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Figure 5.9: Optimisation of the APCl ionisation parameters, (A) corona voltage optimisation and (B) 
APCl temperature optimisation, inserted y-error bars are the standard deviation of the three 
replicate measurements. 
5.3.3 Selection of the extraction chemistry: 
As remarked previously, methods in the literature concerning the determination of 
ZnPT in environmental samples are limited. The method of Thomas 1371 appears to 
be the primary reference for those wishing to examine the presence of ZnPT. 
However, the method uses large sample volumes and LLE for sample enrichment 
with toxic dichloromethane. Little research has to date been focused upon the 
development of preconcentration using SPE for the trace enrichment of ZnPT prior 
to instrumental analysis. Extraction chemistries identified that may offer 
applicability include immobilised metal affinity chromatography (IMAC), chelating 
phases and reversed-phase interaction due to the presence of a central metal ion 
within and the hydrophobicity of the pyrithione complex. IMAC and chelating 
phases were identified as more selective sorbents, for example IMAC has recently 
been used for the selective trace enrichment and characterisation of naturally 
occurring complexing ligands of both copper and aluminium from soil and marine 
water samples [42,43,44,45,46,47]. The original aim was therefore, to use copper 
modified IDA functionalised silica for the IMAC extraction of ZnPT with 
transchelation to the more stable CuPT occurring on the stationary phase as it was 
hoped that such an extraction technique would be less prone to the co-extraction of 
NOM matrix components as compared with reversed-phase sorbents. However, 
initial extractions appeared to show retention of ZnPT but no elution of CuPT, even 
when using abrasive conditions such as 200 mM H' and therefore, an investigation 
was performed in order to determine the exact mechanism of the extraction. 
The behaviour of ZnPT during its passage through the sample pump was 
examined and it was found that at the low sampling flow initially used of 1 mlrninm1 
only approximately 39% of the ZnPT present was actually introduced onto the 
extraction column. Fig. 5.10 depicts an overlay of ElCs for the pseudomolecular 
ZnPT ion (mlz 317.0) at various sampling points on the Merck sample pump. 
Although not shown, EIC traces were also generated for the [pyrithione+H]' ion at 
mlz 127.1 to see if the complex disintegrated but in each instance no peak was 
observed. Therefore, the exact degradation mechanism of ZnPT within the sample 
pump remains unclear. The experiment was repeated using CuPT and a similar 
response was observed. In order to ascertain whether the contact time within the 
pump had an affect upon the degradation of the pyrithione complexes the above 
experiment was repeated using the max loading flow rates for both the IDA silica 
column, i.e. 6 mlmin-I and the CI8 monolithic column, i.e. 10 m~min-I.  It was 
observed that in the case of ZnPT and CuPT when pumping at 6 mlmin-I that a 
degree of degradation still occurred although it was considerably less than at 1 
mlmin-' meaning that a proportion of analyte would be lost prior to extraction when 
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using the IDA silica column either modified with cu2' for IMAC or un-modified 
allowing for pure chelation chemistries. 
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Figure 5.10: Overlay of EIC mlz 317.0 traces showing the degradation of ZnPT upon its passage 
through the Merck sample pump at a flow rate of 6m~min-'. 
In contrast, when pumping the pyrithione complexes through the sample 
pump at 10 m~min-', i.e. the maximum flow rate of the Merck pump, an insignificant 
amount of degradation was noticed for both ZnPT and CuPT, thereby suggesting 
that the contact time within the sample pump is a critical parameter when 
considering the degradation of both ZnPT and CuPT, however, in all instances 
CuPT was observed to show a larger amount of degradation than ZnPT. 
With the knowledge of the instability of the pyrithione complexes during 
sample pumping simple qualitative retention experiments were performed in order 
to evaluate which of the previously mentioned extraction chemistries showed the 
most promise for use as a ZnPT trace enrichment procedure prior to LC-APCI-MS 
analysis. In each instance 10 mL aliquots of 2 rng~-'  solutions of ZnPT and CuPT 
were extracted using previously conditioned IMAC, un-modified IDA and the C18 
monolithic column and the loading effluents were tested for the presence of the 
pyrithione complexes using LC-UV. Elution from both the IMAC and the un- 
modified IDA was performed using 200 mM HN03, excess acid was neutralised 
using concentrated ammonia solution, an excess of cu2+ was added and the 
solution was then tested for the presence of CuPT. With the CI8 monolithic column 
elution was performed using MeOH. 
Using an IMAC interaction on the copper modified IDA silica column ZnPT 
exhibited approximately 50% retention while CuPT exhibited a much higher degree 
of retention, approximately 90%. It was expected that ZnPT would show a much 
higher affinity for the immobilised cu2+ ion due to the higher formation constant of 
the copper pyrithione complex compared to the zinc pyrithione complex thereby 
suggesting fast mass transfer kinetics and it was also expected that it would be 
more thermodynamically unfavourable to form CuPT on the IMAC surface from 
CuPT in solution due to entropic effects. In the extracts of both pyrithione 
complexes no reformed CuPT was determined suggesting that the acidic 
conditions used did not elute the retained complex or formation of the copper 
pyrithione complex did not occur even upon pH adjustment and the provision of an 
excess of cu2+ ions. 
Using the un-modified IDA silica column a similar trend was observed; 
retention of both ZnPT and CuPT was noted, with more CuPT appearing to be 
retained than compared with ZnPT. However, upon testing the extracts no CuPT 
was present in either solution. The absence of CuPT in the tested extracts is again 
attributed to the destruction of retained ZnPT and CuPT using concentrated acid to 
elute the complexes from the IDA surface followed by no formation of CuPT upon 
neutralisation and addition of cu2'. 
Using the short CI8 monolithic column, when tested, the loading effluents for 
both ZnPT and CuPT showed no presence of either complex while the MeOH 
extracts demonstrated considerable peak magnification thereby suggesting that the 
CI8 phase showed a considerable prospect for preconcentration and was hence 
selected for further study. An additional bonus noted was the possibility of 
performing on-line preconcentration using column switching as the elution 
conditions tested in the preliminary experiments matched those of the analytical 
mobile phase. On-line SPE attempts did provide positive promise with minimal 
sample handling and therefore, this approach was pursued. 
5.3.4 Optimisation of column switching LC extraction conditions: 
In order to maximise the recovery of ZnPT from aqueous samples using the CI8 
monolithic column, an optimisation of the extraction pH and the ionic strength of the 
sample was performed. The sample pH was optimised in the working range of the 
monolithic silica column, i.e. pH 2-7, by extracting solutions of 1 p g ~ - l  ZnPT 
prepared in either pH adjusted water or buffer solutions. The resulting percentage 
recovery, calculated by peak area comparison with a 5 m g ~ - '  standard injection 
was then plotted versus the extraction pH as can be seen in Fig. 5.1 1 (A). The plot 
appears to show no definitive trend although the percentage recovery increases in 
a somewhat linear fashion between pH 5 and pH 7. Given that the pKa of the 
mercaptan group of the pyrithione ligand is -4.6 [36], low recovery of ZnPT would 
be expected as observed at pH values less than the pKa, i.e. in this study pH 2-4, 
due to protonation of the mercaptan group and a consequent reduction in the 
overall stability of the ZnPT complex. The increase in the percentage recovery 
observed in the region of pH 5-7 is therefore, attributed to an increase in the overall 
stability of the pyrithione complex with increasing solution pH. Based upon Fig. 
5.11 (A) the optimum extraction pH is clearly pH 7. Such an observation was 
welcomed as most environmental waters are generally in the range of pH 7-8 
meaning that minimal sample handling would be necessary and also previously 
published reports suggested that the co-extraction of NOM containing acidic 
functionalities on the CI8 monolithic column should be reduced. 
Fig. 5.1 1 (B) depicts the effect of increasing the salt concentration of the 
extraction solution upon the percentage recovery of ZnPT. It was observed that the 
percentage recovery of ZnPT increased with increasing salt concentration due to a 
salting out effect i.e. reduced solubility in a saline matrix. Such behaviour would be 
expected due to the hydrophobicity of the pyrithione complex (Log KO, = 9.33 [19]) 
and its low solubility in aqueous solutions. From Fig. 5.1 1 (B) it can be seen that 
the recovery of ZnPT is almost quantitative at salt concentrations greater than 1 M 
NaCI, however, it must be noted that the above experiments were performed in 
reagent water lacking an innate matrix and therefore, for environmental samples it 
was proposed to adjust the salt concentration to 0.5 M NaCl for fresh water 
samples with no adjustment speculated for marine samples. 
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Figure 5.11: Optimisation of the C18 extraction parameters, (A) the sample pH and (B) the salt 
concentration. In each instance an increase in the % recovery is observed with increasing pH and 
[NaCI]. 
5.3.5 Matrix removal: 
Primary on-line SPE investigations with real sample matrices yielded the problem 
of excessive NOM extraction along with ZnPT and consequent APCI-MS ion 
suppression. The co-extracted NOM was observed to elute from the analytical 
column in the same region as the ZnPT peak with large intensity due to the 
presence of a significant ion at each mlz value. As mentioned previously the LC 
gradient and APCl ionisation parameters were altered in an attempt to minimise 
APCl ion suppression. However, the natural matrix was still found to be 
problematic. Therefore, the development of a matrix removal procedure was 
deemed necessary. 
As was performed in Section 4.3.4 a solvent wash step was developed due 
to the ease at which such procedures can be performed on-line. As mentioned 
previously the most exploitable parameter for the extraction of ZnPT is its 
hydrophobicity with no secondary equilibria to be considered when extractions are 
performed at pH neutral. Therefore, the retention of ZnPT and the percentage of 
organic solvent required for elution from the C18 monolithic column were 
investigated. It was found using a 1 pgL-' extracted solution that ZnPT was 
retained upon the CI8 monolithic concentrator column for approximately 4.4 
minutes and -45% MeOH was require for elution. Knowing the elution conditions 
simple experiments to determine the wash solvent composition and the wash 
duration were then carried out. Using isocratic conditions it was observed that 
extracted ZnPT could be retained completely up to and including 40% MeOH in the 
mobile phase with a linear increase to 90% required for complete elution, however, 
when greater than 20% MeOH was used a peak was present at the start of the 
extracted molecular ion chromatograms in addition to the ZnPT peak, which was 
found to increase with increasing percentages of MeOH. Extracted solutions of 1 
p g ~ - '  in reagent water were exposed to the wash solution for increasing periods of 
time in order to evaluate the maximum wash duration without affecting the retention 
of ZnPT. The maximum wash solvent exposure duration was found to be 20 
minutes at a flow rate of 1 mlmin-I, with longer exposures the resulting ZnPT peak 
was significantly diminished in intensity. The optimum wash conditions were 
therefore, 20 mL of 20% MeOH in 80% 10 mM ammonium acetate. Due to the 
bimodal pore structure and increased permeability of the CI8 monolithic column it 
was however, possible to perform the wash procedure in 2 minutes using the 
maximum pump flow rate of 10 mlmin-'. 
The retention of NOM using a river water sample without the addition of 0.5 
M NaCl was then examined upon exposure to the optimised wash solvent, (at a 
flow rate of 1 mlmin-I) with the majority of the retained matrix observed to elute as 
a large peak at the beginning of the chromatographic run within the first 3 minutes. 
Therefore, it appeared that the solvent wash conditions were successful. However, 
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upon the addition of 0.5 M NaCl as previously optimised it was observed that even 
with the wash procedure a significant proportion of NOM was extracted and 
retained due to the increased ionic strength of the extraction solution and not 
removed with washing. The presence of the salt was also found to cause problems 
with the extraction pump such as increased backpressure generation etc. and 
consequently is was decided not to add salt to sample solutions prior to extraction 
in order to prevent damage to the sample pump. 
In order to assess the applicability of the wash procedure a 1 p g ~ - '  ZnPT 
spike in laboratory tap water was prepared, extracted and washed and the resulting 
EIC mlz 316.0 trace is inserted following. It is clear from Fig. 5.12 that even with 
the inclusion of the wash procedure a significant proportion of NOM is still retained 
on the CI8 monolithic column and interfering with the LC-APCI-MS analysis of 
ZnPT. 
Possible solutions to the matrix interference problem identified in the 
literature included increasing the extraction pH to promote dissociation of acidic 
NOM functionalities 1481. However, the extraction was already being performed at 
pH 7, i.e. near the upper stability limit for the silica monolith and therefore such a 
solution was not viable. The addition of detergents or chemical reducing agents 
such as NaBH4 to the extraction solution were also recommended but in the 
interest of simplicity and to prevent unwanted reactions or foiling of the APCI 
source such procedures were avoided [49,50]. 
A more feasible option identified in the literature appeared to be the use of a 
sacrificial strong anion exchange sorbent (SAX) prior to the extraction column, i.e. 
the Cq8 monolithic column, for the retention of NOM containing dissociated acidic 
functionalities [51,52,53]. Due to the absence of an acidic functionality within the 
ZnPT molecule it was decided that the use of a sacrificial SAX sorbent might be a 
possibility due the ease of inclusion of a SAX pre-column prior to the CI8 monolithic 
extraction column. Initial investigations were focused upon using a polymeric SAX 
sorbent, (Alltech Sample Prep Anion Exchange) packed into a 50.0 x 4.0 mm 
polymeric column housing. The backpressure generated by the dual column was 
measured using reagent water at various flow rates in order to ascertain as to 
whether the dual column could be safely used at the required loading flow of 10 
mlmin-I. It was found that at 10 m~min-I  the resulting backpressure was 
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acceptable at -110 bar. A 1 p g ~ - I  ZnPT spike prepared in reagent water was 
prepared and extracted through the dual SAX-CI8 column and elution was 
performed through the CI8 monolithic column using mobile phase back flushing, 
however no ZnPT was present in the resulting trace. It was expected that the ZnPT 
present was retained upon the polystyrene substrate of the polymeric SAX particles 
due to hydrophobic interaction. Also as the SAX sorbent was polymeric and 
therefore unsuitable for use with organic solvents it was decided that the SAX 
sorbent must be silica based (Si-SAX). 
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Figum 5.12: 1 v g ~ "  ZnPT spike in laboratory tap water depicting the matrix interference even after 
the use of a solvent wash procedure. 
The Si-SAX sohent used was Vydac 301SC anion exchange silica packed 
into a 33.0 x 4.6 mm stainless steel column housing. As was the case with the 
polymeric SAX the backpressure generated using reagent water at the required 
sample loading rate and was found to be acceptable at -120 bar. Prior to usage 
the Si-SAX column was conditioned with 0.2 M ammonium acetate and water. In 
order to estimate the system suitability a 1 p g ~ - '  ZnPT solution prepared in reagent 
water was extracted through the SiSAX-CI8 tandem column with elution via mobile 
phase back flush performed through the Cls monolithic column only, the resulting 
trace is shown in Fig. 5.13. 
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Figure 5.13: Overlay of EIC mlz 316 trace depicting the extraction of 1 p g ~ - l  ZnPT using the Si- 
SAX-C18 tandem column. 
The Si-SAX-C18 column was found to function effectively as can be seen 
from Fig. 5.13, with a distinct peak clearly visible for ZnPT (the red trace). 
Retention was evaluated and it was found that the CI8 monolithic column is solely 
responsible for the retention of extracted ZnPT with only a negligible peak 
observed when the Si-SAX column was eluted. The blue trace in Fig. 5.13 depicts 
the resulting chromatogram when tandem extraction followed by elution through 
the tandem column was performed, it can be seen that the ZnPT peak appears to 
be slightly split upon passage through the tandem column. However, no such 
splitting was observed when elution was performed only through the Cla monolithic 
column. It is also worth noting that when elution through the tandem column was 
performed the baseline of the resulting trace was considerably noisier that when 
elution was performed through the Cla monolithic column only. It is suspected that 
the reason for the increased level of baseline noise is due to the elution of loosely 
bound NOM on the SiSAX sorbent with subsequent introduction onto the analytical 
column. In order to avoid such affects elution was performed through the C18 
monolithic column only. 
Having devised and optimised methods of matrix removal, i.e. washing and 
the use of a sacfificial SiSAX sorbent, the applicability of the on-line SPE 
procedure for the preconcentration of ZnPT from river water was examined. Fig. 
5.14 following depicts a 1 p g ~ "  ZnPT spike prepared in river water and extracted 
under optimum conditions. A clear sharp intense peak can be seen with minimal 
matrix interference thereby suggesting that the Si-SAX sorbent efficiently removes 
problematic NOM that was still retained using a solvent wash procedure alone. 
A draw back of the Si-SAX sorbent was, that due to its efficient removal of 
NOM it became rapidly soiled and caused large increases in the operating 
backpressure, e.g. within 2-3 extractions. As a consequence it was decided to 
dilute samples with reagent water ten fold prior to extraction in order to increase 
the lifetime of the Si-SAX sorbent. Sample dilution increased the lifetime of the Si- 
SAX column considerably with no adverse effects upon reproducibility observed 
even after ten extractions thereby making the method more economically viable. 
Dilution also led to a decrease in the baseline noise due the reduced quantity of 
NOM present in the extraction solution. 
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Figure 5.14: EIC mlz 316 chromatogram depicting the extraction of 1 C c g ~ - '  ZnPT from river water. 
Using optimised conditions a 10 ygL-' ZnPT spike was prepared in river 
water, diluted ten fold and extracted. Possible sample to sample carryover was 
then evaluated by checking each component of the analytical system after elution 
and reconditioning. From Fig. 5.15 it can clearly be seen that there is negligible 
sample to sample carryover with no traces of ZnPT detected on either the 
extraction or the analytical C18 monolithic columns and therefore, the possibility of 
cross contamination is expected to be quite small. 
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Figure 5.15: Overlay of EIC m/z 316 traces depicting minimal sample to sample carryover on the 
analytical and extraction columns. 
5.3.6 Speciation in environmental samples; ZnPT or CuPT: 
It was noted that when using APCI-MS detection that ZnPT introduced into the 
system via standard injection or by column switching yielded a more intense ion at 
m/z 316.0 than mlz 317.0. This observation was somewhat confusing as the ZnPT 
pseudomolecular ion previously observed using direct infusion was present at mlz 
317.0 (Fig. 5.6). Upon examining the isotope pattern of resulting LC-APCI-MS 
peaks it was clear that the species present was CuPT and not ZnPT, i.e. ZnPT 
appears to transchelate within the LC system to form CuPT. Such an effect was 
also observed by Doose et a/. who noted that ZnPT injected using LC-ESI-MS was 
detected only as PT2 and FePT, therefore, it appears that ZnPT will automatically 
transchelate with other available metal ions present to form other metal pyrithione 
complexes [36]. Transchelation to form CuPT was also exploited by Thomas [37] 
for the LC-APCI-MS analysis of ZnPT and such an approach was noted by Doose 
et a/. as a reasonable option for the chromatographic analysis of ZnPT [36]. 
Therefore, in order to ensure unavoidable but quantitative transchelation to CuPT it 
was deemed necessary to add a small excess of cu2' ions to all solutions after 
dilution prior to extraction, in this instance a 20 fold excess of cu2' was judged to 
be adequate. Preliminary investigations were performed using copper (11) nitrate, 
copper (11) sulphate and copper (11) acetate and the different counter ions were 
found to have a distinct effect on the resulting CuPT peak. 
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Figure 5.16: The effect of different copper salts upon the transchelation of ZnPT to CuPT: exbacted 
EIC mlz 316 kaces depicting a 1 p g ~ - l  ZnPT extract to which a 20 fold excess of cu2' had been 
added, samples prepared in river water. 
It is clear from Fig. 5.16 that copper (11) acetate allowed for the 
transchelation of ZnPT to CuPT without affecting the APCI-MS response whereas 
both the sulphate and nitrate salts had more profound negative effects upon the 
resulting CuPT peak, the reason for such an effect remains unclear as both copper 
(11) sulphate and copper (11) nitrate were used to transchelate ZnPT by Thomas 
[37]. Due to this observation only copper (11) acetate was used for in further studies. 
5.3.7 Method performance: 
The performance of the on-line SPE LC-APCI-MS was evaluated using river water 
as a real sample matrix collected from the River Broadmeadow prior to its entry 
into the Malahide estuary near Swords in north Co. Dublin, Ireland. Before usage, 
the river water was filtered through Whatman GFIC glass fibre filters to remove 
suspended material. Spike solutions were prepared in the filtered river water, 
diluted with reagent water with the addition of 20 p g ~ "  cu2' and pH adjusted prior 
to extraction. Method performance data is presented in Table 5.2. 
Table 5.2: On-line SPE LC-APCI-MS method performance data. 
Parameter Result 
Sensitivity Validation: 
Limit of detection, ( n g ~ ' )  18 
Limit of quantitation, (ng~- ' )  62 
- 
Method Precision, (%RSD, n = 10) 27 
Linearity, ( R ~ )  0.9802 
The limits of detection and quantitation were calculated as three and ten times the 
standard deviation of the baseline noise respectively for blank extractions of 200 
mL aliquots of diluted Broadmeadow river water. The signal to noise ratio was 
calculated by peak height comparison with a I pgL" ZnPT spike, (as CuPT) also 
prepared in river water. The calculated limits indicate an acceptable level of 
analytical sensitivity as it was previously mentioned that the postulated ZnPT PEC 
in the aquatic environment was 0.04 pgL-' [ I l l .  It should also be noted that the 
sensitivity of the method can be improved by extracting a larger volume of sample, 
therefore, yielding a larger preconcentration factor. Such an approach may not be 
feasible due to subsequent increases in analysis times, greater proportions of NOM 
extraction leading to more rapid Si-SAX spoilage etc. The calculated LOD also 
compares well with that obtained by Thomas [37] who achieved a LOD of 20 ngL-' 
ZnPT, however, the sample volume extracted was 2 L as opposed to the 200 mL, 
(after dilution) extracted using the on-line SPE LC-APCI-MS method. Solvent use 
and waste generated is also minimised. 
The calculated levels of precision and recovery also compare well with the 
method of Thomas, where overall method precision and recovery were 17% and 
77% respectively [37], whereas using the on-line SPE LC-APCI-MS method 
precision and recovery were found to be 27% and 72% respectively. Considering 
the complexity of the sample matrix the calculated levels or precision and analyte 
recovery are deemed acceptable. Linearity was determined in the region of 0.25 to 
10 p g ~ - '  prior to dilution and the calculated regression coefficient was R~ = 0.9802. 
Although not ideal, considering that the overall method of precision was 27% the 
R~ was also deemed acceptable. From the determined method performance data it 
was concluded that the developed on-line SPE LC-APCI-MS method was 
sufficiently sensitive and suitable for the determination of ZnPT in aqueous 
environmental samples. 
5.3.8 Application to samples and shampoo analysis: 
Samples of fresh and sea water were collected from the Malahide estuary in north 
Co. Dublin and analysed for ZnPT content using the developed and optimised on- 
line SPE LC-APCI-MS method. However, no ZnPT was detected in any of the 
collected samples. In order to examine the applicability of the method, two well 
known brands of anti-dandruff shampoo known to contain ZnPT as the active 
ingredient were purchased and diluted in river water as a model waste matrix and 
analysed using the developed method. Dilutions of the shampoo samples of 1000- 
fold (Head and ~ h o u l d e r s ~ ~ ,  Proctor & Gamble) and 500-fold ( ~ o v e ~ ~ ,  Unilever) 
were first prepared, with an aliquot of each further diluted lo4-fold in river water. 
The spiked river water samples were finally diluted 111 0 with reagent water prior to 
analysis. As was previous 20 p g ~ '  cu2' was added to the sample in order to 
ensure transchelation to CuPT. Resulting traces for the on-line SPE LC-APCI-MS 
analysis of the shampoo samples in river water can be seen in Fig. 5.17. 
From Fig. 5.17 it should be seen that anti-dandruff shampoo is a significant 
emission source of ZnPT into the environment via municipal wastewater. The 
quantities of shampoo used for the above experiment, (250 mg Head and 
Shoulders and 500 mg Dove) were significantly smaller than those likely to be 
regularly used by consumers and in this instance even with l o8  fold dilution ZnPT, 
as CuPT, could still be detected in a waste matrix. The similarity in peak areas 
found was highly encouraging, given the lo8-fold dilution of the original samples, 
the ultra trace concentration and the complexity of the sample matrix involved. Due 
to the probability of regular usage and even unwarranted usage of anti-dandruff 
shampoo by the public, it is proposed that household wastewater is a more 
significant source of ZnPT into the aquatic environment than marine antifouling 
booster biocide paints. 
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Figure 5.17: The determination of ZnPT as CuPT in anti-dandruff shampoo samples diluted in river 
water as a waste malrix. The blue trace represents Dove Anti-Dandruff shampoo which contains 
0.37% w/w ZnPT, the concentration corresponding to the blue trace is -76 n g ~ - ' .  The red lrace 
represents Head and Shoulders Classic Clean shampoo which contains 0.80% wlw ZnPT, the 
concentration corresponding to the red trace is -80 n g ~ - '  [6]. 
5.3.9 An assessment of the environmental fate of ZnPT and CuPT: 
As no ZnPT, as CuPT, was present in the collected water samples an investigation 
into the possible fate of the pyrithione complexes was performed. Having noted the 
effect of the copper salt counter ion previously, it was decided to investigate the 
effect of contact with common anions, sorption to suspended materials, sediment 
partioning and photochemical attenuation. 
Solutions of 5 mgL-' ZnPT were prepared in water containing varying 
concentrations of chloride, sulphate, nitrate and phosphate in the range of 5-20 
mgL-' and 5 mgL-' cu2'. The solutions were then analysed using LC-UV in order to 
examine the effect of initial contact and then reanalysed after both 24 and 48 hours 
respectively in order to determine the effect of contact time. Of the anions tested 
only sulphate had an immediate effect upon CuPT contact with a reduction of the 
resulting CuPT peak area with increasing sulphate concentration. Nitrate, chloride 
and phosphate had no pronounced effect upon immediate contact. Contact time 
also appeared to have no effect upon the formed CuPT with a general reduction in 
peak area with time in both control and anion containing solutions. Therefore, ZnPT 
as CuPT in the environment appears to be unaffected by the presence of inorganic 
anions, even though some ions such as nitrates have been previously observed to 
act as photosensitisers to organic micro-pollutants no such effects were observed 
in this study, [54]. 
The sorption of pyrithione metal complexes onto suspended materials was 
also evaluated. 1 L aliquots of collected river and sea water samples were filtered 
through Whatman GF/C filter papers, air dried and then eluted using a solvent 
mixture of 50:50 dichloromethane MeOH. The solvent was filtered through glass 
wool and evaporated to near dryness under a gentle stream of NZ. Resulting 
residue was reconstituted with 200 pL MeOH and analysed using direct injection 
LC-APCI-MS. Both the filter paper and the glass wool used for filtration were also 
checked for cross contamination. However, no CuPT was detected on any of the 
extracted filter papers thereby suggesting that CuPT does not adsorb onto 
suspended media in the aqueous phase. 
Reports concerning the adsorption of pyrithione metal complexes onto 
sediment in the published literature are quite scarce and of those published there 
appears to be a consensus that pyrithione metal complexes will rapidly degrade in 
the aqueous phase and the likelihood of any sediment adsorption is therefore, quite 
small. Any pyrithione metal complexes that do adsorb onto sediment are thought to 
be degraded via either sediment catalysed degradation or microbial degradation 
etc. [ I  1,15,17]. Due to the attenuation of incident light with depth, there exists a 
probability that any pyrithione metal complexes that reach sufficient depth to 
intimately interact with sediment may indeed adsorb due to the absence of 
wavelengths of light thought to cause photolytic degradation. Therefore, using two 
certified reference sediments obtained from the National Research Council of 
Canada, the adsorption of ZnPT onto the sediment phase was determined. The 
two sediment reference materials varied in their total organic carbon content (TOC) 
and also their metal content, of particular importance were the concentrations of 
copper and zinc, values for which are inserted in Table 5.3. 
Table 5.3: TOC and metal content of the two certified sediment samples. 
Component BCSS-I PACS-I 
C (%) 2.19 k 0.09 3.69 + 0.1 1 
Zn (~ t~-g ' l )  119f 12 824 + 22 
c u  (~g.g-') 18.5 f 2.7 452f 16 
Sampling Location Baie des Chaleurs, Esquimalt Harbour 
Gulf of St. Lawrence British Colombia 
Using amber glass sample vials, 5 mL of 5 m g ~ "  ZnPT in water was added 
to 0.5 g of sediment and repeatedly shaken by hand several times over the course 
of two hours. For each sediment sample the behaviour of a control and two ZnPT 
solutions were examined. An aliquot of the aqueous phase was then withdrawn 
and placed in an amber vial for subsequent LC-APCI-MS analysis. The remaining 
aqueous phase was removed via filtration and the sediment sample was air dried 
overnight in the dark. The sediment was then transferred to another amber sample 
vial and extracted with 5 mL of 50:50 dichloromethane MeOH. The solvent solution 
was filtered through nylon filters, reduced in volume under N2 and finally 
reconstituted with 200 pL of MeOH before LC-APCI-MS analysis. Both the nylon 
and paper filters used were also analysed by LC-APCI-MS in order to examine any 
possible sources of cross contamination. The concentration of CuPT was 
determined from a prepared five point calibration curve and can be viewed in Table 
5.4 following. 
Table 5.4: Calculated concentrations of CuPT in the aqueous and sediment phases after a 2 hour 
mixing period. 
BCSS-1 PACS-1 
Aqueous phase, (rngLml) 0.1 1 0.00 
Sediment phase, (mgkg") 0.43 0.86 
Sediment:aqueous phase ratio 3.91 - 
Amount of residue in aqueous phase, (gg vial-') 0.55 0.00 
Amount of residue in sediment phase, (pg viar7) 0.22 0.43 
% Initial dose in aqueous phase 2.20 0.00 
% Initial dose in sediment phase 0.88 1.72 
From Table 5.4 it can be seen that the measured concentrations of CuPT in 
each phase differ for the two sediment samples, see Fig. 5.18. The reason for the 
difference is attributable to the TOC content of the sediments with a higher 
proportion of ZnPT adsorbed and transformed on the PACS-1 sediment that 
contains larger quantities TOC and metals. Therefore, based upon the above 
findings it can be estimated that distribution ratio for the BCSS-I-sediment is -4:l 
and consequently if intimate contact occurs between water containing pyrithione 
metal complexes and sediment, the sediment would be expected to preferentially 
concentrate the pyrithione metal complex from the water due to the high partition 
coefficient of ZnPT. Such an effect is illustrated more clearly with the PACS-1 
sediment whereby all of the detected CuPT was found solely on the sediment 
phase. However, upon conversion of the measured data to a percentage initial 
dose, it can be seen that approximately 97% of ZnPT introduced into the 
experimental vial disappeared over the course of the experiment. Similar 
observations were also noted by Turley et al. who found that ZnPT rapidly 
converted into 2-pyridine sulphonic acid when also performing sorption 
experiments as a result of light exposure [17]. From such data it can be deduced 
that ZnPT and CuPT present in the environment are unlikely to accumulate on 
sediment due to the existence of a more important removal mechanism despite 
their high partitioning behaviour [17]. However, the need therefore, still exists for 
further research to determine the effect of pyrithione metal complexes on sediment 
biota and to also determine the actual fate of pyrithione metal complexes adsorbed 
onto sediment. 
As mentioned previously, photochemical attenuation appears to be the most 
important removal mechanism of pyrithione metal complexes introduced into the 
aquatic environment. However, of the photochemical attenuation studies reported 
in the literature, the majority were performed using bioassays and primarily in a 
marine water matrix. As observed in this study, anti-dandruff shampoo appears to 
be a more significant source of ZnPT introduced into the aquatic environment, 
especially into fresh water systems, than marine antifouling paints and also ZnPT 
introduced into the environment will transchelate to form CuPT. Therefore, a brief 
study was performed to examine the photochemical attenuation of CuPT in filtered 
river water. A 10 m g ~ - '  solution of CuPT in river water,.along with a control sample 
was placed in a clear glass bottle an exposed to natural sunlight on the laboratory 
window during April 2006. Sacrificial samples were withdrawn from the clear glass 
bottle into amber vials and immediately frozen until LC-APCI-MS analysis. The 
relative presence of CuPT was plotted against time as in Fig. 5.19 following. The 
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resulting plot correlates well with previously published data [11,16,17,37] with a 
relatively rapid decline of CuPT observed, the estimated half life from the graph is 
-45 minutes. 
BCSS-1 Sediment Phase 
BCSS-1 Water Phase 
2 4 6 8 10 12 
Time, (mins) 
Figure 5.18: Overlaid EIC m h  316 traces for the analysis of the BCSS-1 extracted and 
preconcentrated sediment phase and the BCSSl  water phase. 
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Figure 5.19: Degradation of CuPT in filtered riuer water upon exposure to natural sunUght under 
laboratory conditions. 
Although CuPT appears to initially rapidly disappear it can be seen from the 
above plot that the rate of photochemical attenuation appears to decrease with 
increasing time, consequently as ZnPT is likely to be constantly introduced into the 
aquatic environment via untreated municipal wastewater, the probability exists that 
ZnPT may at times reach detectable concentrations depending on the input flux of 
ZnPT, the availability of cu2' and also the light exposure of receiving waters. 
However, in waters with high light intensity and high mixing rates it is expected that 
photochemical attenuation is likely to be an extremely efficient removal process for 
introduced metal pyrithione complexes. 
5.4 Conclusions: 
A column switching LC method in conjunction with APCI-MS detection has been 
developed for the extraction and analysis of ZnPT, (as CuPT) in aquatic 
environmental samples. Monolithic silica columns were chosen for use for the 
analytical separation due to the low silanol activity and lack of metallic 
contamination and also for the performance of on-line SPE due the ability to use 
high flow rates without the generation of excessive backpressure. Excessive matrix 
co-extraction and consequent ion suppression was found to be problematic and 
required the use of both a sacrificial Si-SAX sorbent prior to the CI8 extraction 
column and a subsequent wash step for the removal of NOM. The method was 
validated in a real sample matrix and high levels of sensitivity with acceptable 
analyte recovery and reproducibility attained. The method is likely to be of use to 
those who wish to monitor the presence of ZnPT in the aquatic environment. 
Based upon results of an environmental fate study it appears that ZnPT will 
transchelate to form CuPT in environmental waters. CuPT appears to be 
unaffected by the presence of inorganic anions and does not appear to adsorb onto 
suspended solids. Photochemical attenuation appears to be the most important 
removal mechanism of CuPT. However sediment adsorption has also been shown 
to occur, particularly in sediments with a high proportion of TOC. It is therefore 
concluded that ZnPT introduced into the environment e.g. via municipal wastewater 
is rapidly degraded in well illuminated waters with a high rated of mixing, e.g. fast 
flowing streams and rivers. Further research needs to be conducted to determine 
the behaviour and removal of pyrithione metal complexes during municipal 
wastewater treatment, the characterisation and risk evaluation of degradation 
products in water and sediments should also be performed. 
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6.0 Comparison of Monolithic and Sub 2pm Particle 
Packed Columns - Application to  the Determination of 
Drug Contamination on 1rish Euro Banknotes. 
6.1 Introduction: 
It has recently been reported that the use of illicit drugs by lrish society, in 
particular cocaine, has escalated dramatically. For example, one national 
newspaper stated that cocaine usage alone had increased some 829% in the 
period of 2001 to 2005 with cannabis resin usage rising approximately 750% based 
upon drug seizure data [I]. The illicit drug trade is big business to those involved 
and conservatively estimated to be worth close to €650 million annually [2]. Official 
An Garda Siochana statistics available concerning offences committed under The 
Misuse of Drugs Act 1984 corroborate media reports and show that while cannabis 
is still the most commonly abused illicit drug by lrish society, (accounting for -65% 
of all offences), cocaine has now overtaken amphetamines and opiates to become 
the second most commonly abused drug in the country [3]. Statistics mentioned 
are, however, thought to greatly underestimate the actual levels of illicit drug usage 
within the community as they only reflect those cases where a prosecution under 
the Misuse of Drugs Act 1984 has occurred and, therefore, do not include usage 
data concerning social and recreational users. 
Gauging the actual levels of drug use in the country appears to be an 
onerous task. Traditionally survey based methodologies have been used but such 
techniques are inadequate as they are often targeted at specific subgroups within 
the population, e.g. known drug addicts. Such methods are also susceptible to bias 
either positive or negative, depending upon the social group studied. For example, 
it would be expected that a general survey would be negatively biased and 
therefore, underestimate the actual use due to the fact that recreational drug users 
would not be expected to openly admit their behaviour, especially when it involves 
breaking the law. As a consequence survey based methods are likely to report 
anecdotal information and speculation rather than scientific facts [4]. Another 
method previously used for the estimation of drug use has focused upon the 
numbers of people presenting themselves for drug treatment. It was also recently 
reported that such a phenomenon is no longer mainly confined to the capital city 
with numbers seeking treatment in regions outside the Eastern Regional Health 
Authority having almost trebled [5]. However, the problem exists that the Irish 
treatment system has long been focused upon opiates and may not be sufficiently 
equipped to deal with the recent surge in cocaine usage [4]. 
Previously published reports have demonstrated that paper currency in 
general circulation may be contaminated with detectable levels of illicit materials, 
most commonly cocaine [6,7,8,9]. Such contamination is likely to occur due to 
rolled up bank notes being used to 'snort' substances or as a result of transfer 
during drug deals [ lo l l  1,121. Cross contamination between notes during counting 
processes in financial institutions is also possible as it has been demonstrated that 
nanogram quantities of cocaine can be transferred from contaminated to other 
bank notes using both manual and automated counting procedures 1131. Although 
not a quantitative measure, the presence of illicit substances on bank notes in 
general circulation provides an indication that such substances are being used 
within the community under study. Recently, Zucatto et a/. have proposed 
monitoring for the presence of illicit drug residues in surface waters arising from 
human use, which appears to offer a more robust method for estimating drug use 
within the community [14]. 
A limited number of analytical methods for the determination of drug 
contamination on banknotes are available in the published literature and may be 
divided into two groups; those which use GC-MS or GC-MSIMS [6,8,9] and those 
which directly analyse banknotes using thermal desorption tandem MS (TD- 
MSIMS) [ I  3,15,16,17]. Surprisingly, due to the polarity of many illicit substances, 
only one method based upon liquid phase separation techniques is available in the 
peer-reviewed literature, [18]. Xu et a/. explored the possibility of using CE with 
electrochemiluminesence detection (CE-ECL) for the determination of heroin and 
cocaine on Chinese currency. While the method was successfully applied, it is 
worth noting the lack of specificity compared to MS based methods. In the case of 
GC-MSIMS based methods a sample preparation step is necessary in order to 
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elute the compounds of interest from the surface of the banknote. Esteve-Turrillas 
et a/. reviewed sample preparation procedures that usually involve washing the 
note with organic solvents and recommended that in the case of Euro banknotes 
MeOH should be used, as destructive problems previously encountered when 
using other organic solvents were completely avoided [7]. In some cases a SPE 
procedure has also been incorporated into the method in order to remove co- 
extracted compounds such as inks, oils fats and greases and cosmetics etc. [8]. 
TD-MSIMS methods have the advantage of simpler sample preparation, whereby 
dust from the banknotes is trapped on filter meshes and then directly desorbed into 
the source of the MS [15]. Although it would be considered that such a process 
would lead to complete destruction of the sample and therefore, remove the 
possibility for replicate analysis, the authors claim that "the process does not 
remove all material and further analyses may be preformed on any of the meshes" 
[15]. Consequently, it appears that although TD-MSIMS methods provide the 
possibility to analyse a greater number of notes simultaneously, the desorption 
procedure is inefficient and therefore, does not provide an accurate reflection of the 
actual levels of drug contamination on circulating currency. Tandem MS detection 
is commonly used due to the ability to attain a structural fingerprint for the analytes 
of interest and therefore, the ability to unequivocally identify the compounds 
present in a sample, often a necessity if the analytical results are to be presented 
as evidence in court [19]. 
Current advances in the field of LC are driven by the requirement for fast 
high throughput separations and also the requirement to. achieve maximum 
selectivity, i.e. the ability to separate all compounds present in a complex mixture in 
order to permit their quantitation and identification [20]. To facilitate the above 
requirements, recent advances in column technology have included the 
introduction of sub 2 pm particle packed and monolithic type stationary phases. 
Other attempts to achieve faster more efficient analyses have focused upon the 
use of high separation temperatures in order to reduce the viscosity of the mobile 
phase but such an approach is however, not desirable due to potential problems 
with both analyte and stationary phase stabilities at elevated temperatures [21]. 
The advantages of reducing the size of stationary phase particles are widely 
known, namely improved efficiency with faster analysis times and greater 
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sensitivity [20,22]. However, such gains are often offset by, or unattainable due to 
the increased backpressure needed to pump solvents through columns containing 
very small particles. In addition to the generation of excessive backpressure, 
detectors capable of fast responses and rapid sampling rates are also required in 
order to achieve the maximum benefit from the chromatographic analysis. Another 
problem generated by the excessive backpressure required when using sub 2 pm 
particles is that of frictional heating and the generation of non uniform temperature 
gradients within the column and therefore, the resulting effects upon retention and 
efficiency [23,24]. The effect of frictional heating and very high operating pressures 
upon behaviour of analytes is currently attracting attention. 
In contrast to sub 2 pm particulate media, monolithic silica columns, which 
allow for the achievement of high efficiency without the generation of excessive 
backpressure, are now available, (section 2.3.5). Although monolithic columns are 
therefore, an attractive prospect they are not without their limitations, namely 
higher solvent consumption, lack of available stationary phase chemistries and also 
until recently lack of direct compatibility with MS detection [20]. However, the 
recent introduction of a 3 mm i.d. monolithic silica reversed-phase column on to the 
market helps to overcome the above limitations, most importantly facilitating easier 
coupling to MS. 
The objective of this study was first to directly compare a commercially 
available 1.8 pm particle packed column with recently available 3 mm i.d. 
monolithic silica columns for the reversed-phase separation of strongly basic 
compounds, i.e. illicit drugs. Secondly, this work developed, for the first time, an 
optimised LC-MSIMS method based upon the new monolithic phases for the 
determination of illicit drug and abused pharmaceuticals and its application to 
the evaluation of contamination on Irish Euro banknotes in current circulation in 
the greater Dublin area, with the aim of establishing an indication of drug use, 
particularly cocaine, within the community. 
6.2 Experimental: 
6.2. I Chemicals and reagents: 
Reagent water used throughout this study was obtained from a Millipore Milli-Q 
water purification system, (Millipore, Bedford, MA, USA) and was 18.2 M n  or 
greater. MeOH, MeCN and dichloromethane were received from Labscan 
(Dublin, Ireland), all solvents used were HPLC grade. Cocaine hydrochloride, 
morphine sulphate salt pentahydrate, methadone hydrochloride, ketamine 
hydrochloride, heroin and A'-tetrahydrocannabinol methanolic solution (A'-THC) 
were purchased under license from Sigma-Aldrich (St. Louis, MO, USA). 
Benzoylecgonine hydrate, cocaethylene, D-amphetamine sulphate salt, 
temazepam, diazepam, carbamazepine, fluoxetine hydrochloride, lysergic acid 
diethylamide (LSD), papaverine hydrochloride, 3,4- 
methylenedioxymethamphetamine hydrochloride (MDMA) and 2-ethylidine-I ,5- 
dimethyl-3,3-diphenylpyrrolidine perchlorate (EDDP) were purchased under 
license from Sigma-Aldrich (Poole, UK). The chemical structure of each drug is 
depicted in Table 6.1. AnalaR grade glacial acetic acid and hydrochloric acid 
were obtained from BDH Chemicals (Poole, UK). Ammonium acetate, (ACS 
reagent grade) was purchased from Riedel de Haen (Sleeze, Germany) and 
ammonium hydroxide solution, (LC-MS additive grade) was obtained from Fluka 
(Steinheim, Germany). 
Individual 100 m g ~ "  stock solutions of each chemical were prepared in 
MeOH and were stored at 4OC in the dark. Working solutions were prepared from 
the individual stock standards using water as a diluent. In the case of salts, 
standard solutions were prepared in terms of the parent analyte. Stock solutions 
were retained for the duration of the research, working solutions were prepared 
fresh prior to use. 
6.2.2 Glassware preparation: 
Silanisation was performed as per section 3.2.3. 
6.2.3 LC-MS/MS analysis: 
LC instrumentation used was as per section 3.2.5 and 4.2.5. 
Table 6.1: The chemical structures of the illicit drugs and abused pharmaceuticals chosen for study. 
Analyte Structure Analyte Structure 
Morphine Benzoylecgonine 
Amphetamine Cocaethylene 
MDMA LSD 
Methadone Temazepam 
CI 
Papaverine Fluoxetine 
6.2.4 Chromatographic conditions: 
Columns investigated included a Zorbax Rapid Resolution HT Eclipse XDB-CI8 
50.0 x 2.1 mm i.d. 1.8 vm column (Agilent Technologies, Palo Alto, CA, USA) 
and Phenomenex Onyx monolithic CI8 100.0 x 3.0 mm i.d. columns, 
(Phenomenex, Macclesfield, Cheshire, UK). In order to obtain a 200.0 x 3.0 mm 
i.d. column, two monolithic columns were connected in series using an Onyx 
column coupler. For column comparison studies an isocratic mobile phase 
consisting of 60:40 MeOH water was used for the separation of a mix standard 
containing 1 m g ~ - '  carbamazepine, temazepam and diazepam. For the 
separation of the complete mix of illicit drugs a multi-step linear gradient of 5 
mM ammonium acetate, pH 4.5 and MeOH was used. The initial mobile phase 
conditions were 20% MeOH increased linearly to 30% in 2 minutes, followed by 
another linear increase in 3 minutes to 50% MeOH, then to 80% MeOH over the 
next 15 minutes with a final linear increase to 95% MeOH in 2 minutes, which 
was then held isocratically for the remainder of the chromatographic run. A re- 
equilibration time of 8 minutes was applied. In all instances the injection volume 
was 20 vL. 
For least squares weighted regression analysis of van Deemter plots the 
Solver add-in of Microsoft ~ x c e l ~ ~  as previously described by Harris was used [25]. 
6.2.5 Mass Spectrometry: 
For ion optic optimisation, 20 m g ~ "  solutions of analyte in 1:l MeOH 5 mM 
ammonium acetate buffer, pH 4.5 were directly infused into the MS using a Cole 
Parmer 74900 series syringe pump at a rate of 120 v ~ h - '  (Cole Parmer, Vernon 
Hills, IL, USA). All parameters were automatically optimised using the Bruker 
esquire software for the pseudomolecular ions of all analytes. An average of all 
recorded values was then used in order to achieve the ionisation and focusing 
parameters for use in conjunction with LC-MSIMS, (Table 6.2). 
Table 6.2: Optimised ion focusing parameters for ESI-MSIMS detection, (the optimisation was 
performed using a nebuliser pressure of 10.0 psi, a dry gas flow of 3.0 ~ m i n - '  and a drying 
- - 
temperature of 3 0 0 " ~ .  spectra were collected over the range 50 - 600 mlz). 
Parameter Measured Value 
End Plate Offset (V) -603.00 
Capillary Exit Offset (V) 74.20 
Skim 1 (V) 23.50 
Skim 2 (V) 9.40 
4.40 
Octopole A (V) 3.17 
-Vpp) 203.40 
Trap Drive 66.90 
Lens 1 (V) -4.30 - 
Lens 2 (V) -87.80 
Auto MSIMS Fragmentation Amplitude (V) 1.0 - 
Isolation Width (mlz) 4.0 
Tandem MS was performed by generating product ion spectra for the 
pseudomolecular ion of each analyte. Quantitative LC-MSIMS measurements 
were performed using the resulting peak areas in the ElCs for each of the 
analyte pseudomolecular ions, the tandem product ion transitions listed in Table 
6.3 were used for qualitative confirmation. 
Table 6.3: Selected product ion transitions for MSIMS monitoring. 
Precursor Ion Product Ion 
Analyte 
(mlz) (mlz) 
Morphine 286 268 
Amphetamine 136 119 
MDMA 194 163 
Benzoylecgonine 290 168 
Ketamine 238 220 
Heroin 370 268 
Cocaine 304 182 
Cocaethylene 31 8 196 
LSD 324 223 
EDDP - 278 249 
Papaverine 340 202 
Methadone 310 265 
Fluoxetine 31 0 148 
Temazepam 30 1 283 
Diaze~am 285 257 
6.2.6 Extraction of banknotes: 
Euro banknotes analysed in this study were collected from a branch of a 
national bank on the north side of Dublin and extracted using an adaptation of 
the method of Esteve-Turrillas et al. [7]. Briefly, notes were placed in a clean 40 
mL amber glass sample tube to which 10 mL of MeOH was added. The vial was 
then sealed and vortexed at high speed for one minute. The MeOH was then 
removed to a clean 12 mL sample vial and reduced in volume to near dryness 
under a gentle stream of nitrogen. The dried extract was then reconstituted in 
250 pL of initial mobile phase (80:20 5 mM ammonium acetate MeOH) and 
analysed using the developed LC-MSIMS method. 
6.3 Results and Discussion: 
6.3.1 Comparison of monolithic and 1.8 pm particle packed columns: 
The available stationary phases and column lengths were examined for 
optimum chromatographic efficiency using a mixture of the three structurally 
related tricyclic basic drugs; carbamazepine, temazepam and diazepam. 
Experimental conditions were maintained identical throughout all investigations. 
The resulting peak width at half height was used for all efficiency calculations. 
Fig. 6.1 depicts the resulting van Deemter curves in terms of plate height (H) 
and plate number (N) determined for each of the stationary phase 
configurations using diazepam as the test analyte. 
As can be seen from Fig. 6.1(A) the 1.8 pm particle packed column offers 
higher efficiency due to its lower Hmin value than the 10 cm and 20 cm 
monolithic columns respectively. As stated previously by Cabrera, the 
chromatographic efficiency of monolithic columns is comparable to that of 3.5 
pm particles and therefore, the observation that Hmin decreases with a reduction 
in the particle size of the stationary phase can clearly be seen from Fig. 6.1 (A) 
[26,27]. The optimum linear velocity is higher when using the monolithic 
columns compared to the 1.8 pm particle packed column, optimum values were 
determined to be 0.40 mms-' on the 1.8 pm particle packed column, 0.52 mms-' 
on the 10 cm monolithic column and 0.98 mms-' on the 20 cm monolithic 
columns. 
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Figure 6.1: (A) Plot of plate height (H) versus mobile phase linear velocity using diazepam as 
the test analyte, (B) Plot of plate number (N) versus mobile phase linear velocity and (C) Plot of 
plate number (N) versus the generated backpressure on the 1.8 pm column (+), the 10 cm 
monolithic column (m) and the 20  cm monolithic column (A) .  
Fig. 6.1 (B) depicts plate number plotted versus the linear velocity of 
mobile phase. From Fig. 6.1 (B) it can be seen that a significantly higher 
number of theoretical plates is attainable when using the monolithic columns 
compared to the 5 cm 1.8 pm particle packed column. With the 20 cm monolithic 
phase it can be seen that over twice the number of theoretical plates can be 
obtained at -twice the linear velocity, compared to the particle packed column. 
Fig. 6.1 (C) is a plot of plate number versus column backpressure generated. It 
can clearly be seen that the primary advantage of the monolithic columns over 
the 1.8 pm particle packed column is the ability to provide significantly higher N 
at considerably lower operating pressures. With the 20 cm monolithic phase, 
optimum N (-1 5000) was achieved at only 75 bar, compared to -1 50 bar on the 
particle packed column (N = -7000). 
6.3.2 Kinetic behaviour of monolithic and 1.8 pm particle packed columns: 
An alternative method of comparing liquid chromatographic supports of different 
geometries and sizes is to use so-called kinetic plots, whereby traditional van 
Deemter couples such as (po,H) and (po,N), where po is the linear velocity of the 
mobile phase, are converted into kinetic parameters that take into account the 
column permeability, the mobile phase viscosity and the maximum pressure 
drop across the column [28,29]. 
Fig. 6.2 (A) is a plot of to versus plate number and allows for the direct 
visualisation of the range of plate numbers (N) wherein different supports of 
different geometries can provide faster separations or increased levels of 
chromatographic efficiency than the other. It can be seen that for fast 
separations requiring relatively low efficiency the monolithic columns and the 
1.8 pm particle packed column all behave similarly. An interesting observation is 
that the 10 cm monolith and the 1.8 pm particle packed column appear to 
exhibit almost identical plate generation behaviour, however, as was previously 
mentioned the monolithic columns generate significantly less operating 
pressure. Kinetic plots are constructed using the maximum pressure drop 
(APmax) for the system, for the 1.8 pm column APmax was set to 400 bar while for 
the monolithic columns a value of 200 bar was applied. Therefore, it appears 
that the 10 cm monolithic column is a more suitable option for rapid, moderately 
efficient separations (i.e. N -10,000) compared to sub 2 pm column 
technologies. The 10 cm monolith and the 1.8 pm column also appear to 
provide higher numbers of plates more rapidly than the 20 cm monolithic 
column, although the inclusion of the column coupler to generate the 20 cm 
monolithic column may be the reason for such an observation, due to the 
introduction of additional void volume into the chromatographic system. 
A noteworthy characteristic of Fig. 6.2 (B) is its similar appearance to the 
van Deemter curves presented in Fig. 6.1 above. However, the advantage of the 
kinetic plot over the van Deemter plots is the clearly defined minimum that 
corresponds to the optimum attainable number of theoretical plates (Nopt) at the 
minimum separation impedance (E,). From a .detailed discussion of the kinetic 
plot method by Desmet et al. [30], it was noted that E,-H~ and therefore, the 
minimum of the E, versus N/Nopt plot occurs at the same mobile phase linear 
velocities as mentioned in section 6.3.1. However, in this case the minimum 
corresponds to a point where the system generates the optimum number of 
theoretical plates at its best possible kinetic performance / pressure cost ratio 
1301. Therefore, from Fig. 6.2 (B) it can be seen that the 10 cm monolithic 
column offered higher Nopt values at lower E, values, than the 20 cm monolithic 
column and the 1.8 pm column. Such an observation can be explained as the 
shorter monolith would be expected to exhibit a higher degree of permeability 
than the longer monolithic column and in turn the particle packed column. 
However, all the available information should be considered when deciding on 
the actual analytical column to be used and based on the all the data presented, 
it was determined that the 20 cm monolithic column, which offered the highest N 
at acceptable mobile phase flow rates and column backpressures provided the 
best performance for the proposed application. 
6.3.3 Liquid chromatography of illicit drugs: 
Using the 20 cm monolithic column a gradient separation of the chosen analytes 
was investigated. An optimisation of the pH and buffer concentration of the 
aqueous proportion of the mobile phase was systematically performed using an 
experimental design approach to evaluate selectivity effects. For optimisation, 
an experimental space was designed, governed by the buffering activity of 
ammonium acetate and the desire to keep the buffer concentration low enough 
to be compatible with ESI-MS. Therefore, mobile phases containing ammonium 
acetate concentrations of 5 to 20 mM, over the pH range of 2.5 to 6.5 were 
investigated, with a total of twelve experiments run within the above 
concentration and pH range. The resulting chromatograms were assessed using 
the resolution product criterion, R, calculated according to Equation 6.1, [31]. 
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Figure 6.2: Kinetic comparison of the examined stationary phases; (A) a plot of to versus the 
pressure drop limited plate number (N ) ,  and (B) a plot of the t, based separation impedance E, 
versus the ratio of pressure drop limited plate number (N/NOpt). Symbols: 1.8 vm column (+), the 
10 cm monolithic column (m) and the 20 cm monolithic column (A) .  
R (i, i - I )  
n - I  (Eq. 6.1) 
Where: 
n is the number of analytes present and 
R, is the resolution between peaks i and i-1, calculated using peak width 
measured at baseline. 
The calculated R values a minimum resolution response surface as 
shown in Fig. 6.3 was constructed for the separation of the 16 illicit drugs and 
metabolites listed in Table 6.1. 
From Fig. 6.3 it can be seen that two sets of possible optima were 
generated from the optimisation experiments. Of these the lower buffer 
concentration optimum was further refined, resulting in final mobile phase 
conditions of 5 mM ammonium acetate, pH 4.5. MeOH gradient conditions were 
as described earlier under (section 6.2.4 chromatographic conditions). Under 
the optimum mobile phase conditions a complete separation of most analytes 
was achieved with the exception of the ketamine and heroin and the 
cocaethylene and LSD peak pairs wherein a slight degree of co-elution still 
occurred, see Fig. 6.4. A'-THC was strongly retained, however, the total run 
time of only 30 minutes per injection for full screening of all 16 drugs was 
deemed acceptable. 
Figure 6.3 Minimum resolution response surface for the optimisation of the pH and buffer 
concentration of the aqueous mobile phase. Experiments were performed using a 1 m g ~ - '  
standard mixture of analytes. 
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Figure 6.4: Separation of a l m g ~ '  standard solution of all analytes using a multistep gradient 
of MeOH and 5 mM ammonium acetate, pH 4.5 on the 200.0 mm x 3 mm i.d. monolithic column 
at a flow rate of 0.35 mlrnin-' using ESI-MSIMS detection. The traces have been offset for the 
purpose of clarity. Peak identification, '1 morphine, 2 amphetamine, 3 MDMA, 4 
benzoylecgonlne, 5 ketamine, 6 heroin, 7 cocaine, 8 cocaethylene, 9 LSD, 10 EDDP, 11 
papaverine, 12 methadone, 13 fiuoxetine, 14 temazepam, 15 diazepam and f 6 A'-THC. 
6.3.4 MS/MS Detection: 
For the detection of most drugs separated simple easily interpretable spectra 
were recorded, i.e. only pseudomolecular ions [M+H]' were observed. In the 
case of amphetamine and MDMA the product ions generated are as a result of 
the loss of ammonia and methyl amine respectively from the precursor 
pseudomolecular ions. Cocaine and its structural analogues benzoylecgonine 
and cocaethylene were all observed to lose 122 mass units from the parent 
molecule corresponding to the loss of the benzoic acid functionality from the 
molecules. The MSIMS transition of morphine is thought to be due to loss of 
water from the parent molecule while for heroin the MSlMS transition occurs 
due to loss of both acetyl groups as CH3C0 followed by a dehydration to yield 
the same product ion as morphine at m/z 268. Methadone is thought to lose 
dimethyl amine to yield its product ion at mlz 265, its metabolite EDDP loses 29 
mass units corresponding to the loss of the ethyl group while papaverine is 
thought to lose a dimethoxy phenyl group to yield the product ion at mlz 202. 
The product ion of LSD is suspected to arise due to the loss of CON(C2H5)2 
from the molecule. Ketamine and temazepam both undergo dehydration to yield 
their product ions while the MSIMS transition of diazepam occurs due to the 
contraction of the 7 membered ring to a 6 membered ring with the loss of CO to 
yield the ion at mlz 257 [32]. A'-THC is thought to under go a similar transition 
with ring contraction and loss of HOC(CH3)2 resulting in the product ion at m/z 
259. The MSIMS transition of fluoxetine arises as a result of CF3C6H40. All of 
the recorded MSIMS transitions were significantly intense, with in most cases 
complete fragmentation of the precursor ion. These unequivocal chemical 
fingerprints were used for unambiguous identification of resulting peaks when 
analysing banknote samples. 
6.3.5 Method performance: 
Prior to application, the performance characteristics of the developed LC- 
MSIMS method were determined. Linearity was assessed from prepared five 
point calibration curves in the region of 0.01 to 5 mgL-' equating 0.2 to 100 ng 
note-'. Repeatability was determined by performing six replicate injections of a 
0.10 mgL-' mixed standard solution while reproducibility was examined using six 
individually prepared 0.5 mgL-' mixed analyte solutions. The limits of detection 
and quantitation were defined as signals, corresponding to 3 and 100 
respectively of the baseline noise. The determined performance characteristics 
are listed in Table 6.4. Linearity was demonstrated in all cases with R~ > 0.99 
with the exception of amphetamine, heroin, papaverine and A'-THC. The 
calculated levels of precision were also deemed acceptable, in general 
repeatability was ~ 5 %  RSD while reproducibility was in the range of 5-10% 
RSD. The method was also determined to be suitable sensitive with detection 
and quantitation limits in the pg-ng note-', range. The levels of sensitivity 
achieved in this study using LC-MSIMS out perform previously published 
methods using GC-MSIMS [7] and CE-ECL [18], wherein an instrument 
validation was performed. It is a noteworthy comment that many of the 
published methods do not report method performance data. The superior 
sensitivity data obtained in this study further supports the use of LC-MSIMS for 
the determination of illicit drugs due to the majority of such chemicals occurring 
as charged species in solution. 
Table 6.4: Method performance data. 
Linearity Repeat. Reproduc. LOD LOQ Recovery 
Analyte - 
R~ O ~ R S D  %RSD pg note-' pg note-' % 
Morphine 0.9945 2.54 3.98 22 74 26 f 3 
Amphetamine 0.9898 5.18 6.80 1010 3367 64k7 
MDMA 0.9976 4.02 7.02 195 651 48 k 17 
Benzoylecgonine 0.9981 1.25 7.65 4 14 37 + 1 
Ketamine 0.9995 3.00 8.58 18 60 65 f 1 
Cocaine 0.9997 3.69 4.93 3 14 87 f 8 
Heroin 0.9876 2.91 11.29 5 17 53 5 5 
Cocaethylene 0.9991 4.79 9.66 5 17 54k9 
LSD 0.9998 3.33 7.16 10 33 28 f 3 
EDDP 0.9954 3.26 6.15 3 9 74+ 10 
Papaverine 0.9873 8.09 11.97 4 15 79k9 
Methadone 0.9995 2.97 4.51 9 31 - 4453 
Temazepam 0.9998 4.69 6.81 2 1 71 32+2 
Fluoxetine 0.9992 5.01 5.65 52 175 24f 4 
Diazepam 0.9994 2.33 - 4.81 5 16 30f 6 
A'-THC 0.9866 8.60 4.91 150 502 71 524 
-Repeatability and reproducibility have been abbreviated for the purposes of fit. 
The recovery of the test materials was also assessed using a similar 
procedure to that as previously described by Esteve-Turrillas et a/. [7] Recovery 
experiments were performed using €5 banknotes which were first extracted as 
previously described (section 6.2.6) in order to avoid any possible cross 
contamination (n = 3). The cleaned banknote was spiked with 125 ng of all 
analytes prepared in MeOH, after sufficient drying time the note was extracted 
and the percentage recovery was determined by comparing the peak areas 
recorded for the spiked note with a standard injection. The percentage 
recoveries were observed to vary for each analyte, with cocaine and methadone 
demonstrating quite high levels of recovery, but analytes such as LSD and 
diazepam exhibiting poor recovery from the banknote. The reason for the poor 
recovery of some compounds compared to others, particularly those that are 
structurally analogous, is unclear. As the majority of the test analytes are basic 
in nature the possibility that mixed mode retention via adsorption and ion 
exchange on the cotton surface of the banknote was investigated by using 
MeOH containing either 0.1% vlv acetic acid or 0.1 % vlv ammonium hydroxide 
in the extraction procedure. However, the inclusion of the acidic or basic 
modifiers into the extraction solution had no positive affect on the determined 
percentage recoveries and therefore, further research into extraction techniques 
is recommended. It should, however, be mentioned that many of the test 
analytes are administered or taken in tablet form and therefore, minimal residue 
would be expected on banknotes in such cases. 
6.3.6 Application to banknotes: 
The developed LC-MSIMS method was then applied to the determination of 
illicit drug and abused pharmaceutical residue contamination on Euro 
banknotes. Where possible, notes of lrish origin were preferentially collected, 
(serial numbers beginning with the lrish identifier, letter 'T'), in an attempt to 
locally bias the sample, although it must be mentioned that the history of the 
sampled notes is unknown and they may indeed been outside Ireland and used 
in other Euro zone countries. New un-circulated €5, €10 and €20 notes were 
also obtained from the bank to serve as method blanks. Samples were 
extracted as previously described (section 6.2.6) and the re-constituted extracts 
analysed using the developed LC-MSIMS method (section 6.2.4). Fig. 6.5 
shows some typical chromatograms for used (A) 5 and (B) 20 Euro banknotes, 
overlaid with chromatograms from un-circulated blanks. 
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Figure 6.5: Resulting chromatograms from banknote analysis depicting; (A) the presence of 
-24 ng of cocaine (blue trace) on a €5 note overlaid upon the EIC mlz 304 trace for the un- 
circulated €5 note (red trace) and (B) the presence of -20 ng cocaine and -4 ng of 
benzoylecgonine on a €20 banknote, (blue and red traces respectively). 
All of the 45 banknotes tested positive for trace quantities of cocaine with 
the exception of the 3 un-circulated controls. Exact results are listed in Table 
6.5 and shown graphically as Fig. 6.6. In all, two of the notes; a €5 and a €20 
note; appear to be contaminated with significant levels of cocaine that would 
suggest direct contact with the drug, either through drug dealing or more 
probably when using the note to 'snort' the narcotic. From Fig. 6.6 it can be 
seen that significantly higher average levels of cocaine are present on the 
higher denomination notes compared to the smaller €5 and €10 banknotes. The 
presence of benzoylecgonine, the primary breakdown product of cocaine, 
suggests aging of the cocaine residue on the surface of the note, perhaps due 
to hydrolysis of cocaine residues as a result of exposure to moisture. Although 
not currently known, it is thought that the rate of cocaine breakdown and the 
consequent rate of formation of benzoylecgonine could provide a time frame 
concerning the contamination of the note with cocaine. However, the presence 
of benzoylecgonine may also be due to contamination of the note via contact 
with the urine of a cocaine user. Trace cocaine contamination on the remaining 
notes is suspected to have occurred as a result of transfer during the counting 
processes within financial institutions as previously demonstrated by Carter et 
a/.  [I 31. 
Traces of heroin were also detected on three of the analysed notes along 
with trace levels of cocaine, two €5 and one €10 note. The levels of heroin 
detected were in one case less than the levels of cocaine, in one case 
approximately equal and in the final case greater then the quantity of cocaine 
determined. 
Table 6.5: Banknote analysis. 
Cocaine Benzoylecgonine Heroin 
Serial Number (ng note-') (ng note-') (ng note-') 
€5 Banknotes 
T15874943298- 
- - - 
Un-circulated. 
T I  51 808431 02 0.20 + 0.01 - - 
TI5186514803 23.91 + 0.32 0.84 + 0.02 - 
T I  5051 087366 4.1 1 k 0.07 - - 
TI5250805205 0.09 k 0.01 - - 
T I  51 51331 679 2.39 + 0.12 - - 
T I  51 01 438289 0.43 + 0.1 3 - 
T I  51 371 12939 2.77 k 0.68 - - 
T I  561 3930023 0.35 + 0.06 - - 
T I  5229068657 0.67 + 0.1 0 - - 
T I  501 6543359 2.67 k 0.16 - - 
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Figure 6.6: Graphical representation of cocaine contamination on the analysed banknotes. The 
highest levels were detected on one €5 note and one €20 note as labelled in the above figure. 
It can also be seen that the levels of contamination are higher on the €20 and €50 notes than 
on the €5 and €1 0 notes. 
6.4 Conclusions: 
A highly sensitive and relatively rapid monolithic LC-MSIMS separation of illicit 
drugs and abused pharmaceuticals preceded by simple sample preparation has 
been developed and successfully applied for the determination of such 
contamination on Irish Euro banknotes collected from a branch of a national 
bank on the north side of the city. Trace levels of cocaine were found on all 
notes tested. In some instances traces of benzoylecgonine, the breakdown 
product of cocaine was also determined. Interestingly, traces of heroin were 
also found on 3 of the 45 samples. The presence of such illicit material on the 
studied banknote samples provides an indication of the presence of such 
narcotics within the community. However, this initial study does not attempt to 
draw sociological or geographical conclusions regarding the use of narcotics 
within the community and therefore, any such conclusions should only be 
considered with caution. 
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7.0 Using Environmental Analytical Data to  Estimate 
Levels of Community Consumption of I l l icit Drugs and 
Abused Pharmaceuticals. 
7.1 Introduction: 
As mentioned previously in Section 6.1, there has of late, been increased media 
attention concerning the escalating use of illicit drugs, in particular cocaine, by lrish 
society [I]. Such media reports appear to be corroborated by official seizure data 
from An Garda Siochana, wherein a search of press releases available through 
their website reveals no less than eighteen major hauls of cannabis, cocaine, 
opiates and amphetamines in the period of January to November 2006, including 
the largest ever seizure of heroin in this country [2]. However, it was also 
previously noted that current methods for the estimation of illicit drug use within 
lrish society often suffer from significant shortcomings. For example, performing 
surveys that focus upon specific subgroups known to abuse drugs, or attempting to 
gauge cocaine abuse by measuring the numbers presenting themselves for 
treatment for cocaine addiction into an opiate focused and ill-equipped system. Of 
course, any information regarding the extent of the 'drug problem' in Ireland is 
inherently valuable, especially to those governing the allocation of resources to 
ensure adequate funding to the health services and law enforcement in order to aid 
in combating a growing problem. However, the predicament exists that current 
approaches to estimate drug consumption often, if not always, do not contain 
information regarding the use of illicit drugs by social and recreational users and 
hence, the picture of the 'drug problem' presented in the public domain may not 
provide an accurate reflection of the actual state of affairs. 
Several analytical procedures exist in the peer-reviewed literature for the 
determination of illicit drugs. The majority of these methods are however, focused 
on personal testing as part of usage or abstinence monitoring and toxicological 
studies rather than community estimations of current usage. Due to the scope of 
such studies the matrix investigated has always been biological in nature, spanning 
across plasma and serum [3,4,5,6,7,8], to urine [9,10,11] and other bodily fluids 
such as saliva and sweat [ I  2,13,14,15,16]. Hair analysis has also become a recent 
focus in abstinence monitoring programs due to the ability to place a time frame to 
usage periods in accordance with standard hair growth rates and consequently a 
number of methods have also appeared detailing procedures for the determination 
of illicit drug residues in hair [17,18,19,20,21]. To a lesser extent, reports for the 
determination of mother to child substance transfer have also been published, 
wherein meconium was the biological matrix under investigation [22,23]. A 
common feature of the published methods is the widespread use of LC in 
conjunction with either ESI or APCl with MSIMS detection allowing for separation 
followed by unequivocal detection and the garnering of structural information. 
Detailed discussions concerning the quality assurance of generated LC-MSIMS 
data used for confirmatory analysis as part of monitoring and toxicological studies 
have also been published [10,24]. However, although the above methods are all 
suitably sensitive and selective for the analyte set investigated, all procedures rely 
heavily upon invasive sampling procedures in order to determine the desired 
information about the person under investigation. 
In the past decade, a number of reports concerning the presence of 
pharmaceuticals and other medicines in the aquatic environments have entered 
the public domain, wherein classes of pharmaceuticals ranging from common over 
the counter painkillers and analgesics such as ibuprofen and paracetamol to 
specialist cytotoxic agents and x-ray contrast media have been detected in both 
fresh and marine aquatic systems at trace and ultra-trace levels 
[25,26,27,28,29,30]. In some instances the MECs demonstrated a statistical 
relationship concerning the levels of the detected pharmaceutical in the 
environment and that consumed by the population. For example Ashton et a/. 
determined the levels of common pharmaceuticals, e.g. diclofenac, ibuprofen, 
propranolol etc. in treated wastewater and also in the effluent receiving waters and 
found that levels detected downstream of the wastewater treatment plant 
statistically correlated to levels detected in the plant's discharged effluent and a 
further statistical correlation may exist to actual levels of said drug usage within the 
community [31]. 
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The detection of pharmaceutically active compounds within the aquatic 
environment as a direct result of treated wastewater discharge further highlights 
the "intimate, immediate and inseparable relationship between humans and their 
environment through personal use of chemicals" [32]. Daughton further 
hypothesised that in a similar manner to medicinal compounds, residues of illicit 
drugs may also be detected in the aquatic environment as a result of human usage 
and hence, discharge of both parent compounds and metabolites into aquatic 
systems is likely to occur via the municipal wastewater treatment system [32]. It is 
also speculated that wastewater treatment plants are the primary emitters of such 
compounds into the environment, as due to the effort, risk and cost involved in 
obtaining and importing illicit drugs, improper disposal and dumping would not be 
expected to occur. 
The first report concerning the presence of illicit materials in treated 
wastewater appeared in 2004, whereby low n g ~ - '  of methamphetamine and 3,4- 
methylenedioxy methamphetamine (MDMA or 'ecstasy') were individually detected 
in the effluent of two monitored wastewater treatment plants in Nevada and South 
Carolina in the United States, respectively. Although no further research was 
conducted in this instance, it was acknowledged that the detection of these two 
illicit drugs corroborated evidence from the United States Drug Enforcement 
Agency (USDEA) that both chemicals were becoming increasingly problematic in 
the metropolitan areas surrounding the sampled plants [33]. More recently 
amphetamine was also detected in sewage sludge by Austrian researchers in the 
low C1gkg-' range, however, caution must be used when interpreting such results as 
amphetamine and similar compounds may also be presented in wastewater 
treatment plants as metabolites of prescription drugs used in the treatment of 
Parkinson's disease [34]. 
It was also previously noted that the determination of illicit drug residues in 
wastewater could provide an opportunity to non-invasively determine community 
wide consumption of such substances. Pioneering research on this front was 
published by Italian researchers in 2005 where levels of cocaine and its primary 
metabolite, benzoylecgonine, detected in surface waters and treated wastewater 
could be used to statistically estimate consumption of the parent narcotic within the 
community under study [35]. The approach used was to convert MECs to daily 
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doses per thousand population equivalents (PEq) using available information 
regarding the volume of wastewater through the treatment plant per day and a 
correction factor of 2.33 to adjust benzoylecgonine MECs in favour of the parent 
compound, cocaine [35]. Based upon their environmental monitoring data, Zucatto 
et a/. estimated that on average within the general population approximately 7 
doses per 1000 PEq were consumed daily which was further refined to 27 doses 
per 1000 PEq aged in the range of 15-34 years [35]. This research received 
considerable media attention and further sampling was also undertaken along the 
River Thames in London, although the results of this study have not yet been 
published, [36,37]. More recently a publication has emerged from the same group 
where the levels of a broad suite of illicit drugs were determined using isotope 
dilution LC-ESI-MSIMS in the treated effluents of wastewater treatment plants in 
Milan, Italy and Lugano, Switzerland [38]. In both plants the majority of the target 
analytes were detected in the influent samples, while reduced quantities were 
detected in the treated effluent, suggesting the existence of removal mechanisms 
with in the treatment plant. Interestingly, the Milan wastewater treatment plant 
appeared to be extremely efficient at removing illicit drug residues with most 
compounds, including cocaine, being removed . to levels below the LOQ of the 
developed analytical method [38]. Although no 'community consumption' 
calculations were reported in this publication, the authors acknowledge that the 
results obtained could indeed be used to estimate levels of drug . . use within the 
area under study. 
The aims of this research are therefore, to develop a suitably sensitive 
analytical method for the determination of illicit drug residues, in particular cocaine, 
in treated wastewater and receiving waters using SPE-LC-MSIMS. Where residues 
of illicit drugs are detected it is hoped to estimate community consumption data for 
the said narcotic using the approach of Zucatto et a/. [35]. Treatment plants 
identified for study include that in Ringsend, Dublin, Ireland, which currently serves 
-1.7 million PEq along with smaller plants servi.ng areas in the north and south of 
the capital city. Treated effluent from wastewater treatment plants in rapidly 
expanding 'commuter' towns surrounding Dublin such as Navan, Co. Meath and 
Leixlip, Co. Kildare were examined. 
7.2 Experimental: 
7.2. I :  Chemicals and reagents. 
Chemicals and reagents used in this study were as per section 3.2.2 and 
section 6.2.1 unless otherwise stated. Individual 100 m g ~ - '  stock solutions of 
each chemical were prepared in MeOH and were stored at 4OC in the dark. 
Working solutions were prepared from the individual stock standards using 
water as a diluent. In the case of salts, standard solutions were prepared in 
terms of the parent analyte. Stock solutions were retained for the duration of the 
research, working solutions were prepared fresh prior to use. 
Buffer solutions used for the optimisation of the extraction pH were prepared 
by mixing the appropriate amounts of acid and its conjugate base for formate and 
acetate respectively. In the case of MES and TRlS weighted proportions of salt 
were dissolved in -900mL Milli-Q water and titrated to the desired pH using either 
1 M HCI or 1 M NaOH. 
7.2.2: Glassware preparation. 
Silanisation was performed as per section 3.2.3. 
7.2.3: Sample Collection. 
24 hour composite samples of treated effluent were obtained from the wastewater 
treatment plants listed in Table 7.1, (with the exception of the Shanganagh 
treatment works where only a grab sample could be obtained). Corresponding 
influent samples were also collected from the Ringsend wastewater treatment plant 
in Dublin. Grab samples of receiving water were obtained immediately downstream 
of the treatment plants during each sampling campaign in an attempt to investigate 
the effect of dilution within the aquatic environment. 
Samples from the plants (Table 7.1) were collected during the week 
beginning November 20" 2006. Samples were extracted within 24 hours of 
collection and the dried SPE cartridge was immediately frozen pending 
instrumental analysis. 
Table 7.1: Wastewater treatment plants sampled for the presence of illicit drugs. 
No. of Through 
Tvae of 
-,r- - -  Treatment Plant Governing Authority Population Flow, 
Treatment 
Equivalents (Lday") 
Ringsend Dublin City Council IY, 2Y- 1,700,000 5.00 x 10' 
Swords Fingal County Council l Y ,  2Y. 48,000 1 .OO x 10' 
Dun Laoighre Rathdown Shanganagh County Council 1 only. 65,000 2.20 1 o7 
Leixli 280,000 3.00 x 10 
Navan Meath County Council IY, 2Y. 40,000 1.05 x 10' 
Key: IY; primary treatment, 2y; secondary treatment using activated sludge. 
7.2.4: Solid phase extraction. 
Sorbents investigated for sample extraction included Phenomenex strata-xTM1 
strata-xcTM and strata-XCW~", all 200 mg sorbent mass pre-packed into 6 mL 
cartridges (Phenomenex, Macclesfield,  hes shire, UK). From initial investigations 
the strata-xcTM sorbent provided the highest degree of analyte recovery and 
hence, was considered for further study. Prior to extraction 500 mL aqueous 
samples were filtered through Whatman GFIC glass micro-fibre filters to remove 
particulate matter (Whatman, Maidstone, UK). The filtrate was then adjusted to pH 
6.0 using concentrated HCI. Prior to use the SPE cartridge was conditioned with 2 
x 6 mL MeOH and 2 x 6 mL water, respectively. Samples were introduced by 
vacuum through Teflon tubing and extracted under an operating pressure of 20" Hg 
on a vacuum manifold. After complete sample introduction but without letting the 
cartridge run dry, the sorbent was washed with 50 mL of 10% v/v MeOH in 100 mM 
formic acid. Finally, 500 pL of glacial acetic acid was then added to each cartridge, 
which was allowed to slowly percolate through the sorbent bed in order to aid with 
dehydration. The sorbents were then dried by vacuum aspiration for a minimum of 
30 minutes. Elution was performed using 10 mL of 5% vlv ammonium hydroxide in 
1:l acetone ethyl acetate, the elution solvent was allowed to slowly percolate 
through the sorbent bed and was collected in a 12 mL glass vial. The collected 
eluate was then reduced in volume to near dryness under a gentle stream of N2 
with heating if necessary. The resulting residue was then reconstituted in 200 pL of 
30% vlv MeOH in 5 mM ammonium acetate pH 4.5 fortified with 0.1 m g ~ - '  
papaverine that served as an internal standard for quantitation and transferred to 
an autosampler vial containing a low volume polypropylene insert for LC-MSIMS 
analysis. 
7.2.5: Liquid chromatography tandem mass spectrometry. 
LC-MSIMS analyses were performed as described in section 6.3.4. The optimised 
ion optic parameters were as previously reported in Table 6.2; the nebuliser 
pressure was set at 30.0 psi with a dry gas (N2) flow rate of 8.0 ~ m i n '  and a drying 
temperature of 325OC. MSIMS transitions monitored were previously mentioned in 
Table 6.3. Product ion MSIMS transitions were used for qualitative confirmation, 
quantitation was also performed using the area from the resulting product ion peak. 
Analytical separations were performed on a 200.0 x 3.0 mm i.d. Phenomenex Onyx 
monolithic CAB column, (Phenomenex, Macclesfield, Cheshire, UK) using the multi- 
step linear gradient of MeOH and 5 mM ammonium acetate pH 4.5 developed in 
Chapter 6.0. 
7 .3  Results & Discussion: 
7.3. I SPE sorbent selection: 
The illicit drugs and abused pharmaceuticals chosen for study comprise a set of 
analytes that are weak to moderately basic, with the exception of A'-THC which is 
uncharged and also span across a broad range of polarities as can be seen from 
the pK, and the octanol water partition coefficient data (Log P) values in Table 7.2 
following. 
Due to the expectation that the majority of the chosen analytes would be 
presumed to exist in their protonated cationic form in solution mixed mode cation 
exchange sorbents, both weak and strong, were investigated along with the 
previously used hydrophilic lipophilic balanced polymeric sorbent. The sorbents 
used were from the Phenomenex Strata-X family of polymeric functionalised 
phases for analyte enrichment, the structures of which are shown in Fig. 7.1. 
Fig. 7.1: The structure of (A) the Phenomenex strata-xrn hydrophilic lipophilic bilanced polymeric 
sorbent, (B) the additional strong cation exchange functicnality of the Strata-XC sorbent and (C) 
the weak cation exchange functionality of the Strata-XCW sorbent [55]. 
Table 7.2: pK, and Log P, (as theoretically calculated XLogP) data for the selected illicit drugs and 
pharmaceutical anal ytes. 
Analyte PKa Log P 
Morphine 9.85 [39] 0.96 [40] 
Amphetamine 9.80 1411 1.76 I421 
MQMA 9.90 [43] -0.32 [44] 
BenzoyJecgonine 2.25. 11.2 1451 1.29 [46] 
Ketamine 7.50 (471 2.88 [42] 
Cocaine 8.60 [48] 2.31 [42] 
Heroin 7.60 [49] 1.69 [42] 
Cocaet hylene 
LSD 7.80 [501 2.10 [42] 
In order to ascertain which of the above sorbents provided the highest 
degree of analyte recovery, a 500 mL aliquot of a 2 p g ~ '  mixed analyte spiked 
solution prepared in reagent water was extracted using each of the above 
sorbents. The solution pH was adjusted to pH 7.0, 2.0 and 5.0 for the strata-x", 
strata-xcTM and strata-xcwTM sorbents, respectively. Elution was performed using 
10 mL of MeOH or in the case of the mixed mode cation exchange sorbents, 10 mL 
of 5% vlv ammonium hydroxide in MeOH. The percentage analyte recovery in each 
Methadone 9.10 [51] 3.92 
EDDP - 4.76 
Pa averlne 
instance was determined by comparison of the resulting peak areas with those of a 
directly injected 2 m g ~ - '  mixed standard, see Table 7.3. 
:42] 
1421 
Temazoparn 2.99 [42] 
Fluoxetine 7.37, 4.69 [53] 4.65 [42] 
Diazepam 3.40 [57] 2.92 [42] 
A ~ T H C  10.60 [54] 6.48 1421 
Table 7.3: Initial sorbent selection investigations. Calculated analyte recovery for a 2 p g ~ - l  mixed 
spike using the sorbents and conditions mentioned within the text, (values quoted are mean Oh 
recovery k standard deviation, n = 3). 
Analyte Strata-X Strata-XC Strata-XCW 
Morphine 143f 7 124+6 
A m p h e t a m i n e 0  
MDMA 44 + 1 88 + 1 75 f 5 
Benzoylecgonine 78k2 70f2 58 f 1 
- 
Ketamine 70f3 89 + 5 66+2 
Cocaine 102k 1 115_+1 94f 2 
Heroin 22 + 1 26 f 1 13k1 
Cocaethylene 94 + 1 106+2 91f2 
LSD 56 + 4  52 f 1 57 k 1 
Methadone 29 k 1 97 + 1 71 1 
Temazepam 84f 1 80 + 1 73 + 1 
Fluoxetine 30 + 1 71 _ + I  61 _+ 1 
Diazepam 82 + 1 81 +I 70 + 1 
8"-THC - - 
From Table 7.3 it can be seen that the highest degree of analyte recovery 
was achieved when using the strata-xcTM mixed mode string cation exchange 
sorbent with acceptably high recovery of all analytes with the exception of heroin. 
Although it cannot be said with certainty, it is assumed that heroin hydrolysed to 
morphine under the acidic conditions used, hence the excessive recovery of 
morphine. The sorbent selection study was performed using LC with UV detection 
at 230 nm and therefore, the cases in which analyte recovery greater then 100% 
may have arisen due to co-elution with unknown peaks. High levels of analyte 
recovery were also achieved with the weak mixed mode strata-xcwTM sorbent. 
However, recovery was generally less than the strata-xcTM sorbent with the 
exception of LSD where results achieved with the three investigated sorbents were 
similar. When using the strata-xTM sorbent, which exploits both reversed-phase and 
hydrogen bonding as mechanisms of retention, analyte retention can be observed 
to increase with increasing levels of hydrophobicity. Analytes such as MDMA and 
methadone, which are expected to exist as cations in solution under the 
experimental conditions exhibited low levels of retention as expected. It must also 
be mentioned that EDDP was not included in the above study as it was received at 
a later date. In all cases no appreciable recovery of both amphetamine and A'-THC 
was achieved. Although the reasons for such are not inherently clear, it has 
previously been noted that amphetamine is readily purged from solution during 
solvent evaporation using nitrogen and often requires acidification of the elution 
solvent in order to prevent such effects [34]. A'-THC was expected to be neutral in 
solution under the experimental conditions, the reported pK, value corresponds to 
the dissociation of the phenolic group of the molecule, and therefore, retention was 
expected when using the Strata-X sorbent. A'-THC exhibits high retention during 
the chromatographic analysis and therefore, the possibility of excessive retention 
on the extraction sorbent was investigated. However, when the Strata-X sorbent 
was eluted with larger volumes of solvent, still no recovery of A'-THC was noted. 
As a result of these observations both amphetamine and A'-THC were omitted 
from further study as their enrichment appeared unfeasible using the SPE 
approach. 
7.3.2 Elution solvent selection: 
As the chosen Strata-XC sorbent contains the same sorbent 'backbone' as the 
Strata-X sorbent which was previously used for the enrichment of pharmaceutical 
residues in Chapter 3.0, it was decided to investigate whether the elution solvent of 
5% vlv ammonium hydroxide in MeOH as recommended by the product literature 
[55] could be replaced with 5% vlv ammonium hydroxide in 1:l acetone ethyl 
acetate as used previously due to both the increased solvent strength and ease at 
which the acetone ethyl acetate mixture can be reduced in volume under nitrogen. 
To determine which solvent system provided the optimum levels of analyte 
recovery, 1 p g ~ - l  spiked solutions of chosen analytes prepared in reagent water 
were adjusted to pH 2.0 using HCI and extracted using the selected Strata-XC 
sorbent. After complete sample introduction and sorbent drying SPE cartridges 
were individually eluted with 10 mL the aforementioned solvent systems that were 
then reduced in volume under nitrogen, reconstituted in internal standard solution 
and analysed using LC-MSIMS. Analyte recovery was determined by comparison 
with the resulting peak areas of a directly injected 1 mgL-' mixed standard, see 
Table 7.4. 
Table 7.4: Calculated analyte recovery for the optimisation of the elution solvent. 
Analyte 
5% vlv NH40H in 1 :1 Acetone 
5% vlv NH40H in MeOH 
Ethyl Acetate 
Morphine 53 8 
MDMA 107 60 . . . - . . . . . - - 
122 
- 
Ketamine 132 109 
Cocaine 164 87 
Heroin 0 27 . . - . - . . . - 
Cocaethylene 100 73 
LSD 33 43 
EDDP 62 62 
Methadone 93 83 
Fluoxetine 31 36 
Temazepam 8 1 - 90 
Diazepam 83 77 
In most instances, analyte recovery was again acceptably and comparably 
high. However, recoveries obtained when using 5% vlv NH40H in MeOH were in 
some instances excessively high, for example, in the case of cocaine, which was 
almost double that obtained when using the 5% vlv NH40H in 1:l acetone ethyl 
acetate elution solvent system. Another observation noted was that there was no 
recovery of heroin when using 5% vlv NH40H in MeOH. In an attempt to ascertain 
whether or not there was a significant difference between the levels of analyte 
recovery obtained using both solvent systems a students t-test was performed 
using Microsoft Excel assuming unequal variances, (after a previously performed 
F-Test, wherein Fexperimental 0.669 was found to be greater than Fcritical 0.403 at the 
95% level of confidence). From the performed t-Test it was found that there was no 
significant difference between the levels of analyte recovery obtained using either 
elution solvent system, (tmperimental 0.765 < tcritical 2.052 at the 95% level of 
confidence) and therefore, for all subsequent investigations elution was performed 
using 5% vlv NH40H in 1 :I acetone ethyl acetate. 
Having selected the elution solvent, the minimum volume of solvent required 
for complete analyte elution was then determined. A Strata-XC cartridge was 
successively eluted with fifteen 1 mL portions of 5% vlv NH40H in 1: l  acetone 
ethyl acetate, each of which in turn was reduced in volume under nitrogen, 
reconstituted and analysed using LC-MSIMS. The relative recovery of each analyte 
was determined and plotted against the volume of elution solvent as depicted in 
Fig. 7.2. For the purposes of clarity Fig. 7.2 has been simplified and only depicts 
the resulting elution profiles of cocaine, methadone and temazepam, however, 
identical traces were recorded in the case of all of the investigated analytes. From 
Fig. 7.2 it can be seen that 8 mL of solvent is sufficient to remove all retained 
analyte from the sorbent bed, however, an elution volume of 10 mL was chosen for 
all further investigations in order to ensure completeness. 
6 8 10 
Elution Volume (mL) 
Figure 7.2: Plot of % relative recovery versus SPE elution volume using Strata-XC SPE cadridges 
and elution with 5% v/v NH40H in 1 :I acetone ethyl acetate. Key: black trace; methadone, blue 
lrace; cocaine, red trace; temazepam. 
7.3.3 Extraction pH optimisation: 
The pH of the extraction solution was next optimised in order to determine the 
sample loading pH that provided the highest levels of analyte recovery. 500 mL 
aliquots of 1 pg~ - l  spiked solutions were prepared in 10 mM buffer solutions and 
extracted using the strata-xcTM sorbent. Extractions were performed at pH 2 using 
reagent water adjusted with HCI, pH 3 and 4 using ammonium formate buffer, pH 5 
using ammonium acetate buffer, pH 6 and 7 using MES and pH 8 using TRIS. After 
elution with 10 mL of 5% v h  NH40H in 1: l  acetone ethyl acetate, solvent removal 
and reconstitution, the extract was analysed using LC-MSIMS and as before, the 
levels of analyte recovery were determined by area comparison with a 1 mgl-' 
standard, the calculated recovery values are inserted as Table 7.5. 
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Table 7.5: Recovery data for extraction pH optimisation. 
% Recoverv 
Analyte 
pH 2 pH 3 pH 4 pH 5 pH 6 pH 7 pH 8 
Morphine 5 6 16 2 6 7 14 
MDMA 62 45 55 67 62 62 - 38 
Benzoylecgonine 113 90 112 99 81 106 55 
Ketarnine 70 61 62 71 70 68 73 
Cocaine 11 15 7 33 54 49 0 
Heroin 22 11 5 33 56 55 0 
Cocaethylene 36 38 31 57 69 69 2 
LSD 40 46 48 48 60 60 88 
EDDP 5 1 40 39 62 63 40 45 
Methadone 60 63 59 74 76 74 43 
Fluoxetine 43 25 32 4 1 47 52 17 
Temazepam 79 7 1 87 81 82 92 61 
Diazepam 78 72 85 85 82 94 71 
Analyte recovery was observed to vary quite significantly with the pH of the 
extraction solution and in most instances there appears to be no significant trend 
between the determined levels of analyte recovery and the pH at which the 
extraction was performed. It was expected that recovery would increase with 
deceasing solution pH as all analytes under investigation are weakly basic and 
therefore, by lowering the solution pH they should become positively charged, 
thereby facilitating increased interaction with the mixed mode cation exchange 
strata-xcTM sorbent. Such an effect was expected to be of particular significance 
for benzoylecgonine, which exists as a zwitterion in neutral solution, whereby 
performing the extraction at an acidic pH should result in protonation of the acidic 
functionality of the molecule (pK, 2.25) and therefore, minimise any possible 
electrostatic repulsion from the similarly charged sulphonic acid functionality of the 
extraction sorbent. However, such an effect appears to be absent, with acceptably 
high recovery of benzoylecgonine determined at investigated pH values in the 
range of pH 2.0-7.0. 
Upon examination of the recovery data in Table 7.5, it was decided that pH 
6.0 appeared to be the optimum pH for sample extraction, as levels of recovery for 
the majority of the chosen analytes were acceptable. It must be mentioned that the 
recovery of both morphine and fluoxetine was particularly low in all instances. 
Morphine is a hydrophilic basic compound and it is thought that significant 
breakthrough of retained morphine occurred from the sorbent during the extraction. 
Fluoxetine on the contrary is weakly basic and relatively non polar and therefore, it 
was expected that higher levels of recovery would be achieved under the 
experimental conditions employed. In other cases where recovery was found to be 
less that 70% it was hoped that desired levels of analytical sensitivity would still be 
achieved when using the previously developed LC-MSIMS method for the 
determination of preconcentrated residues. 
7.3.4 Matrix removal using selective washing: 
Having optimised the SPE loading and elution procedures attention was then 
focused upon the development of a selective washing step in order to achieve 
cleaner 'matrix free' extracts. The approach undertaken focused upon the 
determination of the volume of wash solution to which the retained analytes could 
be exposed without the occurrence of significant breakthrough and hence, analyte 
loss from the sorbent bed. From the product literature it was recommended that 
washing be performed with solutions containing low proportions of organic solvent 
and also when using mixed mode cation exchangers the wash solution should also 
be acidic in order to 'lock' retained basic analytes onto the sulphonic acid sorbent 
[55]. Based upon these guidelines, the wash solvent investigated was a solution of 
10% vlv MeOH in 0.1 M formic acid. In order to examine the effect this solution on 
the retained analytes, a 500 mL aliquot of a 5 p g ~ - l  spiked solution, prepared in 
MES buffer pH 6.0, was extracted using the strata-XC'" SPE cartridges. The 
spiking level was deliberately higher than usually used during method development 
so as any analyte breakthrough during the sorbent washing procedure was clearly 
detectable upon LC-MSIMS analysis. Without allowing the cartridge run dry, the 
sorbent was successively washed with twenty 1 mL portions of the wash solution, 
each of which was collected and individually determined using LC-MSIMS. After 
washing the sorbent with the first 20 mL of wash solution, a further 3 x 10 mL 
washings were performed leading to a total of 50 mL solvent washing altogether. 
The final mL of wash solution was collected and analysed in each of these 
instances. Upon complete sorbent washing, 500 pL of glacial acetic acid were then 
added to the sorbent and allowed to percolate slowly through the packed bed in 
order to aid with drying. In an attempt to ascertain as to whether or not the addition 
of the glacial acetic acid had any effect upon analyte retention, the 500 pL portion 
added was also collected and subsequently determined using LC-MSIMS. 
The ElCs for both the pseudomolecular ion and the MSIMS product ion 
transitions were generated for each of the test analytes in all of the determined 
wash solutions and also the 500 pL addition of glacial acetic acid. However, no 
traces of any analyte were detected in any of the collected wash solution fractions. 
Based upon this finding it was suggested that the sorbent could be washed with 50 
mL of the 10% v/v MeOH in 0.1 M formic acid solution without any significant 
analyte loss. Knowing the minimum volume of wash solvent that could be applied 
to the sorbent bed, the effect of washing upon a real sample matrix, in this case 
river water collected from the River Boyne, near Navan, Co. Meath, Ireland was 
then investigated. Fig. 7.3 depicts the resulting chromatogram for a 200 ng~ - '  spike 
in river water adjusted to pH 6.0. 
From Fig. 7.3 it can clearly be seen that the washing procedure appears to 
be highly effective in removing any retained matrix components as large 
distinguished peaks, corresponding to the MSIMS product ion transitions, can 
easily be detected at a low spiking level in a real sample matrix. It is worth noting 
that the recorded baseline in each EIC is extremely stable and relatively free of 
noise, therefore, it was hoped that high levels of analytical sensitivity could be 
achieved, even when using a moderate sample size of 500 mL. 
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Figure 7.3: Extracted ion chromatograms for a 200 n g ~ '  mixed analyte spike solution prepared in 
river water collected from the River Boyne. Peak identification: 1 Morphine mlz 286 - rnlz 268, TR 
4.1 mins; 2 MDMA rnlz 194 - rnlz 163, TR 8.6 mins; 3 Benzoylecgonine rnlz 290 - m/z 168, TR 9.7 
mins; 4 Ketamine mlz 238 - rnlz 220, TR 10.0 mins; 5 Cocaine rnlz 304 - mlz 182, TR 10.2 mins; 6 
Cocaethylene rnlz 318 - rnlz 196, TR 11.5 mins; 7 LSD mlz 324 - rnlz 223, TR 11.8 mins; 8 EDDP 
m/z 278 - rnlz 249, TR 12.5 mins; 9 Papaverine (Internal Standard) mlz 340 - m/z 202, TR 13.9 
mins; 10 Methadone rnlz 310 - rnlz 265, TR 16.8 mins; 11 Temazepam m/z 301 - rnlz 283, TR 17.9 
mins; 12 Fluoxetine rnlz 301 - rnlz 148, TR 18.3 mins; 13 Diazepam rnlz 285 - rnlz 257, TR 20.0 
mins. 
7.3.5 Method performance: 
Prior to application, the performance characteristics of the developed SPE LC- 
MSIMS method were determined using Boyne river water as a sample matrix. 
Linearity was assessed using seven point curves prepared by extracting mixed 
analyte spike solutions in the region of 0.01 to 1 p g ~ "  (concentrations quoted are 
those prior to extraction). Repeatability was determined by performing six replicate 
injections of a 0.20 pgL-' mixed extract while reproducibility was examined using 
six individually extracted 1 pgL-' mixed analyte solutions. The limits of detection 
and quantitation were defined as signals corresponding to 3 and 100 respectively 
of the baseline noise in each of the extracted MSIMS production ion transition 
traces. The determined performance characteristics are listed in Table 7.6. 
Table 7.6: Method performance data for the developed SPE LC-MSIMS procedure. 
Linearity Repeatability Reproducibility LOD LOQ Recovery 
Analyte 
R~ %RSD %RSD n g ~ '  n g ~ '  YO 
Morphine 0.9951 7.10 4.13 257 856 4 k O  
MDMA 0.9967 4.92 5.22 7 22 52 k 1 
Benzoylecgonine 0.9940 4.53 5.70 1 2 53 + 3 
Ketamine 0.9975 6.44 1.73 1 4 51 f 3 
Cocaine 0.9980 6.64 2.15 1 2 56 + 2 
Cocaethylene 0.9535 6.93 5.79 1 5 65 + 3 
LSD 0.9967 5.29 5.96 3 10 51 k 3  
EDDP 0.9929 6.07 3.69 2 7 59 k 2 
Methadone 0.9771 8.08 2.34 4 14 55 k 0 
Fluoxetine 0.9621 6.19 6.74 93 312 3 3 k 2  
Temazepam 0.9978 7.79 7.21 7 23 59 k 3 
Diazepam 0.9923 7.56 6.95 38 127 55 k 3 
Levels of determined linearity were excellent within the range of 
concentrations extracted, calculated regression coefficients greater than 0.99 
determined were in all cases with the exception of cocaethylene, methadone and 
fluoxetine, although even in these instances regression coefficients greater than 
0.95 were achieved. The upper limit of linearity was set at 1 CIg~-l as it was 
previously reported by Castiglioni et a/. that deviations from linearity were observed 
when similar levels were exceeded when using MSIMS detection [38]. Extraction 
repeatability was determined using a low level spiked standard, 200 n g ~ "  and was 
on average in the range of 5-8% RSD for the six replicate extract injections. 
Reproducibility was determined using a higher spiking level and was in the region 
of 2-6% RSD for the six replicate extractions, both determined levels of precision 
compare well with those of Castiglioni et a/. who achieved levels of precision 4 0 %  
for repeatability and 4% for reproducibility using low rng~- '  level mixed analyte 
solutions prepared in wastewater, however, without any preconcentration [38]. 
Analyte recovery was determined to be in the region of 50-65% for the most 
analytes, although morphine demonstrated insignificant recovery and fluoxetine 
also exhibited relatively low affinity for the strata-xcTM sorbent, both such 
observations were previously noted. Recovery values determined in this study are 
considerably lower than that achieved by Castiglioni et a/. wherein analyte recovery 
in the region of 85-1 12% was achieved for illicit drugs using Waters Oasis MCX'~, a 
mixed reversed-phase cation exchange sorbent similar to the strata-XC" sorbent. 
Although the levels of analyte recovery were low, extraction repeatability denoted 
by the quoted standard deviation values in Table 7.6 were acceptable. The reason 
for the determined low levels of analyte recovery is not clear, although, the use of 
the large volume of wash solvent appears not to be to blame, as no breakthrough 
from the sorbent was determined during the development of the selective washing 
step. 
An unfortunate consequence of the low levels of analyte recovery was a 
possible limitation on the levels of analytical sensitivity attainable during the study. 
However, it should be noted from Table 7.6 that the levels of analytical sensitivity 
obtained are still suitable for the determination of ultra-trace quantities of any illicit 
drug residues that may be present in wastewater and surface waters, even when 
using a moderate sample volume of 500 mL. Detection limits presented in Table 
7.6, calculated as 30 of the peak-to-peak baseline noise in each of the extracted 
ion chromatograms for each analyte MSIMS transition using river water as a 
sample matrix were all found to lie in the low n g ~ '  region. LODs calculated 
compare favourably with those achieved by both Zucatto et a/. and Castiglioni et a/. 
who then successfully determined residues of illicit drugs in treated wastewater and 
surface water in both Italy and Switzerland [35,38]. Again the LODs for morphine 
and fluoxetine are higher than those achieved for other analytes but this is directly 
attributed to their low levels of recovery during the extractive enrichment step. The 
calculated LOD for diazepam was also high. It is thought that this is due to the low 
intensity of the rnlz 257 MSlMS product ion. However, similar sensitivity data was 
obtained when calculated using the EIC for the pseudomolecular ion; mlz 285, 
(LOD: 36 ng~- ' ,  LOQ: 120 ng~ - ' )  and therefore, due to the higher level of specificity 
imparted, it is recommended that the MSlMS product ion would still be used for all 
quantitative purposes. 
7.3.6 Determination of illicit drug residues in wastewater and surface waters: 
The developed analytical method was then applied for the determination of illicit 
drug residues in wastewater treatment plants and their receiving waters in Dublin 
and also in the surrounding counties of Meath and Kildare, both of which have 
experienced large increases in population in the last decade. In Dublin, wastewater 
treatment plants investigated included the Ringsend Wastewater Treatment Works 
which is located at the mouth of the River Liffey on the south side of Dublin Bay 
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and caters for all of the greater Dublin metropolitan area (1.7 million PEq), the 
Swords Wastewater Treatment Works in north County Dublin, which discharges 
into the River Broadmeadow prior to its entry into the Malahide Estuary and the 
Shanganagh Wastewater Treatment Works which is located in south County 
Dublin, which discharges via a sea ouffall 1.6 km offshore from Killiney Beach into 
the lrish Sea. Samples of treated effluent were also collected from Leixlip 
Wastewater Treatment Works in County Kildare which serves the towns of Leixlip, 
Maynooth, Celbridge and Kilcock, from which treated effluent is discharged directly 
into the River Liffey and the Navan Wastewater Treatment Centre in County Meath 
which serves the town of Navan and discharges treated effluent into the River 
Boyne. All of the plants sampled employ both primary and secondary treatment 
using activated sludge with the exception of the Shanganagh Wastewater 
Treatment Works which offers primary screening only prior to discharging the crude 
wastewater into the sea. The Ringsend Wastewater Treatment Works also offers 
tertiary treatment using ultraviolet irradiation, however, tertiary disinfection is only 
employed during the bathing season (May to September) and therefore, samples 
collected were not exposed to UV light [56]. Official weather data for the weekend 
of the 18119'~ November was obtained from The lrish Meteorological Service 
wherein total precipitation at the Dublin Airport monitoring station was 5.3 mm [57]. 
Collected samples were analysed as previously described and levels of analytes 
detected are presented in Table 7.7. 
Table 7.7: Concentrations (ng~- ' )  of illicit drugs detected in collected wastewater and surface water 
samples. 
Concentration Detected. ~na l " l  
a ,  " . Sample 
Morphine Benzoylecgonine Cocaine EDDP Temazepam 
Ringsend Influent - 290 + 1 1  489 k 117 320 + 56 
Ringsend Effluent < LOQ 22 +4 138 f 20 48 f I 126 k 14 
Swords Effluent 874 + 86 - 206 5 10 - 
River - 
- 25+7 - - 
Broadmeadow 
Shanganagh 31 -1 18 77 f 25 - Effluent 
Killiney Beach - - - - 
Leixlip Effluent < LOQ - 47k 10 951 106 k3 
River Liffey 33k11 - - 
Navan Effluent 452 + 86 - 111_+15 67_+10 - 
River Boyne - * * 
From the list of selected analytes only morphine, benzoylecgonine, cocaine, 
EDDP and temazepam were detected in the collected wastewater and surface 
water samples. Morphine was detected in relatively high concentrations in the 
treated effluents of the Swords and Navan wastewater treatment plants. However, 
such levels are more likely to be attributable to medicinal use of morphine and 
related opiates rather than consumption of illicit heroin. Morphine was not detected 
in the influent of the Ringsend Wastewater Treatment Works but was present at a 
detectable level below the LOQ in the corresponding effluent sample. Such an 
observation may occur due to cleavage of glucuronide metabolites of morphine 
during the treatment process [26,38]. 
Benzoylecgonine and cocaine were detected in both the influent and effluent 
samples of the Ringsend Wastewater Treatment Works and also in the grab 
sample collected from the Shanganagh Wastewater Treatment Works. Cocaine 
was also detected at low n g ~ - '  levels in the treated effluent of the Navan and 
Leixlip treatment plants. The presence of cocaine and its primary urinary metabolite 
benzoylecgonine provides a reliable indication of human consumption of cocaine. 
However, unlike previous reports from Zucatto et a/. and Castiglioni et a/. the levels 
of cocaine detected in the present study were higher than those of 
benzoylecgonine [35,38]. Previous pharmacokinetic studies reveal that cocaine is 
readily metabolised into benzoylecgonine and therefore, it was expected that 
higher quantities of benzoylecgonine should be present compared to those of 
cocaine [58]. A reason for the low levels of benzoylecgonine detected may be due 
to higher rates of removal via either degradation or sorption during the treatment 
process compared to cocaine. Based upon the levels of both benzoylecgonine and 
cocaine detected in the influent and effluent of the Ringsend Wastewater 
Treatment Works it is estimated that the removal rates within the plant on the day 
of sampling were 93% and 72% for benzoylecgonine and cocaine, respectively. 
Levels detected compare well with those reported by Castiglioni et a/. when 
analysing the effluents of wastewater treatment plants in Italy and Switzerland [38]. 
Interestingly, cocaine was also detected in the samples (collected near the point of 
discharge) of the River Broadmeadow and the River Liffey. However, the levels 
detected were lower than those detected in the treated effluent samples therefore, 
suggesting dilution within the receiving water. It would be expected that levels 
detected would decrease significantly with increasing distance from the discharge 
point. Such an effect can be seen in the case of the River Boyne wherein the 
sample, in which no illicit drug residues were detected, was collected 
approximately 4 km downstream from the Navan Wastewater Treatment Centre. 
EDDP, the primary metabolite of methadone, was detected in a number of 
effluent samples in low n g ~ - '  concentrations, although methadone was not 
detected in any of the collected samples. The presence of EDDP in the absence of 
methadone is somewhat surprising, Castiglioni et a/. detected EDDP in the 
presence of methadone in a ratio of -2: l  in both treatment plants studied [38]. 
However, EDDP exists as a charged species in solution and would therefore, be 
expected to persist in the aqueous phase during wastewater treatment and be 
detected in the final effluents. 
Temazepam was detected in both the influent and the effluent samples of 
the Ringsend Wastewater Treatment Works and also in the effluent of Leixlip 
Wastewater Treatment Works. Temazepam is a prescribed medication and was 
included in the list of target analytes along with diazepam as both sedatives have 
the potential for abuse. The presence of temazepam in the wastewater samples is 
thought, like morphine, to be a result of medicinal and therapeutic use rather than 
illicit or abused consumption. As was noted for both benzoylecgonine and cocaine, 
the level of temazepam detected in the Ringsend treatment plant decreased from 
influent to effluent suggesting a removal of approximately 60% via either sorption 
or degradation during the passage of temazepam through the treatment works. 
For the purposes of illustration, Fig. 7.4 depicts MSIMS product ion 
chromatograms showing (A) the presence of benzoylecgonine and cocaine in the 
influent and effluent of the Ringsend Wastewater Treatment. The excellent 
retention time reproducibility should also be noted from Fig. 7.4 (A) along with the 
clear reduction of the levels of both substances detected in the effluent sample 
compared to the influent sample. Fig. 7.4 (6) depicts the suspected presence of 
EDDP in the effluent sample collected from the Navan Wastewater Treatment 
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Centre. The term 'suspected' is used only due to the absence of methadone in the 
sample. However, Fig. 7.4 (B) unequivocally shows the presence of trace levels of 
EDDP in the collected sample. 
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Figure 7.4: (A) The presence of n g ~ - '  quantities of benzoylecgonine and cocaine in the influent and 
effluent of the Ringsend Wastewater Treatment Works, key: benzoylecgonine influent; red trace, 
benzoylecgonine effluent; pink trace, cocaine influent; blue trace, cocaine effluent; black trace, and 
(B) the presence of ngL- quantities of EDDP in the treated effluent of the Navan Wastewater 
Treatment Centre. 
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7.3.7 Estimation of community consumption of cocaine from environmental data: 
Having detected levels of illicit drugs, in particular cocaine, in the effluents of the 
examined wastewater treatment plants, an attempt was made to estimate 
consumption of cocaine within the community served by those treatment works. As 
mentioned previously, the presence of morphine and temazepam in treated effluent 
is most likely to be attributed to medicinal and therapeutic use of such compounds 
and therefore, it would be inappropriate to relate such levels to heroin consumption 
or benzodiazepine abuse, respectively. Calculations were not performed on 
measured EDDP concentrations due to the absence of the parent compound 
methadone, and also a lack of available pharmacokinetic information regarding the 
transformation of methadone. 
The approach used in this instance is based upon that of Zucatto et a/. 
however, as previously mentioned, cocaine was found in greater quantities in this 
study than its primary urinary metabolite benzoylecgonine and was therefore used 
for the performance of community consumption calculations rather than 
benzoylecgonine [35]. From the levels of cocaine detected it is possible . . to calculate 
the load of cocaine within the treatment plant on the day in which the sample was 
collected simply by multiplying the analytical data by the flow through the plant, 
such data is presented in Table 7.8. 
However, a further refinement of the data can be performed when 
considering the pharmacokinetic behaviour of cocaine, wherein only approximately 
10% of the parent dose ingested is excreted as cocaine via the urine [59]. 
Therefore, based upon such information, the data in Table 7.8 can be further 
refined as displayed in column 3 of Table 7.8. Even though the calculated cocaine 
loads may seem high, it is thought, that results generated are actually conservative 
when considering consumption of the drug within the community under study as a 
high probability exists that analyte degradation or removal within the treatment 
plant or wastewater transport system may have occurred prior to collection of the 
sample. The cocaine load value quoted for the Ringsend Wastewater Treatment 
Works refers to that determined in the influent sample in order to minimise extra 
variability such as analyte removal during treatment etc. Although the value for the 
Ringsend Wastewater Treatment Works appears high it should be remembered 
that the plant caters for the entire Dublin metropolitan area, (1.7 million PEq) and 
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also the sample corresponds to the weekend, a time in which cocaine consumption 
would be thought to be at a maximum. 
Table 7.8: Cocaine loads within the sampled wastewater treatment plants. 
Cocaine Load Refined Cocaine Load 
Wastewater Treatment Plant 
(9.day-'1 (g.day-') 
Ringsend 224.50 2245.00 
Shanganagh 1.69 16.90 
Leixlio 1.41 14.10 
Navan 1.17 11.70 
From the cocaine load within the plant it is possible to estimate the use of 
cocaine by the population catchments served by the wastewater treatment plants. 
Combining the data from Tables 7.1 and 7.8 the estimated use of cocaine within 
the community is presented in Table 7.9. 
Table 7.9: Estimated community consumption of cocaine within the catchments served by the 
sampled wastewater treatment plants. 
Estimated Cocaine Consumption 
Catchment Per 1000 PEq Per 1000 PEq 
(9 day-') (doses day-') 
Rinasend 1.44 14.38 
The results presented in Table 7.9 compare favourably with those previously 
published by Zucatto et a/. [35]. The dose per day data presented in Table 7.9 were 
calculated based upon information present in [59], which states that one dose 
equals approximately 100 mg cocaine. Zucatto et a/. further refined their data to 
include a positive bias against young adults in the age bracket of 15 to 34 years old 
due to a higher consumption of cocaine by persons within this age bracket when 
compared to the general population. It was hoped to undertake a similar 
transformation in this study. However, official statistics available from The Central 
Statistics Office concerning the population census 2006 are only preliminary in 
nature. It is stated in the opening lines of the available preliminary report that 
record increases in population have been recorded within the four year period 
since the last census in the catchment areas studies, particularly due to the influx 
of young immigrants and therefore, it was felt that it would be incorrect to use the 
data from the previous census conducted in 2002 [60]. 
The levels of cocaine consumption estimated in this approach suggest that 
large quantities of the drug are being consumed within Dublin but it can also be 
said that the problem of cocaine consumption is not wholly confined to the capital 
city but present in smaller towns outside Dublin. The detection of cocaine and its 
urinary metabolite in the wastewater treatment plants adds weight to the 
assumption that the presence of cocaine arises due to human consumption and not 
improper disposal of the narcotic. The problem exists in Ireland that there are 
currently no reliable statistics regarding cocaine consumption to compare the 
generated data against. The developed analytical procedure could be applied for 
the routine monitoring of cocaine consumption within the community in order to 
assess sociologically whether usage trends are stable, thereby indicating regular 
use and possibly addiction within the community or whether trends are sporadic, 
which may indicate whether cocaine lives up to its 'party drug' reputation. It is also 
felt that the developed method and any results generated provide a much more 
reliable snapshot of community consumption of cocaine compared to survey based 
population investigations due to the non invasive sampling employed in the current 
study. 
7.4 Conclusions: 
A suitably sensitive and validated analytical method using SPE LC-MSIMS for the 
determination of residues of illicit drugs in wastewater and surface water has been 
described. Cocaine was detected in samples of wastewater and subsequent 
receiving waters collected from treatment plants in Dublin city and surrounding 
counties. From the environmental analytical data it was possible to estimate 
community consumption of cocaine within the catchment areas of the sampled 
wastewater treatment plants. Estimations of cocaine consumption as doses per 
1000 PEq per day compare well with previously published data from Italian 
researchers. From the estimated consumption data it is concluded that cocaine is 
widely used within the country at present and that such an observation is not solely 
confined to the capital city. The present study provides a precedent in Ireland 
concerning drug consumption within the community and it is therefore, 
recommended that the approach presented here should be used for the continuous 
'real time' monitoring of illicit drug consumption within society by regulatory bodies. 
The method is cheaper and faster to apply than survey based methodologies and 
offers a new prospect to social scientists and those with a key interest in monitoring 
the lrish drug problem. 
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8.0 Overall Conclusions & Future Research Direction. 
8.1 Overall Conclusions: 
In the research presented here, efficient and sensitive methods for the 
determination of pharmaceuticals and illicit drugs residues in environmental 
samples, based upon monolithic silica column technology were developed. In the 
first instance a highly efficient dual gradient LC separation of a selection of 
environmentally relevant pharmaceuticals was developed using a 20 cm 
monolithic CI8 column. It was found that when combined with SPE, detection 
limits were in the sub pgL-' range and the method was applied to the monitoring 
of the selected drugs in a variety of environmental matrices. The use of PDA 
detection imparted a greater degree of selectivity to the developed method 
allowing for the collection of UV spectra at the ultra trace level from which semi- 
qualitative data could be obtained. The method may be particularly useful to 
those who wish to monitor pharmaceutical residues but who do not have access 
to LC-MS instrumentation. 
The second developed method involved the adaptation of the dual 
gradient LC method with the coupling to ESI-MS to increase detection specificity. 
The use of short monolithic columns as online SPE extraction traps was also 
evaluated and it was found that detection limits in the low ngL-' region were 
readily achievable. It was however, noted that excessive matrix magnification 
was a major problem but the incorporation of a simple solvent wash step was 
found to remove the preconcentrated matrix by >80%. A major limitation to the 
use of monolithic silica columns in conjunction with ESI-MS detection was 
encountered as due to the flow mismatch and the need for the incorporation of a 
splitting device. Therefore, ESI-MS could only be used to provide qualitative 
information and could not be used as a quantitative detector. 
Monolithic silica columns were also effectively used for the development of 
an analytical procedure for the determination of the highly toxic antifouling and 
anti-dandruff agent zinc pyrithione in environmental waters. Due to the low silanol 
activity of the high purity monolithic silica stationary phase, easier LC was 
facilitated, wherein previous problems concerning tailing and non specific 
interaction with metal ion contamination were completely avoided. Short 
monolithic columns were successfully employed for the rapid trace enrichment of 
low n g ~ - '  levels of ZnPT from water samples. The inclusion of both a sacrificial 
silica strong anion exchange sorbent prior to the monolithic trap column and a 
solvent wash procedure aided with the minimisation of APCI-MS ion suppression 
by co-extracted matrix components. Using the developed method it was found 
that ZnPT transchelates with cu2' ions to form the more stable CuPT complex in 
the environment. The formed CuPT is rapidly degraded upon exposure to 
sunlight, with and experimentally determined half life of 45 minutes under 
laboratory conditions. It therefore, appears that ZnPT, (as CuPT) does not pose 
an environmental problem provided that the rates of photolytic removal exceed 
the rates of introduction. 
Two methods were then presented concerning non invasive analytical 
procedures for the estimation of illicit drug use within the community. A 
comparison of the efficiency and kinetic behaviour of newly available 3.0 mm i.d. 
monolithic silica reversed-phase columns and sub 2 pm particle packed columns 
was also undertaken and it was observed that the monolithic columns were 
considerably more efficient chromatographic supports with significantly lower 
operating pressures than the sub 2 pm particle packed columns. The first 
approach to estimate drug use within the community focused upon the 
determination of illicit drug contamination of banknotes in general circulation 
using simple sample preparation followed by LC-MSIMS analysis. 45 notes of 
different denominations were collected along with three un-circulated controls. 
Trace levels of cocaine were detected on all of the investigated samples 
accompanied by benzoylecgonine in many instances. Traces of heroin were 
found on three lower denomination notes. Of the levels of cocaine detected, it 
appears that the majority of contamination is thought to result due to transfer 
during counting in financial institutions. Two notes out of the 45 tested showed 
levels significantly high to suggest direct contact with the drug; most likely the 
note was used to snort cocaine. To further refine the estimation, a solid phase 
extraction procedure was developed in order to increase the sensitivity of the 
analytical procedure and samples of wastewater and surface water were 
analysed for the presence of illicit drug residues. In cases where drugs were 
detected, it was possible to apply an adaptation of the approach previously 
presented by Italian researchers for the estimation of cocaine consumption in 
both weight' and doses per 1000 population equivalents. Based upon the 
generated analytical data it was estimated that 14 100 mg doses of cocaine were 
consumed per 1000 population equivalents in the twenty four hour period of the 
collected Ringsend Wastewater Treatment Works composite sample, which 
caters for the entire Dublin metropolitan area. It is thought that the developed 
analytical method should be further applied for the routine monitoring of illicit 
drug consumption within the community by the State and relevant interested 
authorities. 
Interesting data was generated using each of the developed methods. 
With regard to the samples tested, levels of illicit drug residues were detected 
more often than levels of medicinal pharmaceuticals. However, the reason for 
such an observation lies in the matrices tested and also the detection 
mechanisms employed. The methods developed concerning the use of LC- 
MSIMS for the determination of the illicit drug residues highlight the need for both 
the sensitivity and specificity imparted by mass selective detection. The lack of 
analyte detection when using the dual gradient methods is a combination of the 
use of optical detection to determine ultra trace residues in samples wherein high 
dilution of any possible pharmaceutical input is guaranteed, i.e. fast flowing 
rivers. Although not applied to treated wastewater, a level of confidence exists 
that traces of the investigated analytes would indeed have been found as the 
levels of sensitivity attainable with the dual gradient methods is suitable for the 
monitoring of such. 
Another notable conclusion from the research undertaken in the present 
study is that of the unwanted effects of the sample matrix. Co-extraction and 
magnification of the sample matrix presents a limiting problem, especially when 
mass selective detection is employed as problems such as ion suppression are 
readily encountered, thereby adversely affecting sensitivity and detection in 
general. It was also noted that distinct matrix diversity exists across the range of 
samples investigated, with some more problematic than others. A solution 
encountered in the literature is often to develop methods that are matrix specific, 
i.e. one for wastewater, one for surface water, etc. However, such an approach 
increases both the time and cost of the analysis and is therefore, not a feasible 
solution. The need therefore, exists for the development of more specific 
extraction chemistries and procedures. For example, as was previously 
mentioned in Chapter 5.0, the incorporation of a sacrificial anion exchange 
sorbent prior to the reversed-phase trap column radically minimised the matrix 
suppression of the APCI-MS signal. When using polymeric SPE cartridges efforts 
should be focused upon sample washing and clean up, again referring back to 
Chapter 7.0 the effect of a selective washing procedure allowed for almost 
complete removal of the sample matrix with no observed effects on analyte 
recovery or the ESI-MSIMS signal. It is therefore, recommended to those 
developing methods for trace enrichment of organic micro contaminants in 
complex matrices that selective sample clean up will be of paramount importance 
in order to achieve the desired levels of sensitivity. 
The advantages offered by monolithic silica columns, in particular the 
newly available 3.0 mm i.d. column are also worth mentioning again. The high 
purity of the silica substrate and low silanol activity of the functionalised 
stationary phase should be noted, especially for the chromatography of basic 
compounds and as demonstrated in Chapter 5.0 labile compounds such as metal 
ligand complexes. As shown in Chapters 6.0 the primary advantage of monolithic 
silica columns lies within their high inherent porosity and therefore, the ability to 
use longer columns with high chromatographic efficiency. It is hoped that further 
reduction in the 'bore size' of the monoliths and a wider array of stationary phase 
chemistries will soon become commercially available. 
One last question to be posed concerns the detection of pharmaceutically 
active compounds in the environment. It can be suggested that the levels 
detected are so small, they pose no environmental risk or toxicological threat. 
This indeed may be true; it is only with recent advances in analytical chemistry 
that the detection of such residues has become possible, even though the 
introduction of such compounds to the environment has been occurring for years 
previous. Although the presence of many drug residues at low environmental 
concentrations may be harmless, the ability to demonstrate the presence of 
pharmaceutically active compounds in the environment is still important. As 
shown in this research, it affords to opportunity to non invasively monitor 
community behaviour and consumption of drugs and other substances. The 
threat, however, exits in cases where the presence of high potency low dose 
compounds such as anti-neoplastic agents and hormones and therefore, the 
development and application of methods for the determination of such are of high 
importance. With continuing advances in analytical methodologies and 
instrumentation we may soon approach the situation of 'seek and you shall find'. 
8.2 Future Research Direction: 
The following areas have been identified as possibly requiring further research 
and may be of relevance to those undertaking similar studies: 
The development of more specific and selective extraction methods is an area 
which undoubtedly requires increased attention by the analytical community. 
The availability of high performance sorbents such as the hydrophilic lipophilic 
balanced polymers has increased the applicability of SPE. However, as 
discovered in this study, these sorbents also magnify the matrix significantly 
and therefore, the development of complimentary wash steps to selectively 
remove or minimise matrix retention is an area that requires attention. 
The inclusion of metabolites into the analytical methods should also be 
addressed. This will require availability of both information and reference 
standards for pharmaceutical manufacturers. A current limitation in the area is 
the lack of reference standards, especially of pharmaceuticals that are still 
under patent. 
It is felt that the non invasive community consumption approach presented in 
Chapter 7.0 should be routinely applied by the State and relevant authorities 
or interested bodies in order to gather accurate data regarding the use of illicit 
drugs within the community. The method presented is specific and sensitive, a 
further refinement could, however, focus upon the substitution of the 
Phenomenex strata-XC" SPE sorbent used by the Waters Oasis MCX" SPE 
sorbent in order to see if analyte recovery and hence analytical sensitivity can 
be further improved. 
. The behaviour of pharmaceutically active compounds during the wastewater 
treatment process also requires further investigation, particularly the 
adsorption of drug residues to solids and estimations of partitioning behaviour. 
Other environmental processes, such as photo transformation of 
pharmaceutical residues should also be examined, thereby allowing for the 
refinement of analytical methods to include relevant compounds, e.g. 
photoproducts rather than parent compounds etc. 
